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Abstract 
Background and aim: Epidemiological studies on incidence, prevalence, and other 
epidemiological variables of Oman’s treated kidney failure population have been limited, 
and questionable as to their use of rigorous research methods. The main aim of this study 
was to identify the epidemiological variables of treated patients with advanced kidney 
disease in Oman, the status of publishing on the studied population, and describing the 
dialysis sub-population characteristics in the northern region of Oman.  
 
Methods: First, a secondary data analysis was performed using data from the Oman's renal 
replacement therapy (RRT) register (1980-2015). The studied epidemiological variables 
included: incidence, prevalence, death figures, causes of death and treatment costs of the 
Oman’s treated kidney failure population, especially dialysis sub-population.  The 
publications on chronic kidney failure population of Oman were explored at this stage. 
Secondly, a multi-centre, cross-sectional study (i.e. survey research) was conducted 
covering the dialysis sub-population of the northern region of Oman. The basic aim of the 
survey was to assist in developing the first description of the main characteristics (e.g. 
demography, primary diagnoses, and co-morbidities) of dialysis-treated patients with 
advanced kidney disease living the northern region of Oman. A convenience sample (n = 
341) of participants were  recruited from four renal dialysis centres (RDCs). Those who 
met the pre-specified study inclusion criteria were surveyed using a researcher-
administered survey during October and November 2014. SomeFrom December 2014 to 
December 2015, there were some additional data was gathered (e.g. death figures) from 
December 2014 to December 2015. 
 
Results: The first RRT care that started in Oman was peritoneal dialysis (PD) in April 
1980, while the well-structured PD programme started in 1992 and was boosted in 2007. In 
1983, the first dialysis center was opened with seven machines for haemodialysis, serving 
35 patients. By the end of 2015, the Ministry of Health (MOH) had 18 RDCs serving 1,439 
patients on dialysis per annum for Oman’s population. The analysis of the RRT register's 
data showed that the mean prevalence for all years (1983-2015) was 724.9 dialysis patients 
per year. The mean incidence for the same years was 203.7 kidney failure patients per year. 
The mean death rate calculated for all years (1983-2015) was 58 deaths per year. The 
recorded causes of death were cardiovascular diseases, and infection. Over the years, it was 
described that death due to infections and cardiovascular diseases were increasing among 
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the RRT population and particularly within dialysis cohort. The cost of the dialysis 
sessions increased dramatically from 2,246,627 OMR (~ 4.5 million GBP) in 1998 to 
9,543,572 OMR (~20 million GBP) in 2015, which is a 325% increase. Among the 
databases searched, there were 44 articles, which either focused on, or mentioned Oman’s 
chronic kidney failure population.  Most of these articles focused on kidney transplantation 
and were of limited and questionable methodologies. 
 
In the multi-centre cross-sectional study, the northern region of Oman was divided into two 
subdivisions. The average age of this population was 51.7 ± 15.8 (mean ± SD) with no 
statistical evidence of difference between the subdivisions of the northern region of Oman 
(P = 0.177). There were more males (n = 187 = 54.8%) than females (n = 154 = 45.2%), 
with no significant difference between subdivisions (P = 0.598). It was described that the 
divorce frequency was low in this population (n = 22 = 6.4%), with no significant 
difference between subdivisions (P = 0.49), but unemployment was high (n = 292 = 
85.9%), showing no significant difference between subdivisions (P = 0.537). Nearly half 
of this population were illiterate (n = 164 = 48.1%), with more  illiterate females (n = 
103= 66.9%) compared to males (n = 61= 32.6%), and no significant difference between 
subdivisions (P = 0.174). Nearly half of the participants had been on dialysis for five years 
at the time of data collection (n = 165 = 48.4%).  The most common co-morbidities 
reported by these participants were hypertension and diabetes combined (n = 156 = 
32.4%). The main reported causes of death shown by the data gathered were cardiovascular 
diseases (n = 41 = 41.5%) and infection (n = 10 = 10.2%). More than half of the 
participants were hoping to have kidney transplantations as soon as possible (n = 173 = 
50.7%). 
Conclusion: This study is a comprehensive description of the Oman’s RRT epidemiology. 
The data showed a significant increase in the incidence and prevalence of treated chronic 
kidney failure in Oman. It showed the increase in the cost of dialysis  in Oman for the past 
17 years (1998-2015), which is in line with the recent publications  from Oman (Al-Alawi 
et al., 2017; Al-Ismaili et al., 2016) and is in line with  global findings. This research’s 
results have contributed to providing a deeper understanding of the Oman’s treated chronic 
kidney failure population. It appears that there is a heavy burden borne by the country, the 
health sector and the patients on dialysis because of the complex nature of  life-long 
treatment.  Oman’s publications on this health problem were limited. Therefore, it is 
necessary to conduct additional research with rigorous methods to obtain a complete 
picture of this health problem in Oman. 
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Preface 
To put one self in the shoes of a kidney failure patient is a difficult feeling to live with or 
tolerate for even a short time. The kidney failure patient, especially on dialysis, has a 
mixed feeling of pain, anger, and frustration. These patients are due the greatest sympathy. 
They live their daily life in the trap of their dialysis sessions and their disease 
complications.  
 
 These patients expect death at any time, but some of them still have  space for hope. So  
how can we provide hope for these patients? As I am an academic fellow, I believe hope 
can come from investment in research. Researchers need to find ways to make spare 
healthy kidneys available for patients who are eligible for kidney transplantation and for 
the ineligible patients they need to find alternatives to replace traditional dialysis 
treatments. The proposed future treatment should offer patients more freedom in life, less 
pain, and overall a life of better quality and happiness. Also, programs of prevention, 
screenings, and awareness of kidney disease should be increased among the public and 
communities as soon as possible. I believe that researchers around the world can 
collaborate to achieve these goals because the campaign to fight kidney disease is very 
active at present, especially in the western world. 
 
As a researcher from the eastern part of the world, I believe that my role is to constantly 
contribute to the body of research regarding kidney disease and other research issues. 
Therefore I have attempted to critically describe the status of knowledge regarding chronic 
kidney failure in Oman, and I have found that kidney failure treatments, especially dialysis, 
drain a significant amount of the health sector budget. The disease is flourishing, but there 
is no precise data on it, as there is no formal national renal registry at present in Oman. In 
this thesis, I have tried to gather data on the treated chronic kidney failure population in 
Oman. It has been a hard journey, full of challenges and mysteries at some points. 
Research is not an easy task to undertake; it is always a learning opportunity even for 
experts, and more so for beginners like me.  
 
The flow of this thesis is through eleven chapters.  It starts with introduction and literature 
review, continues with some background about Oman, followed by the methods and 
materials, the results, the discussions, and finally the conclusion.. The main intention of 
this thesis is to provide the kidney disease research community with the database necessary 
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to explore the treated chronic kidney failure population in Oman, and thereafter help to 
map the route for future kidney disease research. To the best of my knowledge, this is the 
first step ever under taken in this regard, in this context, I hope the data provided in this 
thesis are communicated well, to convince policy makers to adopt the recommendations 
given at the end of this thesis. I hope this thesis is worthwhile and would provide much 
needed knowledge in this area. 
 
Ruqiya Al-Za’abi 
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GNI…………………………………………………………………. Gross National Income 
HD………………………………………………………………………….....haemodialysis  
HRQoL…………………………………………………………health related quality of life 
HTN………………………………………………………………………….....hypertension 
IBM SPSS……………………………………………statistical package for social sciences 
IF……………………………………………………………………………... Impact Factor  
IMRaD……………. Introduction, Methods and Materials, Results, abstract and Discussion 
IQR…………………………………………………………………….. ...interquartile range  
J-RBR………………………………………………………..Japan Kidney Biopsy Registry  
J-KDR……………………………………………………… Japan Kidney Disease Registry 
KDIGO………………………………………Kidney Disease/Improving Global Outcomes 
JVC…………………………………………………………jugular venous cannula/catheter   
KDOQI ……………………………………….Kidney Disease Outcomes Quality Initiative  
KDQOL…………………………………………………..kidney disease and quality of life 
KF……………………………………………………………………………. kidney failure  
KSA……………………………………………………………... Kingdom of Saudi Arabia 
M…………………………………………………………………………………………………..mean 
ME………………………………………………………………………………Middle East  
Med…………………………………………………………………………………. median 
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Max………………………………………………………………………………. maximum 
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MOH……………………………………………………………………...Ministry of Health 
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QoL…………………………………………………………………………….quality of life   
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UK………………………………………………………………………….United Kingdom  
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UN…………………………………………………………………………....United Nations 
USA……………………………………………………………….United States of America 
USRDS………………………………………………The United States Renal Data System 
WHO…………………………………………………………….World Health Organisation 
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Glossary 
Arab World: “Arab is a cultural and linguistic term. It refers to those who speak Arabic as 
their first language. Arabs are united by culture and by history. Arabs are not a race. 
Some have blue eyes and red hair; others are dark skinned; many are somewhere in 
between. Most Arabs are Muslims, but there are also millions of Christian Arabs and 
thousands of Jewish Arabs, just as there are Muslim, Christian, and Jewish Americans. 
The Arab World consists of 22 countries in the Middle East and North Africa: Algeria, 
Bahrain, the Comoros Islands, Djibouti, Egypt, Iraq, Jordan, Kuwait, Lebanon, Libya, 
Morocco, Mauritania, Oman, Palestine, Qatar, Saudi Arabia, Somalia, Sudan, Syria, 
Tunisia, the United Arab Emirates, and Yemen. Iran and Turkey are not Arab 
countries, and their primary languages are Farsi and Turkish respectively. Arab 
countries have a rich diversity of ethnic, linguistic, and religious communities. These 
include Kurds, Armenians, Berbers and others. There are over 300 million Arabs” 
(American-Arab Anti-Discrimination Committee, 2009). 
 
BEINGS: “can serve as a mnemonic device for major categories of risk factors for disease, 
some of which are easier to change or eliminate than other. BEINGS stand for biologic 
and behavioural factors, environmental factors, immunologic factors, nutritional 
factors, and services, social, and spiritual factors” (Katz et al, 2014). 
 
ME countries: Middle East countries, composed of 16 countries which are as follows: 
Egypt, Iran, Turkey, Iraq, Saudi Arabia, Yemen, Syria, UAE, Jordan, Lebanon, Oman, 
Kuwait, Qatar, Bahrain, and Palestine (Wikipedia the free encyclopaedia, 2017).  
 
SSA countries: Sub-Saharan Countries which include Benin, Botswana, Burkina Faso, 
Burundi, Cameroon, Cape Verde, Central African Republic, Chad, Comoros, Congo, 
Cote D’Ivoire, Djibouti, Equatorial Guinea, Eritrea, Ethiopia, Gabon, The Gambia, 
Ghana, Guinea, Guinea-Bissau, Kenya, Lesotho, Liberia, Madagascar, Malawi, Mali, 
Mauritania, Mauritius, Mozambique, Namibia, Niger, Nigeria, Reunion, Rwanda, Sao 
Tome and Principe, Senegal, Seychelles, Sierra, Leone, Somalia, South Africa, Sudan, 
Swaziland, Tanzania, Togo, Uganda, Western Sahara, Zamia and Zimbabwe (The 
library of Congress, 2010). 
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1.1 Introduction 
1.2 Overview 
Worldwide, the rates and burden of chronic diseases or non-communicable diseases 
(NCDs) are rising due to the ageing population and the increased prevalence of diabetes, 
hypertension and obesity (Farag et al., 2012; Thomas et al., 2015; Hill et al., 2016). Out of 
57 million deaths worldwide, 63% were due to NCDs in 2008 and increased to 65%  in 
2010 (Perico and Remuzzi, 2012; Lozano et al., 2013). As a result, the United Nations 
(UN) initiated a programme to reduce the premature mortality secondary to NCDs by 25% 
by 2025 (World Health Organisation – WHO, 2014; United Nations – UN, 2014). 
 
Kidney failure is a chronic disease that is not yet included in the UN initiative, but 
diabetes, which is a major cause of kidney failure is included. Also chronic kidney disease 
is becoming a health priority in many agendas of health care systems across the world. The 
global evidence shows the increasing incidence and prevalence of treated kidney failure 
patients, who need kidney dialysis or kidney transplantation, with poor outcomes, 
increased cost and increased health burden (Couser et al., 2011; Hill et al., 2016). In the 
UK, around three million people have kidney disease, 60 thousand people die prematurely 
because of chronic kidney disease every year, and there are 64 thousand people with 
kidney failure undergoing treatment   (Kidney Research UK, 2013). Worldwide, 
maintenance dialysis treatment has dramatically increased 1.7 times from 165 per million 
population (pmp) in 1990 to 284 pmp in 2010 (Thomas et al., 2015). Although patients 
who need dialysis or transplantation are only 1-2% of the Chronic Kidney Disease (CKD) 
population, the cost for this 1-2% is considerably high, where it can reach 5% of the annual 
budgets of  national health services  (Kidney Disease/Improving Global Outcomes – 
KDIGO, 2013; National Institute for Health and Care Excellence – NICE, 2015). In the 
USA, the cost of treating kidney failure increased from $30.4 billion (£23.4 billion) in 
2012 to $30.9 billion (£23.8 billion) in 2013 and accounted for 7.1% of total Medicare 
spending (National Institute of Diabetes and Digestive and Kidney Diseases, 2016). In 
Saudi Arabia, the annual cost was 800 million Saudi Rials (£162 million) per year for 
14,562 treated kidney failure patients in 2012 (Saudi Center for Organ Transplantation – 
SCOT, 2013). 
 
Chronic kidney failure is a life-threatening disease where the majority of patients have to 
undergo dialysis treatment for the rest of their lives. Dialysis treatment is associated with 
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high rates of mortality and morbidity, with patients frequently experiencing infection and 
hospitalisation (Lafrance et al., 2014). For example, treated patients with advanced kidney 
disease in the USA experienced hospitalisation twice a year on average, and an average of 
one unplanned rehospitalization for about 30% of this population within the 30 days 
following their discharge (United States Renal Data System – USRDS, 2015). In the UK 
renal dialysis population, the Methicillin Sensitive Staphylococcus Aureus (MSSA) 
bacteraemia infection reached a rate of 1.59 per 100 dialysis patient from 1
st 
May 2012 to 
30
th April 2013 which leads to patients’ hospitalisation (United Kingdom Renal Registry- 
UKRR, 2014). 
 
Mortality rates in dialysis populations are ten times higher compared with people of a 
similar age without kidney disease (United States Renal Data System – USRDS, 2013). For 
example, three years after starting dialysis in 2006, only 52% of haemodialysis patients and 
61% of peritoneal dialysis patients remained alive in the USA (United States Renal Data 
System – USRDS, 2013). Also, the patient with chronic kidney failure has to cope with 
many major stressors in their lives, including first their diagnosis with kidney failure and 
ending with symptoms like itching and lack of energy, limited food and fluid intake, and 
psychosocial stressors such as impaired self-esteem and feeling uncertain about the future 
(Murphy, 2014). 
 
Also, renal care providers experience major stressors while treating CKD and especially 
while treating dialysis patients as these patients undergo prolonged dialysis treatments. 
Renal care providers continuously try to improve survival rates and the quality of this 
treatment, or attempt to improve the dialysis outcomes by, for example, increasing dialysis 
frequency and duration which at the end lead to increasing their load of work (Kidney 
Disease/Improving Global Outcomes – KDIGO, 2015). The advancement in kidney failure 
care management and technologies (especially dialysis), the increasing prevalence of 
kidney failure leading to increasing workload, and the complexity of caring for such a 
demanding condition, place a greater burden (i.e. physical and emotional) on renal nurses 
particularly, because nurses have more contact with these patients on a daily basis 
compared to other renal care providers, such as nephrologists, nutritionists, psychologists, 
and social workers (Thomas, 2014, p.xi). Renal nurses and other renal care providers have 
to keep up-to-date with new technologies of kidney failure treatment, with the best 
guidelines and management strategies for kidney failure patients, with the latest 
epidemiological profiles, and with the best evidence-based practices in renal care to 
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provide optimal care for their patients (Thomas, 2014, p.xi). Renal nurses especially have 
to adapt to an increasing workload as a result of the increasing prevalence and incidence of 
kidney failure globally. In general, renal care providers and renal nurses particularly are 
challenged on a daily basis by the physical and psychosocial needs (e.g. some patients face 
depression, anxiety and poor coping mechanisms) of their kidney failure patients and their 
patients’ families (Thomas, 2014, p.xi). 
 
In some parts of the world, for example Europe, there is an extensive database on some 
aspects of kidney failure, such as the epidemiology, and the characteristics of the treated 
kidney failure population in Europe. These data are collected and archived by the renal 
registry called the European Kidney Association - European Dialysis and Transplant 
Associaton (ERA-EDTA) and published on an annual basis. The ERA-EDTA is a pioneer 
in retrieving data for kidney diseases and kidney failure from 1964 until the present 
(Davids et al., 2016). On the other hand, there are parts of the world that do not have a 
well-formed renal data resource or specialised renal data source for kidney failure 
population. For example China, which has around 20% of the world’s population, does not 
have a national renal registry yet, but it does have Chinese Society of Nephrology which 
cover a broader spectrum of renal aspects (Yao et al., 2009; Liu, 2015).  So this imbalance 
in data availability and data production between the west and the east parts of the world 
make the picture of chronic kidney failure incomplete. It is determined that the eastern part 
of the world, which includes the developing countries such as the Middle East (ME) and 
Arab world (see Glossary, p.18), has to work harder to provide the world with accurate 
statistics and findings for chronic kidney failure. Access to this information will help the 
world first to assess the real situation regarding kidney diseases across the board, and then 
to plan ahead to prevent deeper and more complicated outcomes of this critical disease 
globally.  
 
1.3  Kidney failure 
Kidney failure and renal replacement therapy (RRT) are the key concepts of this project.  
The only treatment for kidney failure is RRT, which means kidney transplantation or 
dialysis, and if not, then a conservative treatment should be followed by patient. The data 
available on the use of conservative treatment is limited (Chandna et al., 2010; Teruel et 
al., 2015). A study by Teruel et al., 2015, assessed the frequency of conservative treatment 
among chronic kidney failure patient from 1
st
 July 2013 to 30
th
 June 2014, and found that, 
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out of 232 patients with kidney failure, about 39% received conservative therapy. The 
major factors associated with selecting conservative therapy were age, co-morbidity, and 
functional disability. Another single-centre cohort study conducted in the UK (Carson et 
al., 2009) concluded that patients (n=29 = 14%, chose conservative therapy from the 202 
elderly patients involved) who follow maximum conservative therapy, can achieve a 
similar number of hospital-free days and can survive a considerable length of time 
comparable to haemodialysis patients. The generalizability of the evidence from these two 
studies is limited due to their small sample size and the unavailability of further evidence 
to compare with. This area is generally underexplored.  
Kidney transplantation as the optimal treatment for kidney failure is faced with major 
challenges, such as shortage of kidney donors and religious or cultural beliefs, which 
restrain the process of kidney donation. In the UK there are no major objections to organ 
donation and transplantation from religious groups (Dunsmore, 2014). However, there are 
groups such as the Jehovah’s Witnesses who allow organ donation and transplantation only 
if Jehovah's Witnesses religious leadership approve it (Dunsmore, 2014). For a long time, 
Muslims have thought that organ donation was not allowed in Islam. However, the fatwa 
(i.e. decision) from the Muslim Law Council allows for organ donations and 
transplantations as long as the process causes no harm to either donor or recipient 
(Dunsmore, 2014). However, the concept of “doing good while doing no harm” still 
encompasses an ethical dilemma for some stakeholders around the world and can cause 
delay or objection to organ donation (Beauchamp and Childress, 2013; Dunsmore, 2014).  
 
Dialysis is the second sub-optimal treatment for kidney failure. This treatment has its own 
areas of controversy. There is an on-going debate on whether convective dialysis (see 
Glossary, p.18) is preferred over traditional haemodialysis (Nistor et al., 2015). This 
evidence was evaluated by two reviews conducted by the Cochrane Collaboration and 
published in the Cochrane Library. The first Cochrane review was conducted in 2006, and 
after reviewing 20 studies, including 667 patients, the review found insufficient evidence 
supporting convective dialysis over traditional haemodialysis (Rabindranath et al., 2006). 
The second systematic review was in 2015 and included 40 studies with 3,483 patients. It 
concluded that convective dialysis may reduce cardiovascular mortality, but the evidence 
produced by the included studies was not reliable due to serious limitations in study 
methodologies. Therefore, this area still needs further scientific testing and reliable 
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assessment to prove that convection dialysis can give better outcomes over traditional 
haemodialysis (Nistor et al., 2015). 
 
The patient on haemodialysis has to regularly undergo at least four hours of haemodialysis 
three times a week (Murphy, 2014; Kidney Disease/Improving Global Outcomes – 
KDIGO,  2015). It is quite impossible for a dialysis machine to achieve similar results to 
that of a normal kidney within twelve hours of dialysis per week (i.e. dialysis dose); this 
regimen, in fact, provides less than 10% efficiency compared to normal functioning 
kidneys (Zhu et al., 2012). This could be the main reason behind the high rates of mortality 
and morbidity among dialysis patients across the world compared to the normal population.  
Even if compared with a kidney transplant, the dialysis patient’s mortality rate is five times 
higher (Zhu et al., 2012; United States Renal Data System – USRDS, 2015). 
 
In general, patients on dialysis can choose between home or in-centre haemodialysis. 
However, an on-going debate suggests that there are some described benefits of home 
haemodialysis over in-centre haemodialysis, such as high survival rate, less hospitalisation 
frequency and overall better quality of life (Palmer et al., 2014). The evidence supporting 
home dialysis over in-centre dialysis is limited as evidenced by the following systematic 
reviews.  A Cochrane review reported that there were numerous observational studies on 
home haemodialysis, which showed that the described patients had a better quality of life 
and improved survival rate (Palmer et al., 2014). The same review, found there was only 
one randomised control trial (RCT) testing the same aspect and it included only nine 
patients, which implies the limited generalizability of this study’s results (Palmer et al., 
2014). In general, the randomisation feature and the comparison between the treatment 
cohort and the control cohort may reduce the research methodological defects such as 
having younger or fewer health problems in one of the cohorts. Also, the pre-specified 
outcomes that are measured by any RCT allow for more objective comparison and more 
reliable analysis. This suggests that the evidence available for home dialysis is not yet 
reliable until more randomised control trials are conducted to measure the benefits of 
adequate home haemodialysis over the traditional in-centre haemodialysis (Palmer et al., 
2014). 
 
Regular and prolonged haemodialysis requires long-term vascular access. The ideal 
choices are arteriovenous fistulae (AVF) and arteriovenous grafts (AVG). The least 
favoured option is central venous catheters (CVC) because CVC are at high risk of 
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complications such as bleeding and infection (Fluck and Kumwenda, 2011). Arteriovenous 
fistulae and arteriovenous grafts are recommended for patients on haemodialysis because 
of their better outcomes, such as long-term patency, improved flow rates and fewer 
described complications (Challinor, 2014). However, vascular access creation needs early 
planning and preparation, and needs an expert surgical team to handle the procedure 
(Murphy, 2011). The standard procedure is to plan for vascular access creation when the 
patient reaches CKD stage four (usually 3-4 months before initiating dialysis), so that 
access will be ready by the time the patient needs haemodialysis (Fluck and Kumwenda, 
2011).  
 
Peritoneal dialysis is less costly than haemodialysis because it does not require expensive 
equipment, machines and specialised staff and technicians to handle the procedure 
(Karopadi et al., 2013).  One of the major challenges of peritoneal dialysis is the need for 
an individualised treatment plan that considers the clinical and lifestyle needs of each 
patient, such as the appropriate peritoneal dialysis modality and dose, and the special diets 
the patient must follow. There is an agreement across the literature on the cost-
effectiveness of peritoneal dialysis compared to haemodialysis, but despite the vast studies 
investigating the cost effectiveness of peritoneal dialysis, the systematic reviews on this 
aspect are rare (Main, 2014). Only two systematic reviews weighing the evidence on 
peritoneal dialysis cost effectiveness were identified by author. First one is a bit of old date 
which is  Cochrane systematic review conducted by Vale et al. (2004) concluded that there 
is insufficient data coming from robust RCTs and well-designed observational studies on 
comparing the effectiveness of peritoneal dialysis (CAPD or APD – see Glossary, p.18) to 
the different haemodialysis modalities (Vale et al., 2004). The second systematic review  
and meta-analysis study included 13 publications up to August 2013, from Europe, the 
USA, Asia and Canada, concluded that over a five-year horizon, peritoneal dialysis is 
significantly more cost effective compared to haemodialysis treatment (Pike et al., 2017).  
However this conclusion was based on studies that had high risk of bias and their 
evidences appraised as low to very low quality which indicate that the evidence supporting 
the cost effectiveness of peritoneal dialysis is yet need further investigations and support. 
 
There is sufficient literature reporting the primary causes of kidney failure as respectively, 
diabetes, hypertension and vascular diseases, and risk factors such as gender, ethnicity and 
obesity. Also, the cause of kidney failure in many instances was reported as ‘unknown’. 
This area of understanding the cause-and-effect relationship is complex for all diseases, 
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and kidney failure is no exception. However, the evidence available on the increasing 
epidemic of this serious disease, on the high cost and hardship of kidney failure treatments, 
and on the high mortality rates, all add urgency  to study this disease further from its all 
aspects. 
 
1.4 Conclusion 
The previous two sections (i.e. 1.1 and 1.2) were helpful in understanding the topic of 
kidney failure, its treatments and its significance as an irreversible chronic disease that 
affects many people across the world. However, further review of the literature was needed 
to explore the epidemiology of renal replacement therapy in Oman, and of the international 
picture, and also to explore the international state of the quality of life of people with 
advanced kidney disease. Also, the literature review helps to identify the major data 
sources of treated people with advanced kidney disease, like renal registries and helps to 
identify potential areas for research and similar research studies that have been conducted. 
Therefore, the following chapter is dedicated to exploring these concepts. 
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2 Published reports used to obtain data on the 
epidemiology of RRT  
2.1 Published reports used to obtain data on the 
epidemiology of RRT of Oman  
2.1.1 Search strategy (initial stage) 
 
This task accomplished in late 2013 and early 2014 via searching different databases such 
as EBSCOhost, Ovid MEDLINE, Web of Science, PubMed, Medscape, and University of 
Sultan Qaboos Library Website (Oman database). There were few studies matching the 
inclusion criteria that found in Ovid MEDLINE, Web of Science, PubMed, Medscape, and 
University of Sultan Qaboos Library Website. The inclusion criteria were mainly; the 
subject has to have kidney failure; the context should be Oman; and the scope is 
epidemiology. The exclusions were any articles that did not fit with the inclusion criteria or 
were duplicated. There was no single article identified on the epidemiology of kidney 
failure while searching Sultan Qaboos Library. On the other hand, the most retrieved 
articles were identified by EBSCOhost search engine accessed via the University of 
Glasgow library link. Therefore EBSCOhost searched strategy will be described here in 
some detail. First of all, the search terminologies used were “nephrology in Oman”; “renal 
failure in Oman”; “ESRD in Oman”; “Nephrology AND in Oman”; “ESRD AND Oman”;  
“kidney failure AND in Oman”; the larger volume of retrieved studies were gathered by 
using the search term “renal or kidney failure AND Oman”. The words epidemiology, 
incidence or prevalence was not added to the search terminologies at this stage to avoid 
narrowing down the search and therefore avoid missing any study that mentioned kidney 
failure in Oman, but failed to include epidemiology, incidence or prevalence terms putting 
in mind that retrieved articles will be screened for eligibility later on. The search options 
selected were all the ones on the default search screen of EBSCOhost without restrictions 
except “published date” was limited from January 1980 to December 2013 because 
nephrology started in Oman in 1980s. The first dated study paper the search engine was 
able to find was for the year 1988. Also the search was limited to English language only 
because English is the main medium of publishing health subject articles in Oman. The 
search engine picked 145 studies; after screening only two studies mention Oman’s kidney 
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failure epidemiology (Figure  2-1). Also one more study was found by using Google 
scholar search. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure ‎2-1 Flow diagram for selection of studies 
After reviewing these reports, there were only three articles (i.e. Al-Marhuby, 1998; 
Abboud, 2006; Hassanien et al., 2012) which have focussed on the Oman’s treated kidney 
failure epidemiological data. At this point, the conclusion was that the published 
knowledge coming from Oman about kidney failure was limited. Also this conclusion was 
confirmed by Dr.Omar Abboud, the author of the above mentioned 2006 article (see 
appendix B-5 on p. 251). However, this conclusion was handled with caution because at 
this stage the grey literature of Oman (e.g. unpublished MOH reports or studies) was not 
145 papers identified through 
database search 
4 duplicated removed 
 
104 excluded, subject 
was not kidney failure 
epidemiology 
7 excluded, context was 
not Oman 
28 excluded, sample was 
animals 
1 paper retrieved from 
Google scholar database 
3 papers included at 
this initial stage about 
“Oman’s kidney failure 
epidemiology” 
2 study papers 
included 
141 papers screened 
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accessible to the author. The author has to be physically present in Oman to get access to 
the unpublished data and sometimes the national published data. Access can be obtained 
only after getting the ethical approval from the MOH of Oman. Therefore there was 
intensive hand and online search conducted later in 2014 for the grey literature while the 
author was in Oman and also a follow-up online search while back to the University of 
Glasgow. As all the intensive literature searching was conducted in 2014, the search 
deadline was always limited to the end of 2013.  
 
 
2.1.2 The search strategy (intensive stage) 
The published and unpublished reports used to obtain data on the epidemiology of RRT of 
Oman was mostly gathered by this search method. This search was conducted during the 
data collection stage, however, it is detailed here so all literature review on this aspect is 
complied together in one section to avoid confusion. This stage was launched by getting 
the ethical approval letter of Oman’s MOH so access to published and unpublished 
materials is gained. The ethical approval letter was handed to the nephrologist in charge of 
the central RDC in the capital of Oman and the heads of the other four RDCs (i.e. data 
collection locations) in the northern region of Oman. The requested data were any 
publications on Oman’s kidney failure epidemiology. Only one single study was retrieved 
from the nephrologest incharge of the central RDC (i.e. WHO study (EMRO SPLT 
GRANT – TSA 03/23) –  research proposal on “frequency of diagnosed  hypertension, 
proteinuria,  haematuria,  urinary tract infection impaired kidney function and their 
geographical distribution amongst different age group of individuals in Sultanate of 
Oman.” This study was published on the national level of Oman and its subject is not 
entirely on kidney failure epidemiology. 
 
Moreover another step was taken to find more grey literature on Oman's kidney failure 
epidemiology. The author visited the medical library of the Sultan Qaboos University in 
the capital and inspected the national and local publications and records relevant to the 
subject Oman’s kidney failure, by doing hand search through the Oman Medical Journal 
(OMJ), the main scientific journal publishing medical and healthcare research in Oman. 
All the OMJ issues (found available in the SQU-medical library) were searched by hand 
and there were 15 potential reports retrieved. Thereafter, all the relevant reports found 
related to kidney failure in Oman were extracted, copied and compiled for further 
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screening and reviewing (i.e. 15 reports – sample of these reports are under appendix E-2, 
p.267). One additional report was referred to by a colleague, and its abstract was 
successfully retrieved by the SQU librarian and sent to the author. Also, the annual health 
records of the MOH of Oman were manually inspected when they were not available 
electronically. This annual record was very helpful in tracking the prevalence of dialysis 
patients since 1998 (first published annual report found by the author) until 2015 (the last 
published record until the last point of inspection of this research– sample of the section 
relevant to kidney dialysis in the MOH health annual report is under appendix E-1, p.266).  
 
Further online searching followed this stage and this time with a librarian consultation. As 
a result considerable numbers of publications, which potentially covered Oman's kidney 
failure subject, were gathered via the online search facility of the University of Glasgow 
Library. Hence this search was critical and vital for this study; the search strategy is 
illustrated in the following. 
 
After some consultations with the librarian of the UoG (nursing school), it was suggested 
that searching the databases of MEDLINE, Web of Science, and Cochrane library might 
give similar or even less search results to an Ovid Embase search and that was the 
conclusion arrived after some trials on searching these databases. The OVID Embase was 
more comprehensive and gave more results even when compared to EBSCOhost database. 
Therefore the OVID Embase search strategy is illustrated here in some details.  
 
The OVID Embase ‘1947-present, updated daily’ option was selected. The search 
terminologies were classified as themes to ensure the best filtration process for the required 
articles. The major themes and terminologies are illustrated in Table  2-1. The 
terminologies under the three themes were searched separately, then the similar themes’ 
terminologies were combined using OR, and lastly the three different themes search were 
combined using AND. Some search limitations were added such as a date limit from 
January 1980 to December 2013 because nephrology started in Oman in 1980 and the 
study search target deadline was the end of 2013. Also, the search was limited to English 
language only because it is the main medium for publishing health topics in the scientific 
journals in Oman. After all searches had been completed on OVID Embase, 1000 articles 
were identified.  
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Table ‎2-1 The main themes and terminologies used to search OVID Embase database 
Theme One: Population 
(terms) 
Theme Two: Intervention 
(terms) 
Theme Three: Condition 
(terms) 
(Oman or Gulf Cooperative 
Country or GCC or Arab*) 
adj2 (World or countr*) or 
Middle East Countr* or 
(developing or 
underdevelop*) or Sahel or 
Third World Countr* 
(kidney or renal) adj2 (dialysis 
or support or hemodial*) adj2 
(therap* or treatment) 
 
(kidney or renal) adj2 
(transplant* or replacement) adj2 
(therap* or treatment) 
(end or terminal or final or 
chronic) adj2 (kidney or 
renal) adj2 (disease* or 
failure or dysfunction or 
impairment or insufficien*) 
 
The articles identified from other databases like EBSCOhost were 257 articles. Also, the 
Cochrane library by subject (kidney) was searched, and 38 articles and reviews were 
identified. Also, Enlighten of University of Glasgow, was searched to retrieve theses, and 
there were 33 potential relevant theses, however after scrutinizing these 33 theses, none 
were found relevant to this study. ProQuest database was searched, and there were 321 
theses were identified, but after scrutinizing none of them were about the epidemiology of 
kidney failure in Oman (Figure  2-2).  Noticeably, on ProQuest database, there were two 
theses identified for Oman, but neither of them was about kidney failure or RRT; one 
thesis focused on cardiomyopathy (2006), and the other were about diabetes self-
management (2013).  
 
As a result, there were 1666 potentially relevant references. These were initially retrieved 
from all searched databases and sources (Figure  2-2). At the end of this phase, there were 
44 articles identified as relevant (Figure  2-2).  
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Figure ‎2-2 Filtration process of literature of kidney failure or RRT in Oman 
Among the databases searched, there were 44 articles published until the end of 2013, 
which focused on or mentioned Oman’s RRT population. However, the epidemiology of 
kidney failure was the full focus of two studies (4.5%) only (Woods and Prabhakar, 1985; 
Al-Marhuby, 1998 – see appendix F, p.269) which are both older studies. There were five 
(11.4%) other studies which mentioned epidemiology of kidney diseases in Oman briefly 
(Al-Dhahry et al., 1993; Al-Dhahry et al., 1994; Abboud, 2006; Alashek et al., 2012; 
Hassanein et al., 2012). Kidney transplantation was the most popular researched topic for 
1649 articles retrieved by 
literature online search: 
 
OVID Embase = 1000 
EBSCOhost     = 257 
Cochrane         = 38 
ProQuest          = 321 
Enlighten         = 33 
 
17 articles found by hand 
searching: 
OMJ                  = 15  
SQU librarian   = 1 
Central RDC    = 1 
 
1155 articles selected for 
title/ abstract screening 
1034 excluded: 
Search duplication 
Population was not 
Omani 
KF or CKD was not the 
subject 
121 articles selected for full 
text review 
44 articles included 
511 articles 
excluded 
initially 
77 excluded: 
Population were not 
Omani RRT patients 
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RRT population of Oman, as more than one third of the included studies (n =16 studies = 
36.4%) were handling this topic. The remaining articles (n = 21 = 47.7%) were either 
exploring the risk factors of CKD or discussing general topics related to RRT population in 
Oman. The most popular research design used were cross sectional (n = 14 = 31.8%), 
followed by observational cohorts (n = 8 = 18.1%), and case reports (n = 8 = 18.1% - see 
appendix F, p.269). 
 
2.1.3 The conclusions from the published reports on 
Oman's RRT up to 2013 
Oman is one of these developing countries which need to escalate efforts in kidney failure 
epidemiology (Hassanien et al., 2012). Access to the epidemiology of chronic kidney 
failure in Oman is very limited for the world beyond Oman, because there has been no 
sufficient publication covering this matter until this project was undertaken in 2013. One 
report with older date (Al-Marhuby, 1998) had reported brief and limited information 
about RRT in Oman such as incidence, prevalence, causes of death and brief history of 
kidney transplantation in Oman.  A systematic review published in 2012 reviewed the 
epidemiology of chronic kidney failure in the Gulf Cooperation Council (GCC, i.e. Oman, 
UAE, Saudi Arabia, Kuwait, Bahrain and Qatar), and showed that the incidence of chronic 
kidney failure has increased, whereas the prevalence and mortality rate has not been 
reported sufficiently (Hassanien et al., 2012). Hassanien et al.  (2012) stated that there were 
no studies from either Oman or Qatar. The review recommended conducting more studies 
to describe the epidemiology of chronic kidney failure in the GCC (Hassanien et al., 2012). 
Another study conducted by Omar Abboud (2006) to describe the status of chronic kidney 
failure in the Middle East concluded that few countries of the Middle East published data 
on incidence, prevalence and outcome of treated patients with advanced kidney disease. 
Oman was one of these countries that were not yet publishing in this field (see Appendix 
B-5, p.251 - Abboud,2006). Abboud (2006) and Hassanien (2012) emphasised the need to 
perform well-planned and accurate epidemiologic studies to attain accurate and reliable 
information on chronic kidney failure status in the Arab World and the GCC region.  
 
In general, most of the studies published for Oman’s RRT were difficult to appraise 
because they lack some key information on the method conducted, on the missing data, and 
on the limitations encountered by these studies. However, this again question the reliability 
of the research methods used in these studies and  emphasises the hypothesis of a 
knowledge shortage regarding the RRT population of Oman. The Arab World and the 
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GCC are still suffering from some methodological deficiencies in research that need to be 
improved (Abboud, 2006). Also in support to this notion, the International Society of 
Nephrology has encouraged research on this aspect in the developing countries (Evans and 
Taal, 2011).  
 
2.2 A literature review of the international picture of 
the epidemiology of people with RRT 
2.2.1 Overview 
The epidemic of kidney failure is reported by many countries of the world. The 
information about the incidence and prevalence of kidney failure in the western world is 
flourishing, due to their dynamic renal registries. Many countries, such as the UK, the 
USA, Australia, New Zealand, Canada, and Latin American countries, publish their renal 
data on chronic kidney disease/kidney failure annually. However, with regard to the 
comprehensiveness and the high volume of data, there are two leading renal registries in 
the world, which are The European Renal Association – European Dialysis and Transplant 
Association (ERA-EDTA) and the United States Renal Data System (USRDS). The ERA-
EDTA is an international renal registry, which acts as a source for European RRT data that 
is produced by the national and regional renal registries in Europe (Zoccali et al., 2009). 
The ERA-EDTA registry analyses collected data for the 34 participating countries and 
publishes the results annually in different forms, such as annual reports and published 
summaries (Noordzij et al., 2014). Likewise, the USRDS is a registry that in 2015 included 
renal data for 57 countries from different continents. 
  
Hence the epidemiology of kidney failure is published in the renal registries and many 
articles publishing on epidemiology of RRT population gain their data from  registries, 
similary this section relied on renal registries data.  The following section represents the 
main epidemiological data published on the RRT population of the main renal registries 
and datasets of the world that found relevant to this study such as incidence, prevalence, 
death figures, and reporting the cost of RRT when available. The following information 
helps to present a clearer picture of RRT epidemiology and major characteristics of treated 
kidney failure across the world. The information included were the most recent ones that 
were available at the time of writing this section. The search strategy used to find these 
data is the direct access to the renal registries webpages. All the below listed renal 
registries have their annual reports published and accessible on their registries webpages. 
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Overall these major-below mentioned renal registries reported similar findings such as 
increasing in incidence and prevalence of treated kidney failure, variable rates of kidney 
failure prevalence across the one country regions, reduction in mortality rates and improve 
in survival rates, better survival rates among kidney transplanted patients compared to 
dialysis patients, cardiovascular disease as a major cause of death, diabetes and 
glomerulonephritis as major primary diseases to kidney failure and finally inconsistency in 
reporting some of the data such as reporting the cost of kidney failure treatment by USRDS 
but not by other registries. Further comparison between the data provided by these 
registries and the data coming from Oman are presented in Table  2-2. Also appraisal of the 
world renal registries is untaken under section 2.2.7 (p. 53). 
 
 
2.2.2  United States Renal Data System (USRDS) 
In the USA there were 117,162 new RRT cases registered in 2013, which is equal to 363 
cases of kidney failure per million population (pmp) per year. The incidence of kidney 
failure in the USA increased slightly compared to the previous year, which was 114,813 
(353 pmp/2012) new patients. The incidence of kidney failure was variable across the 
states of the USA: the highest was in Southern California, at 438 pmp/2013, and the lowest 
were in the states of Connecticut, Massachusetts, Maine, New Hampshire, Rhode Island 
and Vermont, at 244 pmp/2013 (United States Renal Data System – USRDS, 2015). 
 
The prevalence, however, was 661,648 cases of kidney failure on 31
st
 December 2013; this 
is equal to 2,034 per million per year - one of the highest in the world. The prevalence in 
2013 increased 3.5% from 2012. The prevalence across the USA was variable, with the 
lowest at 944 pmp in Alaska, Idaho, Montana, Oregon and Washington, and the highest at 
1,855 pmp in Alabama, Mississippi and Tennessee. The prevalence gender ratio was 
57.3% male to 42.7% female. The prevalence in different age groups was 104 pmp for ages 
0-21, 959 pmp for ages 22-44, 3,624 for ages 45-64, 6,347 pmp for ages 65-74, and 6,275 
for ages 75 and over, which implies that the incidence of kidney failure increases with age. 
The overall median age for prevalent patients could not be allocated in this report, but 
based on the previous data, which reported that the highest prevalnce was in age groups 65 
years and older, this imply that the median age would be of older age  (United States Renal 
Data System – USRDS, 2015). 
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The African-American population had kidney failure prevalence 3.7 times higher than 
white Americans. The USRDS (2014) reported that 38% of new kidney failure patients 
received little or no nephrology care pre-kidney failure. Two-thirds of the American kidney 
failure population underwent haemodialysis therapy (63.7%), 6.8% were treated with 
peritoneal dialysis, and 29.2% had a functioning kidney transplant by 31
st
 December 2013. 
The use of home dialysis increased in the U.S. kidney failure population from 8.9% in 
2008 to 11.5% in 2013 (United States Renal Data System – USRDS, 2015). 
 
The listed primary causes of kidney failure in the USA were the following: diabetes (n = 
52,354), hypertension (n = 34,104), glomerulonephritis (n = 9,016), cystic kidney disease 
(n = 2,557), and others/unknown (16,386). The most common and significant comorbidity 
found within the kidney failure population was cardiovascular disease (CVD). In 2013, the 
hospitalisation rate was 1.7 hospital admissions per patient, however, in general the 
average hospitalisation rate for the kidney failure population in the USA is around two 
hospital admissions per year, secondary to cardiovascular events or infection (e.g. vascular 
access site infection -United States Renal Data System – USRDS, 2015). 
 
In the USA, the mortality rate was 169 for dialysis patients, and 35 for transplant patients 
per 1,000 patients per year. The mortality rate continued to fall by 28% (dialysis 
population) and 40% (renal transplant population) since 1996 to 2013 in the USA. 
However, the dialysis patients continue to have higher mortality rates compared to the 
general population and populations with cancer, diabetes or cardiovascular disease (United 
States Renal Data System – USRDS, 2015). 
 
In the U.S. kidney failure population, cardiovascular diseases are the most common cause-
specific for mortality; it comprises 53% of the deaths with known causes (United States 
Renal Data System – USRDS, 2015). The USRDS (2015) reported improvement in 
survival between the years 2000 and 2008. Survival among haemodialysis patients rose 
from 35% to 40%, and rose from 37% to 50% among peritoneal dialysis patients. Survival 
was consistently higher in the kidney transplant population, from 66% to 75% among 
deceased-donor transplant patients, and from 75% to 87% among living-donor transplant 
patients (United States Renal Data System – USRDS, 2015). 
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The arteriovenous fistula (AVF) is the common vascular access among prevalent U.S. 
dialysis patients, with 62.5% of patients having this type of access by December 2013 
(United States Renal Data System – USRDS, 2015). 
 
The kidney transplant waiting list in the USA had 86,965 individuals, and the number of 
kidney transplants accomplished was 17,600 by December 2013. The one-year post 
transplant probability of survival was 95% for deceased-donor and 97% for living-donor 
kidney transplant recipients (United States Renal Data System – USRDS, 2015). 
 
In 2013, there were 1,462 children who had started RRT in the USA. The prevalence was 
9,921 children on 31
st
 December 2013. Haemodialysis is the common initial treatment 
modality used by children in the USA (56%). In the population of children with kidney 
failure, identifiable leading causes were cystic kidney diseases, hereditary factors, 
congenital disorder (33%), glomerular disease (24.6%), and secondary causes of 
glomerulonephritis (12.9%). The average hospitalisation per child is two hospital 
admissions per patient per year. During 2009-2013, 37% of children with kidney failure 
had successful kidney transplantations (United States Renal Data System – USRDS, 2015). 
 
The cost of RRT is high across the world, and the USA is no exception. The USA’s 
Medicare increased the fee-for-service spending for kidney failure beneficiaries in the USA 
by 1.6%, which means the cost increased from 30.9 billion U.S. dollars in 2013 compared 
to 30.4 billion U.S. dollars in 2012, and accounted for 7.1% of the overall Medicare 
expenditure (United States Renal Data System – USRDS, 2015). 
 
 
2.2.3 United Kingdom Renal Registry (UKRR) 
In the UK, kidney failure incidence in 2014 was 7,411 adult patients, which means the 
incidence rate increased from 109 pmp in 2013 to 115 pmp in 2014. The incidence was 
variable across the constituent countries of the United Kingdom. The highest incidence was 
in Wales, equating to 119 pmp/2014, and the lowest was in Northern Ireland, at 93 
pmp/2014 (United Kingdom Renal Registry- UKRR, 2015). 
 
The prevalence of RRT patients in the UK was 58,968 on 31
st
 December 2014, a 4% 
increase from 2013, so the prevalence was 913 pmp in 2014 compared to 888 pmp in 2013. 
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Prevalence increased across the countries of the UK, but at variable rates. The highest was 
in Wales, at 919 pmp/2014, and the lowest in Scotland and Northern Ireland at 874 
pmp/2014 in each country. The prevalence of kidney failure was higher among males than 
females; however the exact figures could not be ascertained. On 31
st
 December 2014, the 
median age for RRT patients was 58.7 years old. The age group distribution was as 
follows: 13.5 % for the 18-39 age group, 50 % for ages 40-64, 20.5% for ages 65-74 and 
16% for ages 75 and above. This indicates that half of this population were in middle age, 
where they should have been active and productive if they had been in good health (United 
Kingdom Renal Registry- UKRR, 2015). 
 
The ethnic group representing the highest percentage among prevalent UK patients was 
White Caucasian (78.5%), followed by Asians (11.4%), Blacks (7.6%), Chinese (0.7%), 
and 1.7% other ethnic groups. The registry identified that 17.8% of patients presented late 
at more than 90 days after diagnosis. The most common modality among prevalent UK 
patients was kidney transplantation (53%), followed by haemodialysis (41%), and the least 
used was peritoneal dialysis (6%).  Home dialysis is increasing year by year, with 1,113 
patients in 2013 compared to 1,080 patients in 2012 - a 3% increase (United Kingdom 
Renal Registry- UKRR, 2014). AV access statistics were not provided (United Kingdom 
Renal Registry- UKRR, 2015). 
 
Glomerulonephritis was the most common identifiable primary kidney disease, with 18.9% 
of patients, followed by diabetes (16.1%), aetiology uncertain (15.8%), other primary 
causes (16.4%), pyelonephritis (10.6%), polycystic kidney disease (9.8%), hypertension 
(6.1%), and kidney vascular disease (3%), with 3.4% of patients identified as ‘missed 
data’. The hospitalisation rate was not allocated in this report. The most common co-
morbidities for this population were ischemic heart disease, peripheral vascular disease, 
malignancy, cerebrovascular disease and diabetes (United Kingdom Renal Registry- 
UKRR, 2015). 
 
The mortality rate had declined in the UK kidney failure population from 395/1000 in 2012 
to 261/1000 in 2013 (United Kingdom Renal Registry-  UKRR,  2014).The survival rates 
among new patients on RRT in the UK improved over the last 14 years until 2013, and 
patients were able to live up to 10 years post-RRT. The most common causes of death 
among the RRT patients were cardiovascular (23%), infection related to dialysis treatment 
(20%) and treatment withdrawal (16% - United Kingdom Renal Registry- UKRR, 2015). 
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The overall number of kidney transplants in the UK in 2013 was 3,257, a 12% increase 
from the previous year. The mortality rate among transplanted patients was 2.4/100 
patients per year (United Kingdom Renal Registry- UKRR, 2014). In the UK, there were 
more than 6,000 patients waiting for transplants from 2011 to 2012 (NHS Blood and 
Transplant, 2012-13). Variations between centres were reported regarding patients 
receiving transplants. Patients at a non-transplanting kidney centre tend to be less likely to 
receive a transplant compared to patients doing dialysis in a transplanting kidney centre in 
the UK, which might indicate inequitable opportunities provided for this population 
(United Kingdom Renal Registry- UKRR, 2014). 
 
The prevalence of established kidney failure among children in the UK was 917 children in 
2014. Prevalence was 60.4 pmp and incidence was 9.4 pmp among children younger than 
16 years old.  On 31
st
 of December 2014, 79.3% of UK children with previous kidney 
failure had a functional transplanted kidney, 11.2% were on haemodialysis and 9.5% were 
on peritoneal dialysis. The most common primary kidney diagnosis in this population was 
kidney dysplasia ± reflux (32.6%). The survival rate for children under two years old 
compared to children aged 12 to 16 years old was at a ratio of 4 -1. Children with kidney 
transplants had higher survival rates compared to children on dialysis, at a ratio of 3-6. The 
overall cost of RRT was not mentioned (United Kingdom Renal Registry- UKRR, 2015). 
 
 
2.2.4  Australia and New Zealand Dialysis and Transplant 
Registry (ANZDATA)  
The incidence of kidney failure in New Zealand was higher than in Australia. In Australia, 
the incidence was 2,610 new kidney failure patients in 2014, at a rate of 111 pmp. New 
patients in New Zealand were 547 in total, and the incidence rate was 122 pmp on 31
st
 
December 2014 (Australia and New Zealand Dialysis and Transplant Registry- 
ANZDATA, 2015).  
 
Prevalence was 22,234 (947 pmp) kidney failure patients in Australia, with 12,091 (515 
pmp) patients on dialysis (home dialysis 9.4%, peritoneal dialysis 20.4%, in-centre 
haemodialysis 70.1%), and 10,143 (432 pmp) had functioning transplants. Prevalence has 
increased in Australia from 488 pmp in 1995 to 947 pmp in 2014. On 31
st
 December 2014, 
there were 4,306 (959 pmp) with kidney failure in New Zealand, 2,678 (596 pmp) on 
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dialysis (home dialysis 18.3%, peritoneal dialysis 30.6%, in-centre haemodialysis 51.1%) 
and 1,628 (362 pmp) had functional kidney transplants. Similarly the prevalence in New 
Zealand had increased from 445 pmp in 1995 to 959 pmp in 2014 (Australia and New 
Zealand Dialysis and Transplant Registry- ANZDATA, 2015). 
 
In Australia, there were 1,666 male patients to 944 female patients, and in New Zealand, 
329 males to 218 females. Many patients in Australia and New Zealand fall within the 55 
to 74 age group, similarly to the UK. The median age was 60 among Australian males and 
64 among females; in New Zealand it was 61 for males and 57.5 for females. The most 
reported common ethnic group with kidney failure among Australians and New Zealanders 
was Caucasian (Australia and New Zealand Dialysis and Transplant Registry- ANZDATA, 
2015). 
 
In Australia and New Zealand, the overall percentage of new patients who referred late to 
nephrology in 2014 was 17% and 14%, respectively. However, for the past ten years, the 
overall trend of late referral decreased in both countries (Australia and New Zealand 
Dialysis and Transplant Registry- ANZDATA, 2015). 
  
New patients in Australia who had diabetes at the start of RRT numbered 1,306 (50%), and 
in New Zealand, 216 (39%). The apparent leading cause of kidney failure in both countries 
continues to be diabetes, followed by glomerulonephritis (Australia and New Zealand 
Dialysis and Transplant Registry- ANZDATA, 2015). 
 
The ANZDATA (2014) reported the declining use of AVG, but the stability of AV fistula 
use. In New Zealand, 77% of dialysis patients used AVF or AVG and 23% used central 
venous catheter (CVC). In Australia, the equivalent figures were not clearly identified 
(Australia and New Zealand Dialysis and Transplant Registry- ANZDATA, 2015). 
 
The four top co-morbidities reported by both countries were coronary diseases, peripheral 
vascular diseases, lung diseases and cerebrovascular disease. The survival rate reported by 
both countries shows a higher rate at one year compared to five years post kidney 
transplantation. The mortality rate in Australia was 13.1 for dialysis patients compared to 
1.9 for transplant patients, per 100 patients per year during RRT in 2014; in New Zealand 
it was 14 with dialysis compared to 2.6 with transplant, per 100 patients per year. The 
primary causes of death in Australia were withdrawal from treatment (uraemia) at 31.5%, 
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cardiovascular at 29.5%, other mixed causes of death (such as suicide) at 24.3%, infection 
at 8.9% and cancer at 5.8%. In New Zealand, the primary causes were cardiovascular at 
36.7%, other causes at 21.5%, withdrawal at 19.6%, infection at 14.9% and cancer at 7.8% 
(Australia and New Zealand Dialysis and Transplant Registry- ANZDATA, 2015). 
 
The kidney transplant waiting list had 1,266 patients on it by the end of 2009, compared to 
1,123 on 31
st
 December 2014. Australia and New Zealand reported the highest kidney 
transplant rates ever in 2014. In Australia 914 transplants were accomplished in 2014 
compared to 442 in 1995. In New Zealand, 138 transplants were accomplished in 2014 
compared to 94 in 1995 (Australia and New Zealand Dialysis and Transplant Registry- 
ANZDATA, 2015). 
 
The incidence of kidney failure among children of Australia and New Zealand varied 
across the different age groups. In age group 0-4 years, the incidence was approximately 
the same in both countries, 10 pmp. In age group 5-9 years, the incidence was 
approximately 2-3 pmp in both countries. In age group 10-14 years, the incidence was 
approximately 14 pmp in Australia and 21 pmp in New Zealand. The prevalence of kidney 
failure among children in Australia is distributed between two main groups: ages 0 to 4 (24 
pmp) and 5 to 14 (58 pmp). In New Zealand, the prevalence in the same age groups was, 
respectively, 13 pmp and 58 pmp. The primary renal disease varied across age groups but 
overall was glomerulonephritis and in young children was commonly renal hypoplasia or 
renal dysplasia. The common modality was haemodialysis in age group 10-17 years and 
peritoneal dialysis was more common in age group less than 10 years, and there are 20% 
received pre-emptive kidney transplant. The overall cost was not mentioned in the annual 
report (Australia and New Zealand Dialysis and Transplant Registry- ANZDATA, 2015). 
 
 
2.2.5  Japan Kidney Disease Registry (J-KDR) 
The kidney registries in Japan are less than a decade old. In 2007 the Japan Kidney Biopsy 
Registry (J-RBR) was started, followed by the Japan Kidney Disease Registry (J-KDR) in 
2009 (Sugiyama, 2013). The figures for kidney failure in Japan over the years are not 
completed, and the recent published data found for Japan was in the USRDS 2015 report, 
with statistics included for the year 2013. In Japan, by the end of 2013, there were 2,411 
pmp kidney failure patients on RRT nationwide - one of the highest prevalences in the 
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world (United States Renal Data System – USRDS, 2015). The incidence was 286 pmp per 
Japanese population in 2013 (United States Renal Data System – USRDS, 2015). The 
average age of the Japanese kidney failure population was 65.3 in 2008 (Akizawa, 2010). 
Japanese diabetic patients constituted 34% of the kidney failure population. The reported 
survival rates showed improvement, with 82% survival after one year of dialysis and 59% 
after five years (Akizawa, 2010).  The preferred form of vascular access was AV fistula, as 
95% of haemodialysis patients had this form. Deaths due to cardiovascular disease 
exceeded 40%, and the most common causes of death reported for the kidney failure 
population on dialysis in Japan were heart failure, infections, and malignant neoplasms. 
The life expectancy for this population compared to the general population was reduced by 
50% (Akizawa, 2010). The annual crude mortality rate was constant around 9.5% among 
dialysis patients in Japan. There were 1,201 accomplished kidney transplants in 2008 
(Akizawa, 2010).  
 
 
2.2.6  Renal data from developing countries and the international 
scene 
In South Africa, the efforts were successful in re-lauching the annual renal reports after an 
18 years pause, so since 2012 the South African Renal Registry has continued to publish 
the annual renal data about their RRT population (South African Renal Society, 2014). The 
last renal reports were published in 2017 including the data for the year 2015. The data 
showed that the South African  population has increased from 40.4 million in 1994 to 52.3 
million in 2012 to 54.96 million in 2015. The prevalence of RRT population increased 
from 70 pmp in 1994 to 164 pmp in 2012 to 189 pmp in 2015. The haemodialysis 
treatment is the common treatment in 2015 but not in 1994. In 1994, there were 29.8% of 
RRT population on haemodialysis compared to 67.1% in 2012 compared to 72.7% in 2015. 
Peritoneal dialysis treatment was relatively stable as 14.7% of RRT patients were using 
this modality in 1994 compared to 14.1% in 2012, and 13.9% in 2015. Kidney 
transplantation dropped significantly from 55.5% in 1994 to 18.8 in 2012 and to 13.4% in 
2015. The mean age of RRT population increased from 49.3 ± 15.1 years to 51.3 ± 15 
years. Male patients under treatment were more (i.e. 59.6% males in 2012 vs. 59.3% in 
2015) compared to female patients. The reported causes of kidney failure in patients were 
the same since 2012 until 2015 and they are subsequently, Unstated or uncertain causes 
(34.1%), hypertensive renal disease (33.7%), diabetic nephropathy (14.4%) in 2015 (South 
African Renal Society, 2014; South Aferican Renal Society, 2017). 
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In China, there are no complete data about kidney failure available. However, it is known 
that there are 120 million Chinese diagnosed with kidney disease, and one million of them 
are predicted to undergo dialysis by 2020 (Thomas et al., 2015). The data from the Chinese 
Renal Data System showed the most common causes of kidney failure on dialysis as 
follows, glomerular disease (57.4%), diabetic nephropathy (16.4%), and hypertension 
(10.5% - Liu, 2015). The kidney transplantation program showed more than 60,000 kidney 
transplantations since 1977 with average of 5000-6000 transplants per year (The database 
center of the Chinese scientific registry of kidney transplantation, 2012; Liu, 2015). 
 
India launched its first registry for chronic kidney diseases (which includes kidney failure) 
in 2005 (Rajapurkar et al., 2012), and also established the first Indian transplant registry 
(Shroff, 2007). However, there were no up-to-date data published, and there is limited data 
on prevalence of CKD from the Indian context, especially there has been no longitudinal 
studies conducted (Rajapurkar et al., 2012).  In India, there was no specific profile for 
kidney failure, but the country reported 52,273 chronic kidney disease patients by the end 
of September 2010 (Rajapurkar et al., 2012), which comprised all chronic kidney diseases 
together with no clear details on what proportion represented kidney failure. Also, it is 
known that diabetes and hypertension compromise of 40-60% of Indian CKD cases 
(Rajapurkar et al., 2012). 
 
The international kidney failure scene is partially covered by two international registries, 
the ERA-EDTA and the USRDS. However, the USRDS has successfully included more 
countries in its report compared to the ERA-EDTA, which focuses on the continent of 
Europe rather than the other parts of the world. Accordingly, data from USRDS was 
favoured and presented in this section due to its comprehensiveness. In 2014 the USRDS 
included data from 54 countries across the world and for the first time included some data 
from the Gulf Countries, except for the United Arab Emirates (UAE). In 2015, the number 
of participating countries in the USRDS had reached a total of 57 countries compared to 
the 35 participating European countries in the ERA-EDTA (United States Renal Data 
System – USRDS, 2015). 
 
According to the available data from the USRDS (2015), the highest incidence of kidney 
failure was in Taiwan (458 pmp/2013), and the lowest in Bangladesh (45 pmp/2013) 
(Figure  2-3). The highest prevalence was in Taiwan (3,138pmp/2013) and the lowest in 
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Indonesia (66pmp/2013 - Figure  2-4).  Diabetes as a primary cause was the most reported 
in Malaysia, with 64% of patients reporting kidney failure secondary to diabetes, and least 
reported in Romania, at 15% of patients (Figure  2-5 - United States Renal Data System – 
USRDS, 2015). The most common modality used in many reported countries was dialysis, 
and the most common type of dialysis was in-centre haemodialysis (80% of chronic 
dialysis patients). In contrast, some other countries were successful in increasing the use of 
PD among treated kidney failure patients, such as in Hong Kong (72% of treated patients 
with advanced kidney disease are on PD), the Jalisco region of Mexico (45%), Iceland 
(34%), New Zealand (32%), Colombia (30%), and Thailand (25%). Kidney transplantation 
rates varied from country to country for many reasons, such as the variation in incidence 
and prevalence, infrastructure and organ availability (United States Renal Data System – 
USRDS, 2015). The highest kidney transplantation rates were reported in Croatia, the 
Jalisco region of Mexico, the Netherlands, Spain, Norway and the USA (53-59 kidney 
transplants pmp). The lowest rates were in Bangladesh, Bosnia and Herzegovina, the 
Philippines, Malaysia, Romania, Russia, South Africa and Thailand (1-9 kidney transplants 
pmp - Figure  2-6). 
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Figure ‎2-3 Incidence of treated kidney failure per million population, by country, 
2013 
©United States Renal Data System, 2015 
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Figure ‎2-4 Prevalence of treated kidney failure per million population, by country, 
2013 
© United States Renal Data System, 2015 
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Figure ‎2-5 Percentage of incident kidney failure patients with diabetes as the primary 
kidney failure cause, by country, 2013 
© United States Renal System, 2015 
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Figure ‎2-6 Kidney transplantation rate per million population, by country, 2013 
© United States Renal Data System, 2015 
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It is difficult to compare kidney failure statistics across the world for a number of reasons 
including the following: there are no kidney registries in some countries, and in the 
countries which have kidney registries there are no unified international standards for data 
collection and analysis across the board. In some countries kidney failure clinical and 
statistical analysis is absent or obscure due to other health priorities on the agenda. Poverty 
and/or lack of resources are further factors. There is also evidence, which needs to be 
tested further, showing that there is under-estimation and under-diagnoses for CKD and 
kidney failure in many parts of the world (Perico and Remuzzi, 2012). Finally, the results 
reported by the USRDS do not cover the entire world; the two largest national populations 
(China and India) are missing, so it can be argued that if these two populations were 
included it could affect the present trends and interpretation of the present data.  
 
The Arab World (see Glossary, p.18), which have estimated population of around 390 
million by end of 2015, have a limited epidemiological profile for kidney failure despite it 
is known that modern nephrology has been established in the Arab region since the 1960s 
(El-Matri, 2013). However, as far as it is known, no single kidney registry has yet been 
established among the Arab countries, which means there is no consistent and up-to-date 
data on kidney failure or CKD coming from the Arab countries (Farag et al., 2012). The 
kidney failure data for most Arab countries has been provided from small-scale studies 
which involve 100 or fewer patients and additionally include old data (Farag et al., 2012). 
The USRDS has covered a few Arab countries such as Egypt and the GCC, but this does 
not yet give the full picture of kidney failure in the Arab World. 
 
Nevertheless, two reviews, published in the years 2006 (Abboud) and 2012 (Farag et al.), 
highlighted some statistics and information about kidney failure in the Arab countries and 
the Middle East (ME – see Glossary, p.18) Region. According to the first review (Abboud, 
2006), the incidence of kidney failure ranged from 64 pmp in Yemen to 212 pmp in Qatar 
per annum. The average incidence was 93 pmp across the Arab countries, which meant an 
estimated overall incidence of 6,750 patients in the Arab countries. The highest prevalence 
was in Saudi Arabia, at 462 pmp, and the lowest was in Kuwait, at 80 pmp, with an 
average of 352 pmp (Abboud, 2006). Haemodialysis is the most common modality 
available, free for citizens and for $100 (£70.49) for non-citizens. Diabetes is the leading 
cause reported (Abboud, 2006). There are well-established kidney transplantation 
programmes in some of the Arab countries, such as Saudi Arabia, Kuwait, Jordan and 
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Lebanon. The average cost of kidney transplantation in the first year of a person’s 
treatment was $15,000 (£10,574) (Abboud, 2006). 
 
The second review, published in 2012 (some of the data included in this review can be 
dated back to 1992), identified the highest incidence of kidney failure in Libya, at 200 
pmp, and the lowest incidence in Algeria, at 34 pmp per year (Farag et al., 2012). The 
highest prevalence was in Qatar, at 480 pmp, and the lowest in Libya, at 30 pmp per year 
(a recent study on kidney failure epidemiology, conducted in 2010 in Libya (Alashek et al., 
2012) reported a prevalence of 624 pmp per annum, which was much higher than what the 
previously mentioned review (i.e. Farag et al., 2012) reported. The review identified three 
major reported causes for kidney failure, which were diabetes, hypertension and 
glomerulonephritis. The review expected that kidney failure incidence and prevalence in 
the Arab World would dramatically increase due the increasing prevalence of diabetes 
(major diabetes risk factors in Arab World were found obesity and lack of exercise), which 
was found in around eight million people in the Arab World in the year 2000 and is 
expected to rise to about 22 million person by 2030 (Farag et al., 2012; Abuyassin and 
Laher, 2016). Both reviews reported different statistics, which could be because the authors 
targeted different time period and may be included less or more countries. However, both 
reviews depended mostly on the available literature and verbal communications to uncover 
the ambiguous epidemiological profile of Arab and ME countries. Much of the data 
gathered was based on estimation, and no rigorous research methodology or designs were 
applied to gather the data. Also some of the gathered data goes back to the 1990s. The 
population in both reviews was not clearly identified, and there was a reporting bias where 
the author did not mention their studies’ limitations. However, Farag et al. (2012) justified 
the shortage of their data by the fact that the data available was very limited and no Arab 
country had up-to-date information on the epidemiology of CKD. Both authors claimed 
that the data used in their reviews underestimated treated kidney failure statistics in the 
Arab World. This claim was supported by a systematic review published in 2012, which 
reviewed the epidemiology of kidney failure in the Gulf Cooperation Council and showed 
that the incidence of kidney failure had risen, while prevalence and mortality rates had not 
been reported sufficiently (Hassanien et al., 2012).  
 
Hassanein et al. (2012) were able to include 44 studies on the epidemiology of kidney 
failure in the GCC. However, 40 studies were from Saudi Arabia only, one study from the 
UAE, one study from Kuwait, one study from Bahrain and only one study included the 
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GCC countries all together. The common designs of these studies were cross-sectional and 
cohort. None of these studies had comprehensive data that reported accurate figures of the 
kidney failure epidemiology of GCC countries. Hassanein et al. (2012) stated that there 
were no studies from either Oman or Qatar. The authors of this review recommended 
conducting more studies to describe the epidemiology of kidney failure in the GCC and 
ME because of the severe shortage and out of date data about chronic kidney disease and 
kidney failure in the ME and all Arabs World (Abboud, 2006; Hassanien et al., 2012; 
Farag et al., 2012).  
 
Oman being one of the Arab countries, its published profile regarding kidney failure is 
limited.  There is one study found published on the epidemiology of Oman’s treated kidney 
failure patients (Al-Marhuby, 1998 – see Table  2-2). Also, the Oman’s Ministry of Health 
(MOH) reported a prevalence of 1,221 treated chronic kidney failure  patients who were 
undergoing maintenance dialysis by the end of the year 2012, but there was no incidence or 
other data reported about kidney failure until the end of 2013 until this study was proposed 
(Ministry of Health - MOH, Oman, 2014). In 2014, Oman had contributed to the USRDS 
report with some data mainly about incidence, prevalence, known primary causes, and 
kidney transplantation rates, yet these data were précised and limited and did not give the 
full picture of kidney failure in Oman. It would be useful if the USRDS reported the 
percentage of missing data coming from Oman, or any reporting deficiencies which would 
help to appraise the quality of the data provided. 
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Table ‎2-2 Comparison‎between‎major‎registries’‎data‎and‎Oman 
Variable USA UK Australia NZ Japan Oman* 
Incidence 363 pmp 115 pmp 111 pmp 122 pmp 286 
pmp 
120 pmp? 
Prevalence 2,034 pmp 913 pmp 947 pmp 959 pmp 2,411 
pmp 
348 
DP/Oman 
M: F M>F M>F M>F M>F M>F NA 
Ethnicity 
with‎↑‎KF 
African 
American 
White 
Caucasian 
Caucasian Caucasian NA NA 
Primary 
cause 
1.DM 
2.HTN 
3.GN 
1.GN 
2.DM 
3.Uncertain 
1.DM 
2.GN 
1.DM 
2. GN 
1.DM 1. GN? 
2. DM? 
Common 
co-morb. 
CVD CVD CVD CVD NA NA 
MR 169/1000 
(D) 
35/1000 
(KT) 
261/1000  
 
131/1000 (D) 
19/1000 (KT) 
140/1000 (D) 
26/1000 (KT) 
9.5% 
(D) 
10%?  
Mortality 
Cause 
CVD NA 1.Withdrawal 
2.CVD 
3.Others 
1.CVD 
2.Others 
3.Withdrawal 
CVD 1.CVD 
2.Infection 
Cost 30.9 
Billion 
(USD) 
NA NA NA NA NA 
Pmp, per million population; DP, dialysis patients; ?, estimated (uncertain); ↑, high; co-morb.,co-
morbidity;  MR, mortality rate; NA,   not available; M,  male; F,  female; KF, kidney failure; DM, 
diabetes; HTN, hypertension; GN, glomerulonephritis; CVD, cardiovascular disease; D, dialysis; 
KT, kidney transplant; USD – United States Dollars 
*These data were obtained from Al-Marhuby’s article published in 1998, and there were no 
updated publications on these statistics until end of 2013 when the author started this research. 
 
 
2.2.7  Appraising the quality of the registries 
The quality of renal registries is judged based on certain parameters, which are a good 
documentation system, good data collection strategy, good data cleaning, complete and 
non-duplicated data, accurate and valid data, clear timelines, and finally accurate data 
interpretation and reporting (Davids et al, 2016). Renal registries are considered a source of 
high-quality data because they are developed to serve a clear purpose: “to carefully 
monitor the quantity and quality of kidney care, and thus improve the quality and 
efficiency of this care” (United Kingdom Renal Registry - UKRR, 1998, p.1).  Most of the 
registries, whenever good, sustainable funding is available, strive for good data quality and 
reliable technologies. They set for themselves good standards, such as a clear purpose, 
clear parameters, clear definitions and clear inclusion and exclusion criteria to sustain a 
good quality operation.  
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A systematic review published in 2015 (Liu et al., 2015) aimed to gain a global overview 
of renal registries, as the authors identified unclear and inequitable, distribution, 
availability and quality of renal registries across the world. The review included registries 
that had information on dialysis use, had more than 300 patients, and had evidence of 
activity between June 2007 and June 2012. The registries were evaluated according to four 
main standards, which were the public availability of information on dialysis, outcomes, 
patient characteristics, and accessibility of the registry for patients and researchers. The 
review (Liu et al., 2015) identified 144 registries across the globe, but only 48 of them met 
the inclusion criteria, 23 of which were in Europe.  Seven out of the 48 gained a perfect 
score when measured against the standards and these seven registries were the Scottish 
Renal Registry (SRR), the UK Renal Registry (UKRR), the Sociedad Argentina de 
Nefrologia (SAN) registry, the Danish Registry of Regular Dialysis and Transplantation 
(DNSL), the Finnish Registry for Kidney diseases, the Uruguayan Registry of Dialysis, and 
the French Language Peritoneal Dialysis Registry. In general, the review (Liu et al., 2015)  
identified a number of gaps in the registries. For example, less than half of the identified 
registries around the world met the review criteria; many of identified registries had either 
difficult-to-access data or less suitable information for the public; the data on the burden of 
RRT on all levels (e.g. patients, health systems) were limited; and there was a lack of 
uniformity in the type and quality of data provided. The review found the majority of 
registries were based in developed countries, and there was a severe lack of renal registries 
in the Asian-Pacific region, the Middle East and Africa. Also China, Russia, and India 
have limited or inadequate renal registries. The review (Liu et al., 2015) recommended that 
all registries overcome the gaps in population coverage, data collection procedures, 
completeness of data and promotion of access to available data, and demonstration of good 
quality and standardization procedures. The evidence provided by this review was partially 
limited as the reported data was gathered for 2012 and published in 2015, which implies 
the loss of registry data that emerged between 2012 and 2015, and also the loss of any 
updated data on the quality of the included registries. Also active registries with no online 
published data could have been undetected and therefore excluded (Liu et al., 2015). 
 
2.1 A literature review of the international state of the 
quality of life of people with RRT 
The kidney failure disease process and its treatment, especially dialysis, have a deep 
impact on health care systems worldwide, and a serious impact on patients’ quality of life. 
It has an impact on patients’ physical, mental and psychosocial well-being (Murphy, 2014). 
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Patients can experience depression, anxiety, impaired sexuality, loss of productivity and 
poor coping mechanisms (Perico and Remuzzi, 2012; Murphy, 2014). Also, patients can 
experience complications pre and post dialysis, including poor appetite, swollen ankles, 
feet or hands, shortness of breath, insomnia and itchy skin (National Health Service – 
NHS, 2015). Literature had agreed on the lower quality of life of haemodialysis patients 
compared to healthy people and even compared to peritoneal dialysis patients or kidney 
transplanted patients (Abdel-Kader et al., 2009; Clement et al., 2009; Cruz et al., 2011; 
Wyld et al, 2012; Rogan et al., 2017; Shafiee et al., 2017). 
 
A systematic review, meta-analysis and meta-regression of peer-reviewed published 
studies and of PhD thesis was published in 2012 (Wyld et al., 2012) and found in total 190 
studies published until 1
st
 of December 2010, reporting 326 utilities and from over 56,000 
patients. The review found that kidney transplantation patients reported improved quality 
of life (i.e. mean utility of 0.82 – 95% CI: 0.74, 0.90) and home-based automated 
peritoneal dialysis may improve quality of dialysis patients’ life (i.e. mean utility 0.80 – 
95% CI: 0.69, 0.91) more than other forms of dialysis like haemodialysis (mean utility 0.69 
– 95% CI: 0.59, 0.80 - Wyld et al., 2012). This systematic review has some limitations 
such as the treatment was not randomly assigned, and the data available from the included 
studies was not standardised in the amount of the data available, which may affect the 
accuracy of the algorithms used in this review. 
 
Another study (conducted between April 2010 and January 2013) compared 143 CKD 
stage-5 patients with a control group of 83 healthy individuals treated for essential 
hypertension (HTN), found significantly lower HRQoL SF-36 scores in CKD group 
compared to the healthy group. The physical component score was 45.0  vs. 53.9 (i.e. CKD 
vs. HTN), p < 0.001; and mental component score was 46.9 vs. 54.9, p < 0.001, which 
indicates significant difference in the statistical scores of physical and mental components 
meaning lower QoL scores for dialysis cohort (Rogan et al., 2017). In addition to this 
study, there is much evidence supporting the lower quality of life of haemodialysis patients 
(Abdel-Kader et al., 2009; Clement et al., 2009; Cruz et al., 2011; Wyld et al, 2012; Rogan 
et al., 2017; Shafiee et al., 2017). A very recent systematic review and meta-analysis study 
(included 60 studies with a total of 15,575 participants) aimed to uncover the psychosocial 
and lifestyle status of young adults (i.e. 16-30 years old) receiving RRT found lower 
quality of  life in dialysis patients', especially limited employment, independence, and 
relationships (Hamilton et al., 2017). The study results included in this systematic review 
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were highly heterogenic and appeared to be biased toward surviving participants and had 
limited comparing scale due to the small evidence base for the measured variables 
(Hamilton et al., 2017). 
 
All treatments and health care are made to achieve an improvement of health related 
quality of life of patients. Yet assessment of the improved quality of life can be 
controversial due to its subjectivity as it is relatively based on the patients’ answers. 
  
 
2.1.1 Economic burden on the health systems 
 In the USA, there were over 400,000 treated chronic kidney failure  patients on 
haemodialysis, with around US $90,000 (£62,496) spent per patient per year in 2012 
(Kidney Disease/Improving Global Outcomes – KDIGO,  2015; Saran et al., 2015). The 
cost of kidney failure care exceeds 6% of the total costs of the American health care 
system (Thomas et al., 2015). According to Thomas et al. (2015) the countries that will be 
affected financially by the increase in prevalence of kidney failure are the countries with 
high rates of health care spending, which could be right as health care spending is already 
high with the current situation then this will be magnified with increasing prevalence and 
cause great loss and drain on health budgets. 
 
The calculation of direct and non-direct costs has not been studied extensively in the 
literature. One study conducted in Saudi Arabia calculated the cost of an average of 2500 
haemodialysis sessions delivered for 200 patients from 1
st
 January 2007 to 30
th
 June 2010 
(Al Saran and Sabry, 2012). The direct costs, defined by this study as the cost related to 
dialysis treatment, such as the cost of dialysis disposables and drugs, staff, out-patient 
medication, laboratories and direct services. The non-direct costs were those for building, 
maintenance and engineering, housekeeping and administrative personnel. The study found 
that the total cost of the dialysis session was USD 46,332 (£32,173) per patient per year. 
The direct costs represent 81.5% and the non-direct costs the remaining percentage (Al 
Saran and Sabry, 2012). This cost calculation remains, however, below the average cost for 
developed countries due to different factors such as the variation in local labour cost and 
variable standards of care (Al Saran and Sabry, 2012). 
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The most cost-effective treatment for kidney failure is kidney transplantation.  Thomas 
(2014) stated that the financial cost of the kidney transplantation in its first year is equal to 
a year’s cost of dialysis, after which the cost of dialysis rises over transplantation because 
it is a prolonged treatment. However, the option of kidney transplantation is faced with the 
challenge of limited kidney donors, increasing the number of people on kidney transplant 
waiting lists and increasing commercialism. 
 
 
2.2  Prevention and screening programmes   
The value and importance of preventing chronic kidney disease/kidney failure are widely 
recognised across the world. Preventing kidney failure means preventing its causes and 
managing its risk factors. Currently, there is ample evidence in the literature demonstrating 
the role of diabetes mellitus as a major cause and risk factor for kidney failure (Perico and 
Remuzzi, 2012). The prevalence of diabetes is alarming, and according to the WHO, it was 
estimated that 171 million of the world’s population had diabetes in the year 2000. At the 
current rate this is expected to rise to 366 million (298 million in developing countries) by 
2030, which represents 6.5% of the world’s population (Perico and Remuzzi, 2012). 
Therefore kidney failure prevalence is expected to double, and exert more of a burden on 
health systems around the world, unless the international community act to prevent 
diabetes soon. World Health Organisation has set out a global non-communicable disease 
action plan to prevent diabetes and other chronic diseases, which should be achieved by the 
year 2020. The plan aims to prevent or reduce the frequency of four modifiable risk 
behaviours that were found to be linked to diabetes, cardiovascular diseases, cancers and 
chronic respiratory diseases, namely tobacco use, unhealthy diet, physical inactivity and 
harmful use of alcohol (World Health Organisation - WHO, 2017). 
 
In 2012, the Renal Association published clinical practice guidelines for detection, 
monitoring, and care in relation to chronic kidney disease. This document conveys 
important messages to primary care providers and it helps to improve the outcomes and 
reduce the complications expected if implemented well. Additionally, the world has tried 
some detection and management programmes for chronic kidney disease such as a web-
based programme called KHDC which aims for the “detection and management of kidney 
diseases, hypertension, diabetes and cardiovascular disease in developing countries”. This 
programme was developed by the ISN (International Society of Nephrology), which was 
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reported to screen around 42,000 people in 25 developing countries (Atkins and Zimmet, 
2010). There were limited published information on KHDC programme to know for 
example more about the characteristics of the sample and what was the inclusion and 
exclusion criteria and also more knowledge are needed to appraise this programme. It is 
not clear whether this programme has been evaluated, but it is known that it has been 
reviewed by ISN experts and used in 25 countries. Also this programme has a global 
template that can be adapted and consulted at 
http://www.nature.com/isn/education/guidlines/isn/pdf/ed_051027_2xl.pdf (Persy et al., 
2008).  However, it was not possible to access this template and on the ISN webpage. So 
due to the shortage of information on this programme, it is difficult to appraise its quality. 
 
Another programme is  KEEP (Kidney Early Evaluation Program), which was initiated by 
the National Kidney Foundation in the USA, aiming to screen people at risk of kidney 
disease in the U.S. communities (Atkins and Zimmet, 2010). The KEEP survey has been 
used to screen thousands of participants since the year 2000. For example 61,675 
participants with diabetes, hypertension, or a family history of kidney disease or diabetes 
or hypertension were screened using the KEEP survey from 1
st
 August 2000 until 31
st
 
December 2006. The survey found that 16,689 (27.1%) participants had chronic kidney 
disease (Whaley-Connell et al, 2008). There was no study known to have tested the 
validity or reliability of the KEEP survey, however, a number of factors imply its good 
quality. Firstly, the survey was used in a national programme, which usually takes a very 
significant amount of time to prepare and to be reviewed by panels of experts. Secondly, 
the survey has been frequently used since the year 2000, tested and retested on participants 
with numbers ranging from 6,071 to 61,675 participants, and by different researchers 
(Brown et al, 2003; McCullough et al, 2007; Stevens et al, 2010). Thirdly, no authors 
identified any shortcomings in the survey, except one (McCullough et al, 2007), who 
commented on the use of dipstick urine for microalbuminuria detection and found that 
instead it was best to do urine-creatinine ratio. This recommendation was undertaken in the 
later KEEP programmes. All of this implies that the KEEP survey has been scrutinized 
thoroughly over the years, and therefore adopted by many researchers. However, it can be 
argued that though this programme has been successful in the USA, it could fail if used in 
a different context such as the Arab World. Therefore, the KEEP programme, if to be used 
in a different context, should be examined and tailored to the individual needs of individual 
nations (Atkins and Zimmet, 2010).  
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2.3   Conclusion 
Up to this point many and different notions have been elucidated, such how the world is 
divided between countries that have kidney registries and others that do not. The kidney 
registries have been found to guide authors, health care providers, financial analysts, 
decision makers, and whomever else it may concern, to improve knowledge and 
consequently prevent kidney failure and manage patients with kidney failure around the 
world. Also, it helps leaders to plan for kidney replacement therapy and health care for a 
population with such demanding care needs.  
 
From the international renal registries such as USRDS (2015), the renal community has 
such significant data. For example, the registry reported that the highest incidence and 
prevalence of treated chronic kidney failure among participant countries was Taiwan. 
Researchers need to investigate the causes and risk factors that led to this outcome in this 
nation, and other nations that have higher figures, such as the USA. Also, on the other 
hand, researchers can study the nations that have lowest incidence and prevalence of 
treated chronic kidney failure to learn how such good practices can be transferred to other 
nations aiming to reduce the occurrence of kidney failure. Certainly, having this 
information can guide other systems towards modifying their programmes in dealing with 
this disease.  
 
The creation of a kidney registry needs funding, resources and a committed, consistent and 
quality data collection team. It requires people to value the data as empowering, have the 
view that no health system or other system in the world can be upgraded or act efficiently 
without investing in research and the data collection of large datasets. In the first place, it 
needs data to be made available. This puts a responsibility on all the countries of the world 
to gather data about their kidney failure population and make it accessible and available as 
published material for the patients and the research community.  
 
Oman shares this responsibility with the world, and it needs to invest more in chronic 
kidney disease/kidney failure research and publication, especially to study the risks and 
causes of kidney failure and then the impact of the disease on patients and systems. 
Nevertheless, Oman is recognised for its good health system, which provides good 
primary, general and nephrology health services for the public. Also expanding of general 
health and renal services are missions for Oman’s MOH.  However, the health sector in 
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Oman and around the globe does have some challenges, which have to be identified so that 
they can then be overcome. Accordingly the following chapter provides more details about 
the context of Oman and its health sector challenges. 
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3 Oman’s background and context 
3.1 Introduction 
This chapter describes the background of Oman. Understanding the background of Oman 
will enable the reader to visualize how the health sector of Oman is situated within the 
whole picture of the country, as nowadays health cannot be isolated from the surroundings.  
Health can be affected by many external factors such as political, economic, social, 
technological, legal and environmental factors (PESTLE framework - Marmol, 2015; the 
Ministry of Health – MOH, 2014). All these are external factors which the MOH may not 
be able to control, but which could have an impact on its operations. Therefore, identifying 
these external factors could help in better management and control for the delivered 
services and provide deeper insight on planning for the future services. 
 
Additionally, as the setting of this study is Oman, some information is purposely 
mentioned in this chapter because it is connected to the data discussed later in the results 
and discussion sections. From these perspectives, this chapter provides the information 
necessary to understand the life of the Omani people and the surrounding factors which 
could affect Omanis’ life and health.  The PESTLE framework is used here to outline these 
factors.  
 
The PESTLE framework appeared first in 1967, developed by Professor Francis J. Aguilar, 
and he called it “PEST analysis”. The PEST analysis was later updated by many 
researchers and called PESTEL or PESTLE analysis or framework (Marmol, 2015). This 
framework is used widely for observing all types of organisations for the purpose of better 
understanding the present situation and overseeing the future to facilitate planning 
(Marmol, 2015). Similarly, this framework is used here to understand the reality of Oman 
in relation to each component of PESTLE. So the remainder of this chapter is discussed 
under each component of the PESTLE framework. 
 
 
3.1 Political and administrative status  
Oman is included as a Middle Eastern country and an Arab world state. Politically, it is 
considered among the most peaceful nations in the world, and it has very good 
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relationships with all countries. The Sultan of Oman (the king and ruler) does not believe 
in war but sees peace as a foundation of his governance.  
 
Oman is located at the South-Eastern corner of the Arabian Peninsula (The National Centre 
of Statistics and Information – NCSI, 2015). It has an area of 309,500 square kilometers 
(almost the size of Poland or Italy), which is bordered by Yemen, Saudi Arabia, and the 
United Arab Emirates (UAE). Oman’s coastline is about 3,165 kilometers starting from the 
Strait of Hormuz and extending to the Arabian Gulf, the Sea of Oman, and the Arabian Sea 
(The National Centre of Statistics and Information – NCSI, 2015). Oman shares the 
coastline of the Arabian Gulf with UAE, Qatar, Bahrain, Kuwait, and Saudi Arabia. 
Therefore, the six of them are called Gulf Cooperation Countries or GCC.  
 
Oman is divided into eleven governorates and these governorates are divided into 61 states 
or districts. These governorates are named in this thesis as the capital which is composed 
of six districts;  the south which is composed of ten districts; the peninsula which has four 
districts;  the east subdivision 2  which has six districts; the east subdivision 1 has five 
districts;  the west consists of three districts;  the interior has eight districts; the middle has 
four districts;  the west end has three districts;  the north subdivision 1 which consists of 
six districts and the north subdivision 2 has six districts (the 12 districts of the north 
governorates were used in this research as locations).  
 
Oman, in general, has sound leadership and management systems, which try to respond to 
the populations’ needs. Accordingly, the health needs of the population were always a 
priority of the government. Therefore, one of the first established ministries in Oman was 
the Ministry of Health established on 22
nd
 August 1970, and one of the health priorites 
addressed after establishing the health infrastructres and fighting communicable disease 
was chronic diseases including renal diseases. The first MOH aims were set at that time “to 
provide health services to all regions of Oman; to carry out a program of preventive 
medicine; to undertake health education, and to train personnel involved in health care 
delivery from doctors to technicians” (Al-Kharusi, 1995). 
 
The Oman’s MOH was the first ministry among all ministries of Oman to release an 
operational manual to guide the health services delivered by the ministry personnel. Major 
developments have taken place in the health sector since the renaissance launched in Oman 
in 1970, inspired by His Majesty Sultan Qaboos bin Said (The current king of Oman since 
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1970). There was an emphasis on building the best possible infrastructure for the health 
services. Consequently, there were many hospitals and health centres opened, and there 
was an increase in the workforce of the health sector in Oman. For example in 1970, there 
were 20 clinics, two health centres, and four hospitals, but no special renal care 
institutions. By 1980, there were 54 clinics, 11 health centres, 14 hospitals and four other 
smaller health institutes, and at this point the renal treatment was started in Oman. As a 
result, the number of outpatients increased from about 24 thousand patients’ visits in 1970 
to about three millions patients’ visits in 1979 (Al-Mughairy, 1985; Al-Kharusi, 1995). 
 
By 1976, nearly all hospitals in Oman had a telephone, which improved the 
communications among different health institutions. The MOH in Oman joined the World 
Health Oganisation (WHO) in 1971, but the WHO’s office was opened in Oman only in 
April 1975. Moreover, the ministry established a close affiliation with the Royal College of 
Physicians and Surgeons of Glasgow, the Universities of Glasgow and Edinburgh, the 
Institute of Child Health, London, and the Oxford University, to send young Omani 
doctors for further training and specialisation in these institutions (Al-Mughairy, 1985). 
 
Since the late 1970s until the present, the health services in Oman developed rapidly and 
made major steps in providing good health services available for Omanis. The MOH funds 
the entire public health sector in Oman, so it was a national public-care model (Ministry of 
Health – MOH, 2014). In 2013, the public sector was composed of 49 hospitals and 195 
other health facilities (Ministry of Health – MOH, 2014). There were five other hospitals 
and 50 other health facilities, which are public but managed by other authorities such as the 
Royal Oman Police and Sultan Qaboos University. Also by this point, the MOH expanded 
the renal dialysis services to cover main regions of Oman through building 18 renal 
dialysis centres across the county. The private sector owned 12 hospitals, 1026 clinics, and 
537 pharmacies. The private sector health services are monitored by MOH (Al-Mughairy, 
1985; Al-Kharusi, 1995).The total workforce for public and private sectors was 7,673 
physicians and 16,930 nurses at the end of 2013 (Ministry of Health – MOH, 2014).  
 
The current main mission for the MOH is “to enhance the health and wellbeing of all the 
people of Oman by ensuring the availability of comprehensive health services throughout 
the Sultanate” (Ministry of Health – MOH, 2014). The ministry puts huge efforts and 
funding into the good planning of health services (including renal services), into education 
and training, and into development and research of all health concerns including renal 
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diseases, however, it is also a critical responsibility of the ministry to manage its expanding 
services, and the consequent increases in demand for human resources, technology, 
medical and other resources (Ministry of Health – MOH, 2014). The general population 
and the renal sub-population of Oman are exerting increased pressure on the health sector 
to respond to their needs and demands. The ministry in response had increased the number 
and the quality of renal care since 1980 and until present as it will be illustrated later on in 
this thesis under the results of study one (see p. 90). 
 
 
3.2 Economic status 
Oman is a high-income country (Ministry of Health – MOH, 2014). Oman’s economy 
depends on oil, gas, trade and budget surpluses.  At the end of March 2015, Oman had 1.7 
billion OMR (3.1 billion GBP) net oil revenue. Oman exported 344.4 million oil barrels in 
2014, mainly to the USA, Japan, and Korea compared to 283 million oil barrels in 2005, 
(The National Centre for Statistics and Information - NCSI, 2015). 
 
Additionally, Oman depends on non-oil resources to support its economy, for example, 
mining, tourism, agriculture and fish exports. Oman produces minerals such as chromite: 
142.2 million OMR (255.4 million GBP) was the total value of the mineral produced in 
2014. Agricultural goods production was 1,514 tons in 2014 compared to 989 tons in 2005; 
the fish production was 211 tons in 2014 compared to 158 tons in 2005 (The National 
Centre for Statistics and Information - NCSI, 2015). Omanis who live on the coast depend 
widely on fish and seafood as a source of income and as a main source of nutrition. 
However, this may change since fast-food is now widely accepted and eaten among the 
younger generation of Omanis which might have a negative impact on population health in 
general and may help in seeing more of kidney diseases among young population. 
 
Oman had rapid economic growth especially in the years 2006-2010 where the Gross 
National Income (GNI) jumped from 8.3% in 2000 to 11.1% in 2010. The GNI has 
decreased relatively since 2011(Ministry of Health – MOH, 2014), and that may possibly 
be due to the decline in oil prices. Oman is actively trying to invest in non-oil resources to 
avoid any fluctuation in the income of the country. 
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The total expenditure for the Oman’s MOH increases steadily on an annual basis. In 2003, 
the MOH expenditure was 148.9 million of OMR, and this was 5.4% of total government 
expenditure (The National Centre for Statistics and Information - NCSI, 2015). In 2013, 
the MOH spent 593.7 million OMR, which was more than a 400 million OMR increase in 
spending, but it was equal to only 5.5% of total government expenditure (Ministry of 
Health – MOH, 2014). Oman was one of the three lowest spenders on health services 
among the Gulf member states (Ministry of Health – MOH, 2014). Also, it is not known 
the amount of expenditure on renal care so far, because the MOH did not include this in the 
annual MOH health report or any other publications. 
 
 
3.3 Socio-cultural status 
More than 90% of Omanis are Muslim and Arabs. The first general census of the Omani 
population took place in 1993, and then in 2003 and the last in 2010 (The National Centre 
for Statistics and Information - NCSI, 2015).The population of Oman has increased from 
two million in 1993 to about four million by mid-2014. The population of Oman is not 
purely Omanis, and there are a considerable proportion of non-Omanis or expatriates such 
as Indians. The percentage of non-Omani has changed dramatically from 26.8% in 1993 to 
43.4% in 2014. In 2014, Oman had over 1.7 million expatriates compared to nearly 2.3 
million Omanis (The National Centre for Statistics and Information - NCSI, 2015).The 
breakdown of the general population per governorates is available in the following table (  
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Table  3-1). So far, there is no statistics highlighting the kidney failure number of patients 
in Oman in relation to Omani population in particular or in relation to non-Omani 
population in particular. The available statistics are for the general population. 
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Table ‎3-1 The‎breakdown‎of‎Oman’s‎population‎in‎mid-2014 
Pop. 
Density 
(Km2) 
Area 
(Km2) 
Omani Expatriate Total 
*Pop. 
Governorates 
310.4 00133 470,085 740,395 1,210,480 The capital 
81.3 900,33 446,444 209,429 655,873 The north subdivision 2 
270,748 89,773 360,521 The north subdivision 1 
14 000,33 181,659 85,663 267,322 The east subdivision 1 
157,211 84,920 242,131 The east subdivision 2 
12.6 090133 310,774 92,238 655,873 The interior 
4.2  ,,0333 137,303 48,293 185,596 The west 
- - 49,695 50,142 99,836 The west end 
3.8 110033 189,501 188,005 377,506 The south 
3., ,10,33 21,994 18,942 40,936 The middle 
22.1 90833 25,292 14,521 39,813 The peninsula 
- - 0 109,867 109,867 Not stated 
- - 2,260,705 1,732,188 3,992,893 Total 
*pop.,  population, the governorates highlighted in blue were the settings of this research 
 
The most densely populated governorates are the capital followed by the north subdivision 
2 and the south (Figure  3-1). The Omani population is a young population where ~90% of 
the population is under the age of 50. The age group 0-19 years are 44.8% (~ one million); 
20-49 years are 44.3 % (~ one million); and 10.9% (~ 250 thousand) are aged over 50 
years old. Omani males to females are in this ratio (males) ~1.14 million: (females) ~1.12 
million and in percentage the ratio respectively 50.6%:49.4% (The National Centre for 
Statistics and Information - NCSI, 2015). 
 
The last formal census conducted in 2010 showed that the size of families in Oman is large 
with an average of 7.8 persons per family. Oman still has an extended-family framework 
where sometimes the grandparents, parents, and children live together in one large house. 
The Omani World Health Survey conducted in 2008 showed the median monthly 
household income was 360 OMR (643.5 GBP) and 81.2% of Omanis get their income 
from wages and salaries. In a survey called “Household Expenditure and Income” survey, 
which was conducted in 2010-2011, results showed an increase in the median monthly 
income to 904 OMR (~1,616 GBP - Ministry of Health – MOH, 2014). 
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Figure ‎3-1 Omanis population distributed across governorates of Oman, 2014 
© National Centre for Statistics and Information, 2015 
 
In general, Oman provides good general services for its population. Most Omanis work in 
civil services mainly in education or health and in defense/military sectors. In 2012, Oman 
had ~ 1.7 million workers, 85.8 % were Omanis (Ministry of Health – MOH, 2014). 
 
Oman has two main types of education, the basic education which is on three levels: level 
1 (primary) grades 1-4 (ages 6-9 years old); level two grades 5-10 (preparatory, ages 10-15 
years old); and level three 11-12 (Secondary, ages 16-17 years old). There were more than 
half a million Omani students (~596 thousands) enrolled in basic education in the academic 
year 2014-2015. Also, Oman has provided literacy centres for people who are not able to 
enroll in the basic education systems because of many and different reasons such as old age 
and job commitments (The National Centre for Statistics and Information - NCSI, 
2015).There were 908 literacy centres in the years 2012-2013 serving nearly ten thousands 
students, of which 97% of these students were women. The illiteracy rate in Oman appears 
to be declining since 1970s and until 2013 as the illitracy rate among 15 year-old Omanis 
reduced to about 14% by 2013 (Ministry of Health – MOH, 2014). 
 
The other type of education is higher education, where the graduates of basic education go 
next to pursue their education and training to be prepared to work in the business market. 
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The higher education can be vocational training centres, fishing institutes, applied sciences 
colleges, technical colleges, military and security colleges, institutes of health and law, and 
university education. Currently, Oman has only one public university called Sultan Qaboos 
University, but there are a few private universities such as Nizwa University (Ministry of 
Health – MOH, 2014). Education is an important pillar for country development as a whole 
and for health development in particular either for the general population or for the renal 
sub-population. Government expenditure on education was 8.7% in 2014 compared to 9% 
in 2010. 
 
 
3.4 Technological Status 
Technologies in different forms, like data technologies, communication, electricity, and 
transportation, are well represented and available in Oman. Oman is well connected 
externally with the world by two international airports, one in the capital and the other in 
the south governorates (The National Centre for Statistics and Information - NCSI, 2015). 
There are three sea ports in Oman in the north, in the south and in the capital governorates. 
Oman internally is well connected by good road networks. Most people of Oman use cars 
for transportation. The country has a good national bus service that’s mainly in the capital, 
and which is mostly used by expatriates, there are no trains or undergrounds (Ministry of 
Health – MOH, 2014), but there is a plan in place to launch train transportation across the 
GCC countries as soon as possible. However, most Omanis own cars and it is the main 
mode of transportation. It is very rare to see people walking to their destinations in Oman, 
which has contributed to low physical activity among the Omani population. 
 
Telecommunication services are well provided across the country. The people in Oman 
have become more aware of the practicality of mobile phones and therefore the subscribers 
increased about thirty-two-fold between 2000 and 2012, while internet subscribers 
increased fourfold within the same period (Ministry of Health – MOH, 2014). The 
government of Oman is interested in adopting the new technologies that benefit the 
development of the country. Therefore, an Information Technology (IT) authority was 
established in 2006 called “Information Technology Authority” to supervise and 
implement the IT evolution in Oman. Nowadays there is an ambitious IT project taking 
place in Oman called e-government, where the country is trying to transform the paper-
based work to become an electronic-based business (Ministry of Health – MOH, 2014). 
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In contrast to the present high standards of technology and infrastructure, in the past the 
people in Oman faced great difficulty by not having modern roads, electricity, and 
telecommunications services. For example, the physicians and nurses had to travel 
occasionally to outreach patients who lived in remote places like the north governorates. 
There were no modern highways, which meant that the travel mission of health personnel 
was undertaken with great difficulty. These medical tours could take 7-10 days of travel by 
a four-wheel Land Rover vehicle. Also, there were many patients (including kidney disease 
patients) who died while they were escorted to the capital for medical treatment on old 
trucks,  donkeys or camels. Moreover, the lack of telecommunication devices like 
telephone created massive delays in delivering the health services to patients around the 
country at that time (Al-Kharusi, 1995). Also, with no proper form of electricity before 
1970, patients and health workers could not find relief from the harsh heat of Oman’s 
climate, especially during summer. The harsh-hot weather that is prominent in Oman could 
be one of the factors led to freqeunt body dehydration and therefore frequent kidney 
problems that might cause kidney failure. 
 
Currently, all the hospitals and health facilities have very good services of electricity, 
telecommunication, technologies, and they are very well connected by asphalt roads. 
However, the internet revolution is progressing fast, and the authorities in the health sector 
have to continue appraising this and all available technologies, to cope with the 
international development and to satisfy clients’ needs. Nowadays health sector facilities 
can be connected with a country network where patients’ data can be accessed anywhere. 
However, this advancement is under development and not yet fully accomplished in Oman. 
Also, the Oman’s MOH has an e-health portal where all essential information about the 
ministry and distircts’ hospitals are available. This portal is comprehensive and 
commuicates many types of information such as the services and latest news of the Oman’s 
MOH. It presents statistical reports and some research studies’ results. Though this e-portal 
is useful for general information gain, but regarding the renal care is of limited use because 
it is not sepcialized e-portal and there is no renal database included and no sepcialised 
educational programmes are structured for renal concerned parties within this e-portal. 
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3.5 Legal status 
The basic law of the country is implemented by all the citizens and people of Oman. The 
“Supreme Council of Justice” and the “Supreme Courts” are the bodies ultimately 
responsible for making sure that the law is implemented and protected by everyone living 
in Oman. The “Basic Law of the State” was last reviewed and updated in 2011 (Ministry of 
Health – MOH, 2014). 
 
The Oman Ministry of Health has its policies and rules which are governed by the general 
law constitution of Oman. The right of the patients and workers in the MOH are protected 
by law. The Health Minister is the highest authority, in MOH, who has to ensure the 
running of the right laws in place, and he is assisted by three undersecretaries, and they are 
respectively the undersecretaries of; planning, health affairs, administrative and financial 
affairs (Ministry of Health Oman - MOH, 2016). The MOH has the needed laws and rules 
to regulate the health affairs in Oman and the renal services in particular. However, the big 
challenge facing the MOH is ensuring that the employees and the clients stay informed of 
the rules and regulations of the ministry at all levels of the organisation (Marmol, 2015). 
 
 
3.6  Environmental status 
Oman consists of different topographical areas such as plains, wadis or dry river beds and 
mountains (Ministry of Health Oman - MOH, 2016). The plain extends on 3% of Oman’s 
land area; the mountains area is about 15%, and the sand or desert area is about 82%. Most 
people of Oman live in the plains and mountain areas (National Centre for Statistics and 
Information - NCSI, 2015). 
 
The climate of Oman is variable across the governorates, and it is different in summer than 
winter, as those are the two seasons experienced in the country. In summer the weather is 
hot and humid in the coastal areas, and it is dry and hot in the interior areas. The weather is 
pleasant in the mountains, with cold periods in winter, and in the south of the country. The 
temperature varies from -1 to 49ᵒ C. The humidity ranges between 2 to 100 % (The 
National Centre for Statistics and Information - NCSI, 2015). 
 
The rain falls irregularly, but heavy rains can fall at some times of the year. The south 
governorate is an exception, which has regular and heavy rains between June and October.  
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The rainfall reported in millimeters in 2014 ranges between 0.4 mm to 274 mm across the 
country (The National Centre for Statistics and Information - NCSI, 2015). Oman depends 
widely on the purification of sea water or “desalination plants”. Currently, Oman has a 
4500 km long piped network where the treated water is distributed among households. The 
data showed that 87% of population use safe drinking water and 77% use safe water in 
general in 2010 (Ministry of Health – MOH, 2014). Accordingly if that later percentage 
(77%) is accurate, then it is worthwhile to investigate the impact of unsafe water on the 
remaining 23% of the population especially in relevance to occurrence of kidney diseases. 
 
Also, Oman has a unique method of water channels called “Falaj”. It is an ancient method 
established by old Omanis and yet still used. The old Omanis made Falaj to transport the 
water falling from the mountains or underground to the earth surface and so this water is 
carried by Falaj channel under the earth’s natural gravity to reach mainly farms. This water 
is pure water and is used for different purposes such as drinking and farm irrigation. Oman 
has Over four thousands Falajs, but only ~ three thousand are currently in use (Ministry of 
Health – MOH, 2014). 
 
An important point to mention here is the effect of cyclones and earthquakes on Oman, 
which is usually very limited. Oman has had five known cyclones in its history and these 
are; 1977 Oman cyclone, 2002 Oman cyclone, 2007 Gonu, 2010 Phet, and 2011 Keila. The 
cyclone in 1977 caused some damage where it killed around 105 people and left ~ 50 
thousands homeless. The major damage caused by a cyclone in recent years was Gonu in 
2007. Gonu killed 50 people and cost some few billions of U.S. dollars in damage 
(Ministry of Health – MOH, 2014). These natural disasters can delay patients from seeking 
medical attention during these disasters and can delay kidney failure patients from 
attending their dialysis sessions. 
 
The Oman’s Ministry of Regional Municipalities and Water Resource is the body 
responsible for environment, food and water safety in Oman. It has rules and regulations in 
place to organise, monitor and inspect the safety of the buildings, food, and water in the 
country (Ministry of Regional Municipalities and Water Resources – MRMWR, 2015). 
However, the Ministry needs to increase the awareness of Oman’s population about things 
like: the environmental standards they need to follow in building their houses, for example; 
how to save renewable energy; climate change and its impact on Oman’s weather and 
health; transport pollution and other types of pollution and their impacts; and the benefit of 
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recycling for the environment. The bad environmental factors can cause critical health 
problems for popultions such as kidney failure which can occur sometimes because of long 
time lasting dehydration or drinking large volumes of contaminated water. Also, food 
safety is a growing concern in Oman secondary to food products deception that were 
recorded recently in Oman like the expired raw rice that were about to be selled for people 
in Oman. 
 
 
3.7 Health sector in Oman 
 Modern medicine started in Oman sometime in the nineteenth century (Al-Kharusi, 1995) 
and Muscat Charitable Hospital was probably the first hospital that opened after 1910. In 
1933,  Arrahma Hospital in the capital was established by the American Mission, which 
was an American non-profit organisation in Oman. In those days there were severe 
shortages of physicians, nurses and other health professionals. The duty started at 6 a.m., 
and it might end at 9 p.m. or later. A physician could see 200-300 patients within one day, 
in addition to their other duties like requesting medications and other administrative work 
(Al-Kharusi, 1995). 
 
Nurses undertook other responsibilities in addition to their caring roles, for example, 
sewing patients’ gowns and planting trees in the hospital garden. The health workers at that 
time worked under a great deal of pressure (Al-Kharusi, 1995). Some strange situations 
could also be described, for example, some patients (Bedouins) preferred the outdoor space 
if admitted to the hospital, which means they were kept under the shade of the trees (Al-
Kharusi, 1995). The trees were numbered in replacement of bed numbers, and doctors 
would see and check these patients as well as the indoor patients.  
 
The most commonly diagnosed medical problems at that time were anaemia, trachoma, 
malaria, tuberculosis and intestinal parasites. Inguinal hernias, Caesarian sections, 
circumcisions and orthopaedic cases were the most common surgical cases (Al-Kharusi, 
1995). Al-Kharusi (1995) noted in her article that diabetes, heart diseases, gall bladder 
disease, and acute appendicitis were very rare in those days.  
 
At present, Oman’s health indicators have improved from the earlier years. For example, 
the life expectancy at birth increased from 76.1 in 2010 to be 76.6 in 2014 (life expectancy 
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in 1970 was only 40 years). Now, Oman’s population life expectancy is considered among 
the highest in the world for +70 years. The crude death rates per 1000 population decreased 
from 3.1 in 2010 to be 2.9 in 2014 which demonstrates the reduction in the mortality rate 
that took place over these years, and implies that there has been an improvement in the 
health services provided for Omanis. 
  
Also, the statistics show that the recorded total live births were ~ 83 thousands in 2014 
compared to ~ 65 thousands in 2010. The recorded total death was 7.8 thousand in 2014 
compared to 7.4 thousands in 2010. Also, Oman has achieved a very important thing in its 
recent history which is establishing, controlling and delivering a successful immunization 
program. Oman achieved at least 90% childhood immunization coverage, and it was one of 
the 12 countries that achieved the year 2000 target which was set by the “World Summit 
for Children 1990” (Ministry of Health – MOH, 2014). Also, the MOH was able to reduce 
the communicable diseases rates to 43 % in 2012. In 2008, the Oman World Health Survey 
(OWHS) was conducted study to assess Omani individuals’ satisfaction with their health 
and their aspects of life using the World Health Organisation Quality of Life (WHOQoL) 
scoring tool. The survey reported that 82% of Omanis are satisfied with their quality of life 
(Ministry of Health – MOH, 2014). 
 
Currently, the health sector in Oman faces number of challenges such as: having a small 
population with a high ratio of expatriates, which challenges the distribution and allocation 
of the health services while maintaining equity and access to health services, especiallly 
with continuously changing expatirate ratios and context; the difficult landscape and 
topography of Oman as huge areas of Oman, where some Omanis are scattered and live in 
a high rough mountains and barren valleys and this is a barrier to accessing health serviecs; 
the high expectations and demands of the Omani population towards the health services in 
Oman which require improved service quality; the expectation of the international 
community for the health services in Oman to provide high quality health services, equity 
among people and good responsiveness for its stakeholders (Ministry of Health – MOH, 
2014). 
 
Accordingly, for the Oman’s MOH to cope up with all the expected challenges, it 
attempted to visualize the future of the health services in Oman until the year 2050 and 
made a strategic plan called “The health vision 2050”. The main aim of this vision is that 
“the Omani people live healthy and productive lives through establishing a well-organised, 
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equitable, efficient and responsive health system, grounded by social values of equity and 
social justice” (Ministry of Health – MOH, 2014). 
 
The demographic analysis of the vision 2050 showed that the total population is predicted 
to be more than seven million by 2050. There will be an age shift where the elderly ratio 
will increase to be 13.1% compared to 10.7% in 2014. Also, the epidemiological profile of 
the country is rapidly shifting to an increase in non-communicable diseases (Ministry of 
Health – MOH, 2014). The evolution and development of the country have perhaps 
contributed to raising the prevalence of such risk factors among the Omani population as 
obesity and high cholesterol levels. For example the Ministry of Health (2014) reported 
that: 35.2% of Omanis were hypercholesterolemic, 32% had low-density lipoproteins, 
29.5% are overweight, 24.1% are obese, 75% of hypertensive patients do not know about 
their high blood pressure, and 52% of diabetic patients do not know their increased blood 
sugar levels. The prevalence of diabetes has increased from 8.4% in 1991 to 13.2% in 
2008. In Oman, the two known leading causes of hospital death were cardiovascular and 
neoplastic diseases (Ministry of Health – MOH, 2014). 
 
Research is one of the most important visions the MOH is looking to improve. The MOH 
had identified research as an area of deficiency. Since 2001, the MOH incorporated 
research in the five-year health development plan, yet there is much work still to be done to 
embed the research culture in Oman. The country’s interest in research is represented in 
three main sites, first the Sultan Qaboos University (SQU), which has nine research 
centres; then the MOH which is central research centre; and recently the Research Council 
(called TRC) which is a national research model that provides an open research grant for 
eligible applicants, especially those who choose a research topic of a national priority. 
Currently, the national research priorities for MOH are for example, NCDs, road traffic 
accidents, molecular biology, and genetics. 
 
Within the 2050 vision, the Ministry has developed sub-visions to provide a framework for 
the development of research in Oman. These sub-visions are: 
 
o Vision 1: Availability and accessibility of reliable, relevant, up-to-date and timely 
health and health-related information ensured. 
o Vision 2: Sustainable funding for health research and development ensured. 
o Vision 3: Health research directed to identify priorities. 
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The Oman’s MOH has to sustain a source of funding which will help in achieving all the 
vision planned by 2050. This sustainability is very challenging since the income of Oman 
is declining because of the reduction in the oil prices in the international market. Renal 
care is also one of the health services that struggling to sustain persistent fund to keep this 
important services running up to the golden standards and free of charge to enhance 
accessibility and equitability. 
3.8  Conclusion 
Since the 1970s and until the present, Oman as a country has achieved a lot of growth in 
political, economic, social, technological, legal and environmental areas. Politically Oman 
is a stable and peaceful country; continuing to follow the same approach will help the 
country and its people to grow and develop further. 
 
Economically Oman is growing fast, but this is sometimes disturbed by any decline in the 
value of oil. So the country has to shift the income source from oil to non-oil because the 
oil resources will not sustain forever. Oman and its health sector have to be well prepared 
for any fluctuation in the economy, so the consumer at all times will maintain stability and 
satisfaction (Marmol, 2015). The Omani government and the health sector especially have 
to make critical observations on key economic indicators of the world, and consumption 
trends to amend their policies as needed (Marmol, 2015). 
 
Oman’s location is very important and having the Strait of Hormuz (shared with Iran) 
gives the country double importance as no sea entry can be made to the GCC or exit 
without crossing the Strait. Oman can make very good use of this Strait through the 
application of reasonable customs fees and taxes if access is to be made by foreigners. The 
administrative distribution of Oman to governorates make it easier for the governors and 
the authorities to manage the country more effectively. This distribution can be utilised 
further to develop strategic plans to develop the governorates and their people further. 
 
The social status of the Omani community is good, and the rapport between families is still 
strong. Also, Omanis as a nation like to help and support others and they are known for 
their hospitality and decent behavior. Omanis are living densely in the capital, the north 
and the interior governorates. The authority may need to overlook this by providing a good 
ratio of services to proportion of the population wherever needed. Also, the capital is a 
very dense governorate and people from the other governorates travel to the captial for 
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work and sometimes decide to live in it. This issue needs in depth study to see the impact 
of this on the whole Omani community. For example, road traffic accidents are high in 
Oman, might be secondary to the frequent use of roads while travelling from governorates 
of Oman, espically from and to the capital.  
 
The population of Oman is growing, and the country has to be prepared for this by 
increasing and improving the services especially of education and health. The education 
sector can work more on eradicating illiteracy and providing all kinds of education for 
Omanis. Education is an important tool used to increasing the health awarness among 
public espically toward preventing health problems such as kidney failure. The proportion 
of non-Omanis is currently high, and the country may need to study the impact of this on 
the system of Oman. Also, household income might be increased in a country with a high-
income like Oman. Transportation and technologies are good and sufficient, but these can 
be developed further. The environment gets great attention from His Majesty and therefore 
it is well taken care of. The healthy water resources need to be maintained and made 
available for all people of Oman. 
 
The health sector has achieved great things from 1970 until the present. The Vision 2050 is 
a very important document, and if implemented well it will upgrade the whole health 
system to a  high-quality international system. Funding for health services needs to be 
secured and sustained. The MOH now is in a critical stage after setting the vision 2050. 
The low spending on health services in Oman needs to be increased, for example, in the 
UK spending has increased in the past 50 years from 3.4 % to 8.2 % (Appleby, 2013). The 
USA was reported as the highest spending country on health services at 17.6% (Ministry of 
Health – MOH, 2014). However, Oman compared to the UK, and some other countries is 
considered low in spending on health services. Oman is aiming to increase the total health 
expenditure by 8-10% by the year 2030 (Ministry of Health – MOH, 2014).  
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4 Methods of study one 
 
4.1 Overview 
The entry point to this research was the author’s interest in kidney failure as a health 
problem affecting some people in Oman and around the world. Polit and Beck (2012) 
suggest that a personal interest in the topic is a “critical ingredient” in establishing good 
research. This interest prompted the author to review the existing literature to determine 
what was known and what was not yet known about kidney failure in Oman. The 
development of the conceptual framework for this research began from the point of the 
literature review. The initial reviewed literature addressed limitations in many knowledge 
aspects of kidney failure in Oman, more obviously a gap in the epidemiology of this 
disease. Disease epidemiology is an essential science that most of research pathways start 
with and build future research on its indications.  As a result, the research questions were 
developed to focus on: (1) the development of RRT care in Oman from the outset, and 
identifying the main epidemiological variables of this health problem, and (2) identifying 
the socio-demographic characteristics, primary diagnosis, risk factors, co-morbidities, and 
death figures of kidney failure patients undergoing regular dialysis in Oman. These 
enquiries could perhaps be answered by reviewing the related literature, but there was no 
sufficient literature available at that early stage in 2013. Therefore, the primary aim was to 
develop a research study to gather some essential statistical data on kidney failure in Oman 
and make this available and accessible.  
 
For this reason, this study consists of epidemiological research. However, for years, and by 
a number of researchers, epidemiology has been considered atheoretical, or a tool kit which 
helps science but does not theorize its science (Bhopal, 2008). On the other hand, Weed 
(2001) argued that epidemiology cannot be atheoretical due to the continued relevance of 
many theories, such as germ theory and epidemic theory, to the science of epidemiology.  
The major core theories of epidemiology reported by Weed (2001) were theories of disease 
occurrence and causation, theories of health, theories of probability, statistics and error, 
and theories of ethics.  
 
Weed (2001) pointed out that theories of disease occurrence and causation are the most 
fitting theories for the science of epidemiology. The multi-factorial causation theory, which 
fits under disease occurrence and causation theory, is the most common framework used 
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by epidemiologists to understand the cause and effect relationship for diseases (Bhopal, 
2008). The idea of this theory is that the disease occurs as a result of the interaction within 
the triangle of causation. The triangle of causation consists of the host, the agent, and the 
environment (Bhopal, 2008).  
 
The triangle of causation model can be used to understand and analyse the causal 
relationships between kidney failure occurrence and the multi-factorial causes (Figure  4-1). 
The best design to test the cause and effect relationships between variables is randomised-
control trials (Killam, 2013). However, the purpose of this study was not to examine cause 
and effect but to focus on creating the data related to kidney failure occurrence and its 
possible causes, not yet testing the relationship between kidney failure and its multi-
factorial causes. 
 
Figure ‎4-1 Kidney failure causation triangle (Bhopal, 2008) 
4.2 Introduction 
The clear conceptual stance, clear paradigm selection, and good determination of the 
research design are necessary steps toward successful answering of a research inquiry. In 
nursing research, the research inquiry has been conducted within two broad paradigms 
which are positivist paradigm and constructivist paradigm (Polit and Beck, 2014). The 
constructivist paradigm or naturalistic paradigm is mainly associated with qualitative 
research. This paradigm views reality as multiple and subjective, and follows the inductive 
process, interacts with those being researched to create findings, and seeks in-depth 
Host 
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understanding of the studied phenomenon (Polit and Beck, 2014).  On the other hand, the 
positivist paradigm is mainly associated with the quantitative research. It follows the 
deductive process; the researcher is independent from those being researched and seeks the 
objective and quantifiable measurement of the studied phenomenon.Positivism embeds a 
scientific approach where the scientist uses a scientific-systematic approach to study a 
question of interest and importance. The data gathered by this study used a scientific-
systematic approach as well by following a pre-determined plan (protocol). The data 
generated are usually numeric information, which results from some formal measurements 
and which are analyzed with statistical procedures (Polit and Beck, 2012).  The assumption 
that guided the positivist paradigm of this study is ontologic which means in this case that 
kidney failure occurrence exists in reality and this phenomenon could be driven by natural 
causes (Polit and Beck, 2012) 
 
 The function of the research design is to answer one or more research questions. On the 
other hand, one research question can be answered by more than one type of research 
design (Katz et al., 2014). Research questions can be answered by numerical values 
(quantitative) where the intention is explanatory and deductive, or by narrative data 
(qualitative) where it is mainly exploratory and inductive (Claydon, 2015). Inductive and 
deductive paradigms are complementary and are both of importance in understanding a 
phenomenon (Polit and Beck, 2012). However, it is claimed that both paradigms are 
descriptive and that neither one is better than the other (Katz et al., 2014). It is the quality 
of the data gathered that gives the research study more or less credibility (Katz et al., 
2014). The paradigm or design selected should serve the ultimate goal of generating a good 
quality of data that fills a knowledge gap (Polit and Beck, 2012). The selection of the 
design can depend on a number of criteria, such as the clinical topic (e.g. rare or common 
disease), cost, and availability and accessibility of the data (Katz et al., 2014). 
The quantitative approach is selected because of the types of questions the quantitative 
research looks at. This research study posed some research questions related; mainly to 
describing the phenomenon of kidney failure in Oman; and to some extent exploring the 
risk factors and antecedents of this phenomenon. The quantitative description as stated by 
Polit and Beck (2012) and Polit and Hungler (1999) involve the prevalence, incidence, size 
and measurable attributes of a phenomenon (i.e. epidemiology). Description in quantitative 
research poses questions like; how prevalent is the phenomenon? How often does the 
phenomenon occur? And what are the characteristics of the phenomenon? (Polit and Beck, 
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2012; Polit and Hungler, 1999).  These questions are exactly the same questions this study 
asked. Why this study asked these questions and perhaps no other questions was because 
the epidemiological data of kidney failure in Oman at the time this research proposed was 
scarce, and so providing this type of data can be the base for establishing a research base 
for this phenomenon (Hussanien and et al., 2012). 
 
The data available on the Oman’s treated kidney failure population at the time this project 
was planned, was limited. So to gather sufficient data about the studied health problem, an 
overall quantitative, mixed methods approach was selected. Also, qualitative data can 
generate a detailed amount of data, often more than quantitative, however it is less concise 
and serves a different purpose such as interpreting people experiences. It was anticipated 
that by conducting a quantitative study, the data generated would form the database which 
would potentially help in forming a renal registry for Oman, and in mapping the road for 
the future research needed in this field. Accordingly, this study was underpinned by 
quantitative research questions, where the research’s major concepts were incidence, 
prevalence, death figures and characteristics of the treated kidney failure patients in Oman. 
These concepts are frequently used in epidemiological studies to describe, analyse, and 
interpret disease patterns (Bhopal, 2008).  
Though the mixed approach of quantitative and qualitative combined is popular nowadays, 
however, the selection of the research approach always depends on the aims and research 
question chosen. Any researcher is advised to choose their research approach to the best 
way that her/his research enquires can be answered. Accordingly, the author chose the 
mixed quantitative approach because it was the best way seen to achieve the research aims. 
The author believes that at this stage there is a need to develop more objective and precise 
knowledge base, on kidney failure in Oman, which can be achieved by following the 
quantitative approach, though, the debate on the best research approach will continue. 
Some researchers support the mixed research approach and others support the entire 
separation of the quantitative approach from the qualitative approach (Hughs, 2014). In 
particular there are wider claims supporting the quantitative approach over the qualitative 
approach as the quantitative is seen as the most scientific and objective approach (Hughs, 
2014).  However both approaches have strengths and limitations. For example the 
quantitative approach is more précised and controlled but on the other hand it fails to 
interpret peoples experiences based on their uniqueness (Hughs, 2014).  The qualitative 
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approach is more subjective but though it gives deeper insights on people experiences and 
differences which help to understand people’s behaviours and actions (Hughs, 2014).  
Accordingly, it all depends on the type of scientific inquiry chosen. Ultimately, the 
selected research approach should satisfy the main goal of research which is discovering 
the true knowledge and finding the maximum possible facts to understand a phenomenon 
or a problem and thereafter find the solutions. Both research methodologies, quantitative 
and qualitative are important and complementary to each other at some instances. 
 
 
4.3 The study’s design 
This first study was a secondary data analysis for the data obtained from the RRT register 
in Oman, and from the annual health reports (see appendix E-1, p.266 ), and published 
resources (see appendix E-2, p.267). The RRT register of Oman contains baseline statistics 
in relation to RRT population of Oman such as treatment modality, sex (see appendix E-3, 
p.268), regional distribution of RRT patients (see appendix E-3, p.268) annual death 
figures and causes of death.  
 
This study measured the following; prevalence of Oman’s RRT (1983-2015), incidence of 
Oman’s RRT (1983-2015), death figures for Oman’s RRT (1983-2015), and cost of 
dialysis treatment of Oman (1998-2015). The prevalence of Oman’s RRT (1983-2015) is 
defined by this study as the number of kidney failure cases that reported in Oman’s 
population in a whole annually since 1983 to 2015, and in the northern region of Oman 
population in particular (2014-2015) with major focus on dialysis statistics (as kidney 
transplantation statistics is not fully maintained and not fully reported on the same level of 
dialysis treatment in Oman). The incidence of Oman’s RRT (1983-2015) is defined by this 
study as the number of new kidney failure cases that reported in Oman’s population in a 
whole annually since 1983 to 2015, and in the northern region of Oman population in 
particular (2014-2015) with major focus on dialysis statistics. The death figures of Oman’s 
RRT (1983-2015) is defined by this study as the number of death among RRT population 
that reported either annually or monthly since 1983 to 2015, and in the northern region of 
Oman population in particular (2014-2015) with a major focus on dialysis statistics. The 
mid-years population estimates were obtained from the National Center of Information and 
Statistics of Oman who publish the annual census of Oman on regular annual basis. 
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The variable of the cost of dialysis treatment of Oman is defined as the healthcare 
utilization in terms of dialysis sessions direct cost, which can be used as a proxy for disease 
burden of the healthcare system of Oman. There is no published data available on the 
direct or non-direct cost of RRT in Oman. However, this study attempted to calculate the 
cost of the dialysis sessions overall Oman because the statistics of total dialysis sessions 
were published by Oman’s MOH webpage. The direct cost of a single dialysis session in 
the public sector was given by MOH as 49.8 Omani Rials (49.8 OMR = 104.7 GBP). The 
cost of dialysis sessions for the years 1983-1997 was not possible to calculate because the 
total number of dialysis sessions was not available. The cost calculated here is the direct 
cost of the dialysis treatment only and not taking into account the cost of staffing, 
equipment, and other non-direct costs. This information is needed by the policy makers to 
map the future policies based on field evidences. The evidence regarding the potential 
economic burden secondary to high expenditure is necessary to be disseminated to 
persuade the policy makers to allocate more fund or resources or to re-allocate resources in 
a way benefiting the public health (World Health Organisation- WHO, 2009). Mainly this 
part of the study is providing data  on how much does the government pay for medical and 
may be for other direct expenses because of dialysis treatment. To measure more 
economical impact of RRT of society of Oman and health services, this will need further 
economic focused design which can be undertaken in the future. 
 
This design in selected to achieve the following research objectives and answer the 
following research questions:  
 
 Study one objectives 
1. To identify the major milestones of Oman’s RRT development. 
2. To identify the incidence, prevalence, death figures, cost and other significant data 
related to Oman’s treated kidney failure population, such as causes of death.  
3. To explore the status of publications related to kidney failure in Oman. 
 Study one research questions 
1. In Oman, how have RRT developed from the outset? 
2. What statistics are available in Oman for dialysis and kidney transplantation, i.e. 
incidence, prevalence, cost, diabetes mellitus (DM), and hypertension (HTN)*?  
3. What pattern emerged from the gathered statistics? 
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4. On the national and international level, what information/studies are available 
concerning kidney failure, dialysis, and kidney transplantation in Oman since 1980? 
*DM and HTN censuses were needed to identify if they are the major causes/risk 
factors leading to kidney failure in Oman. 
 
 
4.4 The study settings 
The data answering the research questions number one and four were gathered mainly from 
the Sultan Qaboos University Medical Library (SQUML), which is the biggest literature 
source for health sciences in Oman. This library was visited by the author in the capital to 
access and gather all local and national published data related to Oman’s RRT population, 
from the 1980 until 2013. Some information about RRT development and publications 
were provided by the current nephrologist in charge of what will be called in this thesis as 
the central RDC. This central RDC is situated in the capital of Oman. In this RDC, all the 
routine and input data about the registred kidney failure patients and their RRT was 
gathered from all of Oman’s RDCs and stored in the central RDC. This RDC was 
frequently visited by the author, and all the statistics available and data related to this study 
were gathered. Also, an online literature search was conducted to satisfy the research 
question number one.  
 
Research question two data were gathered from the RRT register in Oman. According to 
Al-Ismaili et al. (2017), the RRT register data are retrieved in the central RDC, and the 
data are collected using USRDS 2728 survey form, which must be completed by the 
assigned nephrologists in all RDCs around the country once a person reached chronic 
kidney failure stage. All the data retrieved in the central RDC were checked and entered by 
nephrologists and rechecked by two other nephrology team members’ using the computer 
software program Microsoft Access (Al-Ismaili et al., 2017). That process has been 
followed since 1998. The data from the previous years were collected and added 
retrospectively from patients’ files from the only RDC that exist at that time in the capital 
(1983-1997) before the central RDC establishment in 1998 (Al-Ismaili et al., 2017). Most 
of the data obtained from the RRT register were on RRT populations’ incidence, death 
figures, and causes of death, regional distribution of RRT population, modality 
distribution, diabetic nephrology figures and sex of patients. Also data on the incidence and 
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prevalence of the northern region of Oman were obtained from the individual four RDCs 
of the north. Data on prevalence and cost of dialysis of the national level were mainly 
obtained from the MOH health report (Figure  4-2). 
 
Figure ‎4-2 The original sources of data in relation to the research questions of study one 
 
4.5 Study population and sample characteristics 
The study population included all the treated kidney failure patients registred on Oman’s 
RRT register of the central RDC and the other four RDCs the northern region of Oman 
since the register started in 1983, until 31
st
 December 2015. The alive patients found 
registered on 4
th
 November 2014; the day when the author first met with the nephrologist 
in charge of the central RDC, was 2,192 RRT patients. There was no physical contact with 
the sample, and also no individual or personal files where inspected in this study. The data 
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accessed were merely statistical data for the total RRT patients registered on Oman’s RRT 
register since 1983 and until the end of 2015, and for the four RDCS from 1998 (the date 
of the oldest RDC establishment among the four targeted RDCs) to 2015. Also the northern 
region of Oman is administratively  divided into two subdivisions which will be called 
subdivision 1 and subdivision 2. Each subdivision is served by two RDCs out of the four. 
 
 
4.6 Ethical approval and considerations 
Shaping and writing the protocol for this research took months to finalise. It was a requisite 
to have this protocol reviewed by different people, including two experts: two reviewers 
from the Research and Ethical Review and Approval Committee (RERAC) of the Oman’s 
Ministry of Health. At the very end, University of Glasgow Ethics Committee had also 
approved the protocol. 
 
The pilot study was conducted after the original protocol was reviewed by the ethical 
committees (see section 6.9, p.153). After the pilot study was completed, the original 
protocol was revised and a second ethical approval letter was obtained to permit the 
amendments in the revised protocol (see appendix A-3, p.246).  
 
The subjects chosen for this pilot study were from the treated kidney failure population on 
dialysis, but from a different geographical area. This task was extremely helpful in 
identifying the study inadequacies and problems which were resolved before undertaking 
the main study (see section 6.9 on p.153).  
 
Ethical permission was obtained from two ethical committees before starting the data 
collection. The first one was the “Research and Ethical Review and Approval Committee 
(RERAC)”, Ministry of Health of Oman (see appendix A-1 on p.244). The second one was 
from the ethical committee of the University of Glasgow (see Appendix A-2 on p.245). 
The original protocol was revised by the ethical committees after the pilot study was 
conducted and a second ethical approval letter was obtained to permit the amendments in 
the revised protocol (see Appendix A-3 on p.246). 
 
However, all the data obtained from Oman’s RRT register were recevied anonymously 
from the central RDC nephrologist in charge. For this study, all the data obtained were 
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largely statistical numerals; no names and no addresses or other personal identification was 
accessed. Also, all names of places and people (if used) are annonymised as needed in this 
thesis to maintain an objective stance in viewing and analysing these study data. However 
the historical data of places and pioneers of the RRT service in Oman was not usually 
annonymised, to preserve the credits of these pioneers’ achievments. 
 
All kinds of research which involve humans have to adhere to the ethical rules, and have to 
be reviewed to ensure that the research participants are safeguarded, and their rights are 
protected (Polit and Beck, 2012). The first comprehensive consideration of medical ethics 
was published in 1803 by British physician Thomas Percival, followed by the American 
Medical Association’s first code of ethics in 1847 (Beauchamp and Childress, 2013).  In 
1964, the World Medical Association developed the Declaration of Helsinki to legalise the 
ethics of medical practice and research involving human subjects (World Medical 
Association, 2016). The Declaration was amended ten times, from 1964 until the last 
amendments in 2013 (World Medical Association, 2016). The general ethical principles 
emphasised by this Declaration are to ensure respect for all human subjects, protect their 
health and rights, protect their life, health, dignity, integrity, right to self-determination, 
privacy, and confidentiality of personal information, and to maintain ethical standards 
overall (World Medical Association, 2016). Biomedical ethics rely on four major moral 
principles which are: 1) respect for autonomy, 2) nonmaleficience, 3) beneficence, and 4) 
justice (Beauchamp and Childress, 2013). 
 
Respect for autonomy means respecting that a person has the right to make their own 
choices and actions depending on their own values and beliefs (Beauchamp and Childress, 
2013). The participants’ autonomy in this research were respected and maintained. In 
instances when the participant was incompetent, for example children with Down 
syndrome, the author approached the person authorised to make decisions on behalf of that 
participant (e.g. the husband or parents). 
 
The principle of nonmaleficience means not causing any harm to others (Beauchamp and 
Childress, 2013). This research had no interventions, besides that most of the participants 
were surveyed in hospital settings where all preparations for first aid and emergencies were 
in place. Also, the author, in consideration of the patients’ sickness, ensured that the 
interviews lasted for average of 15-20 minutes and no longer than 45 minutes. 
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Beneficence means helping and contributing to the welfare of others (Beauchamp and 
Childress, 2013). In this research, there was no direct benefit gained by participants, such 
as rewards. However, the patients gained by contributing to the data for this research, and 
may gain later benefits such as improved services delivered to them in consequence of this 
research being conducted and published. 
 
The principle of justice means being fair and equitable in providing care for all individuals 
(Beauchamp and Childress, 2013).  All participants in this research were treated in a fair 
and equitable manner. 
 
In the UK, the government also acts to ensure the right processing of information relating 
to individuals by enforcing the Data Protection Act 1998. This acts and legislation 
regulates the process of obtaining, holding, use or disclosure of individuals’ information 
(The National Archives, 2016).  This research complies with all ethical standards and data 
protection acts. 
 
Ethics, however, is involved in every single step in both research and life as well. 
Researchers should be aware of the ethical dilemmas that can be faced at any step in 
conducting research. The author should be able to use all the acts and legalisation in place 
to deal with all kinds of ethical dilemma (LeCompte, 2015). The ability to balance the need 
for data without threat to the participants’ rights should also be demonstrated by the 
researcher in all instances (Cohen et al, 2011). 
 
4.7  Data collection procedure 
The collected data were accessed by submitting the ethical approval letter of Oman’s MOH 
with a written request outlining the data desired for collection. The letters were handed to 
the nephrologist in charge of the central RDC. Also, similar request letters were given to 
the head of the other four RDCs in the northern region of Oman. The letters requested for 
the following data: the statistics of incidence, prevalence, death figures of dialysis sub-
population, kidney transplantation statistics, statistics of kidney failure patients who had 
DM or/and HTN prior RRT; causes of death of treated kidney failure patients; distribution 
of kidney failure patients in Oman; any publications on Oman’s RRT population; and a 
summary about nephrology service devlopment in Oman. Most of the data were collected 
after several meetings and communications with the nephrologist in charge of the central 
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RDC who was cooperative and provided the necessary data as available. The data gathered 
from the other four RDCs were precisely about the development of each individual RDC 
since the commencement of that RDC, their incidence and prevalence, and it was collected 
simultaneously with the cross-sectional study data while visiting these RDCs. 
 
Moreover, the author visited the medical library of the Sultan Qaboos University and 
inspected the national and local publications and records relevant to the Oman’s kidney 
failure, by doing a manual search through the Oman Medical Journal (OMJ), the main 
scientific journal publishing medical and healthcare research in Oman. Thereafter, all the 
relevant information found related to kidney failure in Oman was extracted, copied and 
compiled. Also, the annual health records of the MOH of Oman were manually inspected 
when they were not available electronically. This annual record was very helpful in 
tracking the prevalence and cost of dialysis patients since 1998 (first published annual 
report found by the author) until 2015 (the last published record until the last point of 
inspection).  
 
 
4.7.1 Statistical analysis 
The data from this design were analysed statisticaly by the author using Excel spreadsheet. 
The numerical variables for example prevalence figures were entered and then were plotted 
on bar graphs to draw trends and conclusions. The incidence, prevalence and mortality rate 
were calculated by dividing, for example, the prevalence value for a period by the 
population at risk value, and then multiplying by 100,000 population to identify the rate of 
kidney failure cases per 100,000 population, or multipying by 1,000,000 if the rate required 
is per million population (pmp). Most of the population values used in this study are for 
Omani populations  or general population as indicated. The formula used to calculate the 
annual direct cost was by mutiplying the dialysis session direct expense (49.8 OMR), times 
the total number of dialysis sessions performed per calendar year per Oman. 
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5 Results of study one 
5.1 Overview 
This section reports the results of the study one which is mainly a descriptive epidemiology 
of the RRT population of Oman. This study highlight the main developments of Oman’s 
RRT and main epidemiological statistics (1980-2015),  and status of Oman’s RRT 
publishing. This chapter is structured under four main sections, namely:  The main 
developments of Oman’s RRT (1980-2015), the main statistics about Oman’s RRT 
population, kidney transplantation in Oman, and publications on Oman’s RRT population. 
 
 
5.2 The main developments of Oman’s RRT (1980-
2015) 
Nephrology care was launched in the modern world in the 1950s-1960s, and after two or 
three decades, Muscat arrived on the international scene of nephrology (Woods and 
Prabhakar, 1985; Thomas, 2014). Nephrology care started in Oman in the early 1980s as a 
result of great efforts from the MOH of Oman and some non-Omani nephrology physician 
pioneers. 
 
The first RRT care started in Oman was peritoneal dialysis in April 1980 by Dr. Sayyed 
Laiq who was a consultant in general internal medicine.  Thereafter, general nephrology 
services were made available in the capital in August 1982 (Woods and Prabhakar, 1985). 
This service offered one nephrology Out Patient Department (OPD), a hypertension 
referral clinic, paediatric nephrology and kidney transplantation on a weekly basis in Al-
Nahda Hospital (an old hospital situated in the capital, Muscat, and which still exists). It 
was an active OPD with an average patient load of 300 patients (Woods and Prabhakar, 
1985). Between 1980 -1983, peritoneal dialysis was still conducted in Oman but for only 
acute kidney failure patients.  
 
On March 12
th
, 1983, the first dialysis centre opened in Al-Nahda Hospital with seven 
machines for haemodialysis and serving 35 patients (Woods and Prabhakar, 1985; Al-
Maymmani, 2014). The patients who were on dialysis outside the country in places such as 
Bombay, India were brought gradually to Oman to resume their dialysis in the Al-Nahda 
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Renal Dialysis Centre (Al-Maymmani, 2014-2016).  Al-Nahda Renal Dialysis Centre 
played the role required at that time for teaching and training nephrology staff. This centre 
was part of a program developed by the MOH at that time. This program was called 
Chronic Renal Failure Program (CRFP), and aimed to treat Omani patients in their country 
instead of taking them abroad (Woods and Prabhakar, 1985). Moreover, a plan was made 
by the MOH to establish further dialysis centres in the interior places of Oman (Woods and 
Prabhakar, 1985). 
 
Woods and Prabhakar (1985) reported 113 patients (i.e. 108 Omani patients and five non-
Omanis) who were diagnosed with kidney failure and started dialysis from March 1983 to 
July 1985. They reported 53.4% males to 46.6% females, but if the non-Omani patients 
were excluded then there were slightly more Omani female patients compared to Omani 
males.  
The death percentage among this population at that time was 17.7%  (of the whole treated 
kidney failure population in Oman including acute kidney failure). Ten point five percent 
of kidney failure patients were lost to follow-up which means they had been diagnosed 
with chronic kidney failure but failed to appear for dialysis at the Al-Nahda Renal Dialysis 
Centre before July 1985, but presumed not necessarily dead (Woods and Prabhakar, 1985).  
In 1992, continuous ambulatory peritoneal dialysis was introduced, and the first patient 
was dialyzed in the Royal Hospital at Muscat (Al-Marhuby, 1998), a large tertiary teaching 
hospital where all specialties and subspecialties are offered for all of the Omani’s citizens 
(Ministry of Health, Royal Hospital page, 2014). However, the peritoneal dialysis 
structured program started in 1993 in Oman. 
 
The first remote RDC outside the capital and the second in Oman was launched in the 
northern region of Oman in September 1991 (Al-Maymmani, 2014-2016). On the 4
th
 April 
1992, a third RDC was opened in the southern region of Oman (Al-Maymmani, 2014-
2016).  The central RDC was launched on 29
th 
January 1998 in the capital of Oman, 
Muscat. This RDC is managed by a nephrology team led by a nephrology physician and 
assisted by a nephrology nurse. The creation and maintenance of the Oman’s RRT register 
was a personal effort from Dr. Hamood Al-Marhubi who was the nephrologist in charge of 
the central RDC and at present he is retired. He was the data keeper for the treated kidney 
failure population in Oman for around three decades, and he was the one who transferred 
the hand-written data about this population from the Al-Nahda Renal Dialysis Centre (the 
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previous central RDC) to the current central RDC (Al-Maymmani, 2014-2016). The effort 
was continued after Dr. Hamood’s retirement by Dr. Yaqoob Al-Maymmani, who is the 
current nephrologist in charge of the central RDC. Credit should be given to these people 
for securely retrieving these fundamental data for all these years. The data were stored in 
an electronic form in a central computer in the central RDC. The data cannot be accessed 
by any person except the nephrologist in charge and his delegate. These data were never 
used or published prior to 2014 except on a small scale for the annual health reports and 
once within a study conducted in 2004-2005 (the study called “frequency of diagnosed 
hypertension, proteinuria, haematuria, urinary tract infection impaired kidney function and 
their geographical distribution amongst different age group of individuals in Sultanate of 
Oman” – prinicple author Dr. Hamood Al-Marhuby, 2004-2005). This study also was 
never published in an electronic form but only in a paper form and disseminated only 
among the people concerned. 
 
The annual health report published by the Oman’s MOH for the year 2004 showed that 
Oman had 13 RDCs (Ministry of Health- MOH, 2004). These RDCs had a combined total 
of 113 dialysis stations and served around 558 patients by the end of December 2003 
(Ministry of Health- MOH, 2004). These dialysis centres increased gradually to 15 RDCs 
by the end of 2005 (Ministry of Health- MOH, 2006). The 15 RDCs had a combined total 
of 158 dialysis stations and treated around 618 patients per annum. The ministry closed one 
RDC in 2005, but there were two RDCs established in a replacement during the same 
period. By 2008, the MOH was successfully running 17 RDCs that had a combined total of 
169 dialysis stations serving around 737 patients on dialysis (Ministry of Health- MOH, 
2009). By the end of 2015, the MOH owned 18 RDCs with 217 dialysis stations covering 
1439 patients on dialysis per annum per total population (Ministry of Health- MOH, 2016). 
Between 2012 and until 2015 the MOH did not increase the number of RDCs (Figure  5-1 
and Figure  5-2) but increased the number of dialysis stations in some of the existing RDCs 
such as the central RDC which started with 28 dialysis stations and increased to be 42 
dialysis stations by the end of 2015.  
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Figure ‎5-1 The growth in number of RDCs in Oman 
 
 
Figure ‎5-2 The increase in dialysis treatment capacity in Oman 1980-2015 
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5.3 Main statistics about Oman’s RRT population 
5.3.1  Prevalence of Oman’s RRT (1983-2015) 
Although the dialysis treatment prevalence from 1983-1997 was not available on the 
Oman’s MOH website and could not be found by hand searching in the grey literature, the 
prevalence from 1998-2003 was found by hand searching in the hard copies of the Oman’s 
MOH annual reports, and those from 2004-2015 were available on the MOH website 
(www.moh.gov.om - Ministry of Health- MOH, 2004 - 2016).  Also, the prevalence for 
1983 and 1985 was collected from an article published in the Oman Medical Journal in 
1985 (Woods and Prabhakar, 1985).  
 
The total number of patients registered on the Oman’s RRT register of the cental RDC 
from 1983 until 2010 was 3,524 kidney failure patients (including non-Omanis) distributed 
for the following treatments’ cohorts; haemodialysis, 2,328 patients (66%); kidney 
transplant, 1,144 patients (32.5%); peritoneal dialysis, 52 patients (1.5%). There were no 
data provided for how many of each gender were in each of the treatment cohorts, but 
overall, males constituted 1,904 patients (54%), and females were 1,620 patients (46%). 
However, of the 3,524 (100%) registered patients between 1983 -2010, only 1,818 (51.6%) 
patients were alive in 2010; 1,542 patients (43.7%)  had died, and 164 patients (4.7%) were 
lost to follow-up or could not be traced because they did not come back for their dialysis 
and did not provide any information on their treatment outcomes. By the end of December 
2013, the total alive RRT patients registered on the Oman’s RRT register were 2,069 alive 
patients distributed as 1117 dialysis patients (54%) and 952 (46 %) kidney transplanted 
patients. Accordingly, live patients increased 13.8% in between 2010-2013 with mean 
annual increase of 83.6 patients per year. The last RRT prevalance the author was able to 
record was the point prevalence on 4
th
 November 2014 when the author first visited the 
central RDC for data collection. The point prevalence was 4,228 (100%)  deceased and 
alive patients, however, the alive were 2,192 (42.3%) RRT patients across the country. As 
a result, there were 123 kidney failure patients case were added to the prevalance from end 
of 2013 to the 4
th
 of November 2014. The 2,192 RRT patients were distributed in three 
main cohorts. The haemodialysis cohort had 1,161 patients (52.9%), the peritoneal dialysis 
cohort had 76 patients (3.5%), and the cohort who had functional kidney transplants had 
955 patients (43.6% - Table  5-1). The number of male patients was higher in all cohorts 
except in the PD cohort (Table  5-1). The total population of Oman on 2014 was 3.993 
millions in general or 2.261 million Omani. According to the previous statistics, the 
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prevalence rate is 549 pmp in 2014 if calculated across total population or 969.5 pmp if 
calculated across Omani population only. 
 
Table ‎5-1 Oman’s‎RRT‎population‎distribution‎across‎treatment‎cohorts‎on‎4th 
November 2014 
Variable Males n (%) Females n (%) Total n (%) 
Haemodialysis cohort 636(29%) 525(23.9%) 1,161(52.9%) 
Peritoneal dialysis cohort 34(1.6%) 42(1.9%) 76(3.5%) 
Kidney transplantation cohort 556(25.4%) 399(18.2%) 955(43.6%) 
Total 1,226 (56%) 966(44%) 2,192(100%) 
 
o Prevalence of Oman’s dialysis treatment (1983-2015) 
 
The prevalence statistics from 1998-2015 showed an overall increase in dialysis treatment 
in Oman. The dialysis sub-population increased from 35 patients in 1983 to 1,439 patients 
in 2015. The available prevalence of dialysis treatment in the years 1983-2015 in Oman is 
illustrated in Figure  5-3. The mean prevalence for all years was 724.9 dialysis treatments 
(i.e. patients) per annum. The overall trend showed an increase in dialysis treatment 
prevalence over the years with slight dips in years 2003, 2005 and 2006 (Figure  5-3).  
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Figure ‎5-3 Prevalence of dialysis treatment in Oman (1983-2015) 
 
It was possible to calculate the prevalence rate for dialysis treatment as the estimated 
census for Omani population and total population at risk was available for the years 1986 
and onward. However, the prevalence for the years 2003 and 2013 were selected and 
calculated to the last available census of 2015 (Table  5-2). This prevalence rate was 
calculated across two values the total population and the Omani population in order to 
describe if there is significant differences between the two values. 
 
Table ‎5-2 Prevalence rates for dialysis treated patients in certain years 
Year Prevalence Total Pop. PR of Total Pop.   Omani pop. PR of Omani Pop. 
2003 523 2,341,000 22.3/100,000 1,782,000 29.3/100,000 
2013 1281 3,855,000 33.2/100,000 2,172,000 59/100,000 
2015 1,439 4,159,000 34.6/100,000 2,345,000 61.4/100,000 
 Pop., population; PR, prevalence rate 
 
0
200
400
600
800
1000
1200
1400
1600
19
83
19
85
19
98
19
99
20
00
20
01
20
02
20
03
20
04
20
05
20
06
20
07
20
08
20
09
20
10
20
11
20
12
20
13
20
14
20
15
35 
113 
401 
436 
470 
518 
552 
523 
636 618 608 
680 
737 
872 
946 
1072 
1221 
1281 
1339 
1439 
N
o
. o
f 
p
at
ie
n
ts
 
Prevalence in years 
97 
 
 
o Prevalence of RRT treatement across Oman’s governorates 
 
Woods and Prabhakar (1985) reported that from March 1983 to July 1985, patients 
travelled from all parts of Oman to attend the dialysis sessions in the only centre of dialysis 
in the Al-Nahda Hospital, and that more than 50% of these patients were from the capital 
and in the northern region of Oman (Woods and Prabhakar, 1985). The distance between 
the capital and the nearest point in the northern region of Oman is around 200 km. The 
remaining 40% of the dialysis sub-population came from the rest of the governorates 
(regions) of Oman (Figure  5-4). 
 
Figure ‎5-4 Distribution of the dialysis sub-population in 1983-1985‎ across‎ Oman’s‎
main governorates 
© Data from Woods and Prabhakar, 1985 
 
According to Oman’s RRT register, the 3,524 RRT patients registered in 2010 were 
distributed between nine main governorates of Oman, the highest in the capital (n = 985 = 
28%) and the lowest in the middle governorate (n = 6 = 0.2% - Figure  5-5), also 70 
patients (2%) had no identified residential area.  
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Figure ‎5-5 Distribution‎of‎RRT‎populations‎across‎Oman’s‎governorates‎in‎2010 
 (Note: 179 patients were recorded as unknown diagnosis, and therefore they are not 
included in this figure). 
 
The Oman’s RRT register had a record of all RRT patients treated since the start of RRT in 
Oman. Therefore the register recorded 4,228 treated kidney failure patients (deceased and 
alive together) who underwent RRT between 1983 and 4
th
 November 2014. These 4,228 
RRT patients were distributed among the governorates of Oman as the highest in the 
capital (n = 1,296 RRT patients = 30%), then the north (n = 1039 RRT patients = 25%), 
and the lowest in the middle region (n = seven RRT patients = 0.2% – Figure  5-6). Also, 
there were 67 (1.7%) RRT patients with no identified residential address. 
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Figure ‎5-6 RRT‎patients’‎distribution across governorates on 4th November 2014 
The prevalence rate of dialysis treatment across governorates was possible to calculate 
because the census of the Omani population and the total population at risk across 
governorates was available, and also governorates’ prevalence figures of dialysis treated 
patients were available. The prevalence of dialysis treatment across governorates is given 
here for two years only, which are 2010 and 2015, to allow for a comparison. In 2010, the 
highest prevalence rate for dialysis treatment was in the capital at 71.3 dialysis patients per 
100,000 Omani populations and at 37.4 dialysis patients per 100,000 total populations. The 
lowest rate was in the west at 30.3 dialysis patients per 100,000 Omani population, and at 
23.7 dialysis patients per 100,000 total populations (Table  5-3). In 2015, the highest 
prevalence was in the west end at 99 dialysis patients per 100,000 Omani population, and 
at 49.5 per 100,000 total population. The lowest prevalence was in the north at 46.8 
dialysis patients per 100,000 Omani populations, but per total population it was in the 
capital at 30 dialysis patients per 100,000 total populations (Table  5-3).  
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Table ‎5-3 Prevalence of dialysis treated patients across governorates of Oman for 
2010 & 2015 
Year 
 
Governorate 
Omani 
pop. 
Actual Prev.   Per 100,000 Omani 
pop. 
Per 100,000 Total 
pop. 
2010  
Capital 
South 
Middle 
Peninsula 
North 
Interior 
East 
West 
West E 
 
407,006 
164,073 
19,043 
21,898 
620,950 
269,069 
293,394 
118,877 
43,026 
 
290 
92 
- 
10 
266 
111 
119 
36 
22 
 
71.3 
56.1 
50.2* 
45.7 
42.8 
41.3 
40.6 
30.3 
51.1 
 
37.4 
36.8 
31.5 
31.8 
34.4 
34 
34 
23.7 
30.2 
2015 
Capital 
South 
Middle 
Peninsula 
North 
Interior 
East 
West 
West E 
 
487,592 
196,560 
22,814 
26,232 
743,920 
322,358 
351,506 
142,421 
51,543 
 
384 
159 
- 
17 
348 
201 
205 
74 
51 
 
78.8 
80.9 
72.5* 
64.8 
46.8 
62.4 
58.3 
52 
99 
 
30 
41.2 
37.2 
41.6 
32.9 
48.2 
39 
38.6 
49.5 
PR prevalence rate; pop., population; Prev., prevalence; *the prevalence of the middle governorate 
was never published by MOH and therefore it is most likely that its prevalence is counted within 
the southern governorate’s prevalence; West E, west end  
 
o Prevalence of dialysis treatment in the four RDCs of the northern 
region of Oman (1998-2013) 
RDC1 was established in 2008; therefore, the prevalence data presented here are for the 
years 2008-2013. The dialysis treatment increased from 55 dialysis patients in 2008 to 124 
patients in 2013; full years’ statistics are illustrated in Table  5-4. RDC2 was established in 
1995 and the prevalence was available for the years 1998 to 2013. Also, the prevalence of 
this RDC increased from 27 dialysis patients in 1998 to 47 in 2013 (Table  5-4). RDC3 was 
established in 1993; the prevalence reported was for the years 1998 to 2013, and it 
similarly increased from 40 dialysis patients in 1998 to 95 in 2013 (Table  5-4). RDC4 was 
established in 1997 and the prevalence reported for the years 1998-2013, the prevalence 
similarly increased from 30 dialysis patients in 1998 to 94 in 2013 (Table  5-4).  
  
101 
 
Table ‎5-4 Prevalence of dialysis treatment in the four RDCs of the northern region of 
Oman (1998-2013) 
Prevalence in 
Year 
RDC1 
n 
RDC2 
n 
RDC3 
N 
RDC4 
n 
Total 
n 
1998 *NE 27 42 30 99 
1999 NE 29 30 47 106 
2000 NE 31 31 57 119 
2001 NE 36 30 70 136 
2002 NE 41 36 67 144 
2003 NE 35 32 64 131 
2004 NE 40 35 74 149 
2005 NE 40 36 64 140 
2006 NE 45 35 64 144 
2007 NE 50 40 64 154 
2008 55 28 45 69 197 
2009 77 29 58 72 236 
2010 95 31 61 79 266 
2011 102 31 79 84 296 
2012 114 39 69 114 336 
2013 124 43 95 94 356 
*NE, not established 
 
The overall cumulative prevalence figures for the three to four RDCs (2008-2003) are 
illustrated in Table  5-4; the overall prevalence in the four RDCs increased from 99 dialysis 
patients in 1998 to 356 dialysis patients in 2013 (Figure  5-7). The overall trend shows a 
260% increase in the dialysis treatment prevalence across the four RDCs. However, there 
were some dips in 2003 and 2005. 
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Figure ‎5-7 The overall prevalence of dialysis treatment in the four RDCs of the 
northern region of Oman (1998-2013) 
 
o Prevalence of dialysis treatment in the four RDCs of the northern 
region of Oman at the time of data collection (2014-2015) 
At the time of data collection during October-November 2014, there were 341 (100%) 
Omani patients undergoing kidney dialysis treatment in the northern region of Oman. 
Specifically, there were 335 (98.2%) adult patients and six (1.8%) paediatric patients. In 
2014, the Omani adult population of the northern region of Oman was ~395 thousands and 
the Omani paediatric population was ~322 thousands and total Omani population was ~717 
thousands. Accordingly, the prevalence rate of adult patients on dialysis treatment in the 
northern region of Oman was 84.8/100,000 Omani adult population in November 2014. 
The prevalence rate of Omani paediatric patients on dialysis treatment in the northern 
region of Oman at the same period was 1.8/100,000 in November 2014. However, the 
overall prevalence of dialysis patients across the four RDCs in 2014 was 301 patients in 
January 2014 and 312 patients in 31
st
 December 2014 (Table  5-5). This means that the 
overall prevalence rate for dialysis cohort across the four RDCs was 43.5/100,000 per total 
population of the northern region of Oman on 31
st 
December 2014 (Table  5-5). According 
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to subdivisions, the prevalence rate for subdivision 1 was 61.7/100,000 and the prevalence 
rate for subdivision 2 was 39/100, 000.  
 
Table ‎5-5 Prevalence of dialysis treatment across the four RDCs per month in 2014 
Month in 
2014  
RDC1 
n 
RDC2 
n 
RDC3 
N 
RDC4 
n 
Total 
N 
January 120 
M(70) 
47 
M(26) 
94 
M(57) 
40 
M(21) 
301 
M(174) 
F(50) F(21) F(37) F(19) F(127) 
February 118 M(69) 50 M(28) 94 M(57) 40 M(20) 302 M(174) 
F(49) F(22) F(37) F(20) F(128) 
March 119 M(69) 51 M(27) 93 M(56) 101 M(49) 364 M(201) 
F(50) F(24) F(37) F(52) F(163) 
April 119 M(69) 48 M(25) 90 M(53) 102 M(46) 359 M(193) 
F(50) F(23) F(37) F(56) F(166) 
May 118 M(69) 48 M(25) 90 M(53) 98 M(46) 354 M(193) 
F(49) F(23) F(37) F(52) F(161) 
June 119 M(68) 49 M(26) 89 M(52) 95 M(46) 352 M(192) 
F(51) F(23) F(37) F(49) F(160) 
July 121 M(69) 51 M(28) 89 M(52) 101 M(46) 362 M(195) 
F(52) F(23) F(37) F(55) F(167) 
August 123 M(69) 49 M(26) 88 M(51) 99 M(44) 359 M(190) 
F(54) F(23) F(37) F(55) F(169) 
September 127 M(73) 50 M(27) 86 M(49) 99 M(44) 362 M(193) 
F(54) F(23) F(37) F(55) F(169) 
October 128 M(74) 48 M(27) 86 M(49) 46 M(21) 308 M(171) 
F(54) F(21) F(37) F(25) F(137)) 
November 127 M(73) 48 M(27) 86 M(49) 49 M(22) 310 M(171) 
F(54) F(21) F(37) F(27) F(139) 
December 126 M(72) 49 M(28) 85 M(48) 52 M(22) 312 M(170) 
F(54) F(21) F(37) F(30) F(142) 
n, number; M, males; F, females 
For the year 2015, the overall prevalence for the four RDCs had increased from 312 
patients on 1
st 
January 2015 to 332 patients on 31
st
 December 2015 (Table  5-5).  The 
overall prevalence rate per 100,000 populations calculated on 31
st
 December 2015 was 
43.5 patients in the northern region of Oman (the same prevalence rate as the year 2014). 
According to subdivisions of the northern region of Oman, the RDCs of subdivision 1 
appeared to have a higher prevalence (64.6 cases in 100,000) compared to subdivision 2 
(30.7 cases in 100,000). 
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Table ‎5-6 Prevalence of dialysis treatment across the four RDCs per month in 2015 
Month in 
2015  
RDC1 
n 
RDC2 
n 
RDC3 
N 
RDC4 
n 
Total 
N 
January 125 
M(72) 
47 
M(28) 
84 
M(48) 
56 
M(26) 
312 
M(174) 
F(53) F(19) F(36) F(30) F(138) 
February 126 M(72) 49 M(29) 83 M(48) 56 M(26) 314 M(175) 
F(54) F(20) F(35) F(30) F(139) 
March 122 M(68) 51 M(29) 83 M(47) 42 M(22) 298 M(166) 
F(54) F(22) F(36) F(20) F(132) 
April 122 M(69) 52 M(29) 86 M(49) 56 M(22) 316 M(169) 
F(53) F(23) F(37) F(34) F(147) 
May 122 M(69) 53 M(29) 84 M(45) 47 M(22) 306 M(165) 
F(53) F(24) F(39) F(25) F(141) 
June 123 M(70) 51 M(28) 86 M(45) 46 M(25) 306 M(168) 
F(53) F(23) F(41) F(21) F(138) 
July 122 M(68) 49 M(26) 88 M(47) 60 M(25) 319 M(166) 
F(54) F(23) F(41) F(35) F(153) 
August 123 M(68) 49 M(27) 86 M(47) 59 M(31) 317 M(173) 
F(55) F(22) F(39) F(28) F(144) 
September 124 M(68) 50 M(29) 87 M(48) 53 M(29) 314 M(174) 
F(56) F(21) F(39) F(24) F(140) 
October 124 M(68) 52 M(30) 88 M(48) 60 M(31) 324 M(177) 
F(56) F(22) F(40) F(29) F(147) 
November 123 M(68) 56 M(30) 87 M(48) 47 M(20) 313 M(166) 
F(55) F(26) F(39) F(27) F(147) 
December 124 M(70) 58 M(30) 87 M(48) 63 M(25) 332 M(173) 
F(54) F(28) F(39) F(38) F(159) 
n, number; M, males; F, females 
The figure for male patients appeared higher (n = 170 = 54.5%) when compared to females 
(n = 142 = 45.5%) on December 2014, and relatively the same figures on December 2015, 
males (n = 173 = 52%) vs. females (n = 159 = 48%). The statistics of patients’ distribution 
according to the dialysis modality were as follows: out of the 335 dialysis adult patients, 
there were six patients (1.8%) undertaking peritoneal dialysis and registered in RDC4, and 
329 (98.2%) patients undertaking haemodialysis treatment in all renal dialysis centres.  
 
5.3.2  Incidence of RRT treatment (1983-2015) 
 
Statistics of the RRT incidence were available for the years 1983 to 2015. The new patients 
registered in 1983 were 34 patients, in 1986 were 33, in 2013 were 168 and in 2015 were 
230 patients per total population (Figure  5-8). The incidence of treated kidney failure 
patients across the years per Oman is displayed in Figure  5-8.  
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Figure ‎5-8 Incidence of RTT treatments in Oman (1983-2015) 
 
Furthermore, this study attempted to calculate the incidence rates from the year 1986 and 
onwards as the population censuses for Oman were available for these years. The incidence 
rate was calculated to describe the general incidence rates trend line. So for example, the 
incidence rates calculated for the years 1986, 2003, 2010, 2013 and 2015 was respectively 
2.29/100,000 (22.9 pmp), 7.7/100,000 (76.8 pmp), 7.5/100,000 (75 pmp), 4.36/100,000 
(43.6 pmp), 5.5/100,000 (55.3 pmp) treated kidney failure patients per total population 
(Table  5-7). The incidence rate calculated for the same years across Omani population only 
were respectively 2.8/100,000 (28.9 pmp), 10.1/100,000 (101 pmp), 10.6/100,000 (106.3 
pmp), 7.7/100,000 (77.3 pmp), 9.8/100,000 (98.1 pmp) treated kidney failure patients per 
Omani population (Table  5-7). The Oman’s RRT register reported a grand total of 3,504 
new kidney failure patient since 1983-2010 (28 years), which gives mean incidence rate of 
125 treated kidney failure patients per year per total population of Oman.  
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Table ‎5-7 Incidence rate for treated kidney failure patients across certain years 
Year I Total Pop. IR of Total Pop.   Omani pop. IR of Omani 
Pop. 
2003 180 2,341,000 7.7/100,000 1,782,000 10.1/100,000 
2013 168 3,855,000 4.36/100,000 2,172,000 7.7/100,000 
2015 230 4,159,000 5.5/100,000 2,345,000 9.8/100,000 
I, Incidence; IR, incidence rate; pop., population 
 
 
Since diabetes and hypertension are the major causes of kidney failure incidence across the 
literature, the statistics of the incidence of diabetic nephropathy (DN) were also included in 
the Oman’s RRT register. The statistics available for DN incidence were for years 1983-
2010. The DN incidence was two patients only in 1983, and increased to 94 patients in 
2010 per annum per Oman. The incidence of DN from 1983 to 2010 is displayed in 
Figure  5-9. There were no data on the incidence of hypertensive nephropathy in the 
Oman’s RRT register and also in the USRDS annual reports. 
 
 
Figure ‎5-9 The incidence of DN in Oman between 1983-2010 
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o Incidence of dialysis treatment in the four RDCs of the northern region 
of Oman (2014-2015) 
In 2014, RDC1 had 24 new cases of kidney failure undertake kidney dialysis; RDC2 also 
had 24 new kidney failure cases; RDC3 had 14 new kidney failure cases, and RDC4 had 34 
new kidney failure cases. If subdivisions of the northern region of Oman were reported, the 
subdivision 1 incidence of kidney failure was 48 new kidney failure cases; and subdivision 
2 similarly had 48 new kidney failure cases in 2014. As a whole for the northern region of 
Oman, the incidence was 96 new kidney failure cases. According to these statistics, the 
incidence rate was 17.7/100,000 in subdivision 1 in 2014; it was 10.8/100,000 in 
subdivision 2 in 2014; and 13.4/100,000 in the entire northern region of Oman in 2014.  
 
5.3.3 Death profile for RRT patients (1983-2015) 
o Death profile for RRT patients in Oman (1983-2013) 
The number of deaths for RRT patients was recorded for the years 1983-2013. The 
reported number of deaths in 1983 was four kidney failure patients. In 2013 it was 77. 
Also, there were 47 deaths recorded on the Oman’s RRT register from 1st January 2014 
until 4
th
 November 2014. The highest numbers of deaths among the RRT population were 
recorded for the year 2009 with 114 deaths. The overall recorded deaths for all years are 
displayed in Figure  5-10. The mean of the death rate per year, calculated for all years was 
58 deaths per year. The death rate (i.e. mortality rate) for selected years were 0.004% for 
2010 and 0.002% for 2013 (the denominator used is the mid-year estimate for the general 
population of Oman). The case-fatality rates for the same selected years were 5.9% in 2010 
and 3.7% in 2013. 
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Figure ‎5-10 The number of deaths among RRT in the years 1983-2013 
 
o Causes of death in RRT population (1983-2015) 
 
The causes of death for the three treatment modalities- haemodialysis, peritoneal dialysis, 
and kidney transplantation -were recorded in the Oman’s RRT register at the central RDC 
for the years 1983-2010. There were seven causes of death identified as follows: cardiac 
causes, cerebrovascular accidents (CVA), haemorrhage, hepatic causes, infection, 
malignancy, and other causes where other causes were either not listed, or unknown causes 
secondary to not knowing the cause of death when death had occurred, as most of these 
cases died at their homes. The causes of RRT population death were followed from 1983 to 
2010 in three time blocks which were 1983-1990 (Figure  5-11), 1991-2000 (Figure  5-12), 
and 2001-2010 (Figure  5-13).  
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Figure ‎5-11 Causes of RRT population death (1983-1990) 
 
Figure ‎5-12 Causes of RRT population death (1991-2000) 
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Figure ‎5-13 Causes of RRT population death (2001-2010) 
The overall results for the causes of death statistics over the years 1983-2010 are displayed 
in Table  5-8. Finally, the death causes for years 2011-2015 was reported precisely  in total 
as 449 death cause and the top three causes were unknown (n = 148 = 33%), cardiovascular 
diseases (n = 108 = 24%), and infection (n = 107 = 23.8%).  
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Table ‎5-8 Causes of RRT population death across genders 
All Patients 
n 
PD Patients 
n 
RT Patients 
N 
HD Patients 
n 
Cause of 
Death 
Peri
od 
T F M T F M T F M T F M 
66 
25 
24 
7 
5 
4 
3 
2 
136 
36 
12 
12 
3 
1 
2 
1 
1 
68 
30 
13 
12 
4 
4 
2 
2 
1 
68 
1 
0 
1 
0 
0 
0 
0 
0 
2 
1 
0 
1 
0 
0 
0 
0 
0 
2 
0 
0 
0 
0 
0 
0 
0 
0 
0 
8 
16 
5 
7 
3 
1 
3 
1 
44 
6 
9 
3 
3 
1 
1 
1 
0 
24 
2 
7 
2 
4 
2 
0 
2 
1 
20 
57 
9 
18 
0 
2 
3 
0 
1 
90 
29 
3 
8 
0 
0 
1 
0 
1 
42 
28 
6 
10 
0 
2 
2 
0 
0 
48 
 
Not 
record* 
Infection 
Cardiac 
Hepatic 
CVA* 
Other 
cause 
Malignancy 
Haemorrha
ge* 
Total 
 
 
 
 
1983 
- 
1990 
167 
128 
83 
18 
27 
16 
18 
11 
468 
91 
61 
27 
9 
9 
7 
9 
4 
217 
76 
67 
56 
9 
18 
9 
9 
7 
25
1 
1 
2 
0 
0 
0 
0 
0 
1 
4 
0 
1 
0 
0 
0 
0 
0 
1 
2 
1 
1 
0 
0 
0 
0 
0 
0 
2 
19 
67 
12 
12 
5 
2 
7 
3 
127 
8 
30 
3 
7 
3 
0 
2 
0 
53 
11 
37 
9 
5 
2 
2 
5 
3 
74 
147 
59 
71 
6 
22 
14 
11 
7 
337 
83 
30 
24 
2 
6 
7 
7 
3 
16
2 
64 
29 
47 
4 
16 
7 
4 
4 
17
5 
 
Not 
record* 
Infection 
Cardiac 
Hepatic 
CVA* 
Other 
cause 
Malignancy 
Haemorrha
ge* 
Total 
 
 
 
 
1991 
- 
2000 
284 
241 
222 
15 
44 
53 
31 
16 
906 
136 
110 
109 
4 
22 
29 
12 
6 
428 
14
8 
13
1 
11
3 
11 
22 
24 
19 
10 
47
8 
6 
11 
2 
0 
1 
0 
0 
1 
21 
2 
6 
2 
0 
1 
0 
0 
1 
12 
4 
5 
0 
0 
0 
0 
0 
0 
9 
20 
28 
16 
6 
3 
2 
8 
0 
83 
12 
14 
5 
1 
1 
2 
4 
0 
39 
8 
14 
11 
5 
2 
0 
4 
0 
44 
258 
202 
204 
9 
40 
51 
23 
15 
802 
12
2 
90 
10
2 
3 
20 
27 
8 
5 
37
7 
13
6 
11
2 
10
2 
6 
20 
24 
15 
10 
42
5 
 
Not 
record* 
Infection 
Cardiac 
Hepatic 
CVA* 
Other 
cause 
Malignancy 
Haemorrha
ge* 
Total 
 
 
 
 
2001 
- 
2010 
1,510 71
3 
79
7 
27 16 11 25
4 
11
6 
13
8 
1,22
9 
58
1 
648  Total   
M, males; F, females; T, total; Not record, not recorded; CVA, cerebrovascular accident;  
haemorrhage 
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5.3.4 Cost of dialysis treatment in Oman  
The total dialysis sessions increased from 45,113 dialysis treatments in 1998 to 191,638 
dialysis treatments in 2015 across the whole of Oman, as reported by Oman’s MOH 
(Figure  5-14). So from these data, the cost of the dialysis sessions increased dramatically 
from 2,246,627 OMR (~ 4.5 million GBP) in 1998 to 9,543,572 OMR (~20 million GBP) 
in 2015 which is a 325% increase. The cost for all years is displayed in Figure  5-14. 
 
 
Figure ‎5-14 The cost of dialysis sessions per annum for Oman (1998-2015) 
Also, the data collected showed the cost of peritoneal dialysis across Oman as per a letter 
from Oman’s MOH (see Appendix C on p.252). the cost was 25,000 OMR (~50,000 GBP) 
per patient per year. The peritoneal dialysis patients’ number was 111 patients in August 
2014. The MOH expected the annual increase of PD patients to be 100 new patients per 
year, and therefore requested a budget of two million OMR (~ 4 million GBP) to cover the 
peritoneal dialysis treatment only for the year 2015. The peritoneal dialysis types used in 
Oman are APD and CAPD only (see Abbreviations’ list, p.16). 
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5.4  Kidney transplantation in Oman (1980-2013) 
There were no kidney transplantion centres in Oman from 1980-1988 (Mohsin and et al, 
2007), so, Oxford kidney transplantation centre in the UK was the primary referral centre 
for live related transplantation for the kidney failure patients from Oman (Woods and 
Prabhakar, 1985). All Non-Related Living Donor  (NRLD) kidney transplant patients were 
going on their own to some Asian countries like India. In other words, the kidney 
transplant service started for Omani citizens in 1980, but Oman had no centres providing 
kidney transplant services at that time, so the government was sending the patients abroad 
for surgery. Twenty patients underwent kidney transplantion in the period March 1983 to 
July 1985, of which eighteen patients survived while two died because of graft failure in 
NRLD transplant recipients (Woods and Prabhakar, 1985). Fifty six patients received a 
living donor transplantation within the MOH-Oxford Programme during the period 1983-
1988. 
 
The Oman transplantation program was initiated in 1988 and transplants were performed at 
both the Royal Hospital and the Sultan Qaboos University Hospital (SQUH), the two 
biggest referral hospitals in Oman (Mohsin, 2016). The first kidney transplantations were 
performed  within the same year.  Transplantations were performed by Pr. Abdullah Daar, 
Dr. Qassim Al Busaidy, Dr. Feidhlim Woods and later by Dr. Nabil Mohsin (Al-Sayyari, 
2008). Pr. Daar was a pioneer in kidney transplantation in the Middle East countries (Al-
Marhuby, 1998; Mohsin et al., 2007; Al-Sayyari, 2008). The first paediatric living related 
transplant was conducted in 1992 and the first paediatric deceased donor transplant in 1994 
(Mohsin and Al-Qadi, 2014). Also, Pr. Mohsin and Dr. Daar were successful in 
transplanting a functioning kidney in a 17 month old receipint boy from a 33 week preterm 
donor with brain death in 1994. Therefore they were the holders of the World Record for 
the youngest donor in kidney transplantation (Daar and Moshin, 2016). Dr. Mohsin 
introduced peritoneal dialysis in 1993, introduced tunnelled catheters in 1993, established a 
paediatric nephrology services at the Royal Hospital in 1994, and introduced online 
hamodiafiltration (HDF) at the Royal Hospital in 2009 which was a new advanced service 
added to the kidney replacement therapy services in Oman (Al-Riyami, 2009). 
 
The total kidney transplants by 1992 reached 325 where 115 were living related donors; 
200 living unrelated donors; and ten cadaveric donors (Abomelha, 1996). According to Al-
Marhuby (1998), the total kidney transplanted patients followed up were 174 patients in 
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1998.  Mohsin and et al. (2007) stated in their study that from 1980 to the end of 2005, 198 
kidney transplantations were performed for Omani patients from a living-related donor. In 
summary, the overall number of Oman kidney transplantation patients that was possible to 
gather, was 56 in 1988 (Woods and Prabhakar, 1985), 325 in 1992 (Abomelha, 1996), and 
174 in 1998 (Al-Marhuby, 1998). The Royal Hospital webpage reported more than 800 
patients who had a functional kidney transplant and were on regular screening and follow 
up of the hospital (The Royal Hospital webpage, 2014). The Oman’s RRT register reported 
955 kidney transplanted patients on 4
th
 November 2014. Howevere according to Mohsin 
and Al-Qadhi (2014), there were total of 1656 kidney tansplants were completed for 
Omanis from 1983-2013 with ratio of 1.3 male vs. 1 female and having 690 functional 
kidney transplants by 2013. 
 
Legislation for organ transplantation was approved in 1993 in Oman. The major legislation 
were legislation of living related donor transplants, brain death is a legal death, deceased 
donor transplants must be consented by next of kin, emotionally related donors must have 
ministerial exemption, and prohibition of commercial transaction in organ transplantation 
(Mohsin and Al-Qadhi, 2014). Major achievements in kidney transplantation took place in 
the year 2005. In this year, two vital units were established which are the transplant co-
ordination unit and the kidney donor clinic. These two units helped in increasing the 
average of 6.5 transplants per annum to 12 by the end of 2005 and 23 by the end of 2009 
(see Figure  5-15).  
 
Figure ‎5-15 Major milestones of kidney transplantation (KT) developments in Oman 
2005 Kidney donor clinic 
2005 Transplant coordation clinic 
1994 World record of youngest KT 
1994 1st deceased paediatric KT 
1993 Legislation of organ transplant 
1992 1st living paediatric  KT 
1988 Oman Transplant Programme  
1980-1988 KT patients treated abroad 
Before 1980 No KT treatment in Oman 
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5.5 Publications on Oman’s RRT population 
Among the databases searched, there were 44 articles which focused on or mentioned 
Oman’s RRT population. However, the epidemiology of kidney failure was the focus of 
two studies (4.5%) only (Woods and Prabhakar, 1985; Al-Marhuby, 1998 – see appendix 
F, p. 269); which are both older studies. There were five (11.4%) other studies which 
mentioned epidemiology of kidney diseases in Oman briefly (Al-Dhahry et al., 1993; Al-
Dhahry et al., 1994; Abboud, 2006; Alashek et al., 2012; Hassanein et al., 2012). Kidney 
transplantation was the most popular researched topic for RRT population of Oman, as 
more than one third of the included studies (n =16 studies = 36.4%) were handling this 
topic. The remaining articles (n = 21 = 47.7%) were either exploring the risk factors of 
CKD or discussing general topics related to RRT population in Oman (see Appendix F on 
p. 269). The most popular research design used were cross sectional (n = 14 = 31.8%), 
followed by observational cohorts (n = 8 = 18.1%), and case reports (n = 8 = 18.1%).  
  
116 
 
6 Discussion of study one 
6.1 The main developments of Oman’s RRT (1980-
2015) 
The first nephrology services in Oman were developed in 1980; this was an incredible 
achievement accredited to the pioneers of renal care in Oman. Oman at that time was only 
ten years old after a renaissance, and there were a lot of essential infrastructure projects 
being undertaken across Oman that needed budgets and attention from the top leadership. 
It is understood that the national health care system at that time was just in its infancy; 
however, nephrology care found a place to emerge within this growing health system due 
to its importance and urgency. 
 
On the other hand, it can be argued that the effort was late and insufficient as the patients 
of chronic kidney failure had suffered low quality of life as a result of RRT not being 
available in Oman until 1983. Omani females had a higher occurance of kidney failure 
compared to males in the early 80s, which was potentially because females experienced 
lower health standards compared to males, especially as most married Omani ladies (at that 
time) were classed as multiparity (i.e. multiple pregnacies and births) and this can lead to 
poor nutritional status and thereafter poor general health (Woods and Prabhakar, 1985). 
Multiparity could be one obvious factor for reducing the health standards of Omani 
females but other factors could contribute also such as diarrhoeal and respiratory diseases, 
maternal and perinatal conditions, and lower socio-econmic status (World Health 
Organization – WHO, 2017). Also, the patients living in areas outside the capital continued 
to not have any RDC serving them until 1991. After that, 18 RDCs were created by 2012 
and this number remained constant until the end of 2015 despite the increasing incidence 
and prevalence of kidney failure in Oman. This might imply the insufficiency of the 
current number of RDCs.  
 
Oman’s geographical areas are well connected via good asphalt roads and good national 
bus services, so the MOH can make use of these facilitators to satisfy patients’ needs for 
convenient transportation by giving these patients access to the national bus services via 
offering them free bus-passes. However this latter suggestion is possible in the capital only 
as the bus service is mostly centred in the capital as explained earlier in chapter two (see 
Technological Status, p. 69). Also there is a need to provide one of the kidney failure 
relatives with an evidence to prove that s/he is a relative of the kidney failure patient, and 
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consequently allow her/him to leave their work place to escort the kidney failure patient for 
their dialysis sessions regularly without problems. This option may be more useful for 
patients who cannot use the national bus networks, especially patient from remote regions 
to the capital. It could be a good idea for each RDC to consider having its own 
transportation system, as these patients are chronic cases and most of the time have a fixed 
dialysis schedule, so the RDC may release a bus at each dialysis round to collect the 
patients prior to the start of the dialysis round in their RDCs and then take the patients back 
to their homes when they completed their dialysis. However, the best solution for 
transportation is to increase the number of satellite RDCs to be within walking distance of 
patients’ homes. This latter will increase the cost for the health system, as to run any RDC 
properly will require costly resources like staffing and machines. Furthermore, these 
patients may want to find life insurance as they use the traffic more frequently than normal 
people and therefore they are at higher risks of road traffic accidents, equally there are 
some cases already reported who have died on roads during their journeys to and from 
RDCs. 
 
Furthermore, the most densely populated governorates of Oman were respectively, the 
capital (310.4 person/km
2
), the northern region (81.3 person /km
2
), the peninsula (22.1 
person /km
2
), the eastern region (14 person /km
2
), and the interior region (12.6 
population/km
2
 - Table  3-1). It was described that the top number or percentage (30% - 
Figure  5-6) of RRT patients since 1983 and until 4th November 2014 was reported in the 
capital and the northern region (25%), interior region (14%) and eastern region (12.2%), 
while the least number or percentage (less than 1.5% from each region) of RRT patiens 
were coming respectively from peninsula, west end and middle regions. Accordingly, the 
MOH established three RDC in the capital, four in the northern region and four in the 
eastern region, two in the peninsula, two in interior region, and one in each of the 
following: southern region, western region, the west end region and none in the middle 
region (Table  7-1) in an attempt to well serve all patients. It is understandable that the 
MOH established, for example, two RDCs for the peninsula region which have few 
patients (less than 15 dialysis patients) but also have a complex topographical area. 
 
From chapter two, it is known that Oman leadership prioritize the health needs of Omani 
populations as an important and urgent need. Therefore, time now has come to evaluate 
these needs especially that more than 35 years has passed now since this care has started in 
Oman. The Public Health Action Support Team (PHAST; registered in England and 
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Wales, 2011) suggest that measures of supply and demand are key indicators for “local 
performance management” and “capacity planning of health care providers”. The Public 
Health Action Support Team suggests that measuring of supply can include measuring of 
staffing e.g. nephrologists or renal nurses, dialysis stations available for patients, 
equipment e.g. haemodialysis machines, budget e.g. funds available and income, and 
ability to manage waiting times as increasing waiting time may suggest shortage of supply 
and increase in demand. So this thesis results encourages Oman’s MOH to measure the 
supply and demand of renal care (if not yet done until this moment) so this will help in 
making the necessary renal care available and will indicate the number of renal care 
services the population needs. The present data show that the catchment area of one RDC 
is 0.22 million Omani population. The data from renal registries showed variations in ratio 
of the catchment population to the renal dialysis centres.  Broadly speaking, for example, 
in the UK which had around 65 million populations in total by end of 2015, there were 71 
renal dialysis centres which give a ratio of 0.92 million populations to one RDC. In KSA 
which had around 31.5 million population in total by end of 2015 (213 RDCs) the ratio is 
0.15 million to one RDC. However to have more specific comparison, the dialysis stations 
in KSA were 6560 in 2015 compared to 213 dialysis station in Oman, the ratio respectively 
were 2.4 haemodialysis patients to one dialysis station in KSA and 6.6 haemodialysis 
patients to one dialysis station in Oman. The ASN Dialysis Curriculum (Randolph, 2016) 
recommends that an “18 station facility can dialyze a maximum of 108 patients utilizing all 
stations 6 days per week, three patients shifts per day”. In RDC2, for example, there were 
240 dialysis sessions performed in the 6 days of the week utilising 13 dialysis stations 
which imply that the supply is less than demands in this RDC.  
 
 
6.2 Main statistics about Oman’s RRT population 
The overall trend described from this study showed an increase in the prevalence of treated 
kidney failure across Oman. Also the prevalence of dialysis cohort increased steadily since 
2007 to 2015 with dramatic increase between 2011 and 2015 - Table  5-2). In comparing 
prevalence of the dialysis cohort reported by this study (332 pmp/2013) and reported by 
USRDS (358.5/2013), it is showed that Oman’s prevalence is less than KSA (499.4 
pmp/2012 – no figure for 2013), UK (432.2 pmp/2013), but higher than the Bahrain 
(250.2/2011 – no figure reported for 2013), and Qatar (316.7/2013- Poland and Italy were 
not reported). The prevalence figure of this study agrees with the prevalence figure of the 
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USRDS which may imply that the figures reported for Oman’s dialysis cohort are more 
genuine to what was encountered by the author while gathering field data.  
 
There were some dips described in the prevalence of treated kidney failure in Oman in 
years 2003, 2005, and 2006. The reasons behind these dips were not clear for the year 
2003, but for the year 2005, it could be due to the closure of one of the RDCs. In 2006, it 
could be due to the Gonu cyclone that hit Oman in 2006. The cyclone destroyed some of 
the roads especially roads in Muscat (the capital), so this situation could have stopped 
people from going for dialysis for a while and therefore these patients dropped from the 
statistics of year 2006. Also, it could be that some kidney failure patients died  during that 
weather disaster in 2006. However the dips occurred did not affect the increasing trend of 
kidney failure prevalence in Oman, which is evidenced by the the graph bars representing 
the prevalence for all years across Oman (Figure  5-3). Also comparable year points were 
allocated for years 2003 and 2013, and 2015 and showed an overall increase trend for 
dialysis treated patients overall Oman across the total population and across the Omani 
population (Table  5-2).  
 
This research study attempted to compare the prevalence rates in between total population 
and Omani population to explore if the difference between the two rates is wide or narrow. 
This attempt was made because there are no distinct figures for prevalence of dialysis 
treated patients of Omanis to non-Omanis. Is it essential to do this distinctions, perhaps the 
answer is no, but because the author believes that the prevalence rates of total population is 
inflated and it does not represent the actual figures of prevalence of the country so this 
attempt was made. However, the comparison presented here showed a widening gap in the 
prevalence figures between total population and Omani population. Though the prevalence 
increased at both sides of comparison but the prevalence in the Omani population is 
approximately double that in the total population. The author believes that though the 
numerators used to calculate the prevalence for total population and for Omani population 
are the same (i.e. combined of both), the prevalence figures for Omani is closer to the real 
figures when the non-Omani population is excluded from the denominator (it is preferable 
to exclude non-Omanis because non-Omani population is high in census but their dialysis 
treatment figures is very small at present). The rationale behind this assumption is that the 
difficulty in capturing the dialysis treated cases occurring in non-Omani population 
because usually these patients go back to their home country for treatment, treated in the 
private sector sometimes and if they cannot afford treatment they may return to their own 
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country at some point in time. This means that the number of expatriate on dialysis, at least 
in the north of Oman, is small and this is evidenced by the field data collection of study 
two, where only three patients  (0.8%) were excluded from the study because they were 
expatriate. Based on this assumption, the prevalence reported for total population is 
inflated (due to the high proportion of non-Omanis who are few of them on dialysis) and 
should be adjusted by distinct statistics for kidney failure cases occurring among expatriate 
and among Omanis and thereafter the combination of both can be made on clear judgment 
of the real figures or at least close to real figures. 
 
The prevalence rate among dialysis sub-population for the Omani population was 
61.4/100,000 (614 pmp/2015), but for the total population the prevalence was 34.6/100,000 
(346 pmp/2015). However, the reported prevalence rate for Oman in the USRDS (2015) 
was 656 pmp/2013 per total population for Oman’s treated kidney failure population, and 
358.5 pmp/2013 for Oman’s dialysis sub-population. As a result this study reported 
prevalence for dialysis sub-population per total population agree with what reported by the 
USRDS (2015). Also, this study and the USRDS (2015) agree on that Oman is among the 
countries that have lower rates of RRT and dialysis treatment prevalence (the data 
interpretation in this thesis is the responsibility of the author and no responsibility should 
be made on USRDS or any other registries or any other data source). 
 
Also, when the overall trend of prevalence was described across the four RDCs of the 
north of Oman, there was a drop in the overall prevalence; this was more noticeable in the 
last three months of the year 2014. This drop happened secondary to the drop in RDC4 
prevalence in 2014. The author believes that this is a typing error on the MOH reports as 
the on field reported RDC4 prevalence for the year 2014 was 97 and not 41 as found by the 
author at the time of data collection (Table  5-5). Also, it is noticeable that there were drops 
in the prevalence of dialysis patients in RDC4 in months January and February 2014, and 
again in October – December, 2014 with no clear reason. 
 
This study shows that the highest prevalence rate per 100,000 Omani population in 2015 
was in the west end region, the capital and the southern region (Table  5-3). So it can be 
argued that the number of dialysis centres in these governorates are not sufficient at present 
and has to be increased in predictions for the dramatic increase in the prevalence of kidney 
failure patients in these governorates. In the capital, two of the three dialysis centres are 
close to each other in distance and the third one is around 100 km away from the first two. 
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So a governorate with 3900 km
2
 size perhaps needs more dialysis centres to serve its 
kidney failure population, especially with increasing load of dialysis secondary to the 
increasing in prevalence. However, at the time of writing this chapter, there was one 
additional RDC established to serve the dialysis cohort in the capital which increased the 
number of RDCs to be four in the capital itself. Also, another RDC was established in the 
northern region of Oman, and so there are five RDCs in the north which again support 
what this study has found.  In general, this indicates the good planning by the Oman’s 
MOH and indicates that Oman’s MOH noticed the increasing prevalence of treated kidney 
failure across Oman and it is responding accordingly. However, in the west end region and 
the southern region, there was still the same number of RDCs which was one RDC per 
governorate. Therefore there is an urgent need to increase the number of RDCs across 
these governorates and across the entire country as well. 
 
Two factors need be considered when planning for RDCs’ capacity; these are the density 
of the population in the catchment area around the RDC in relation to the current 
prevalence of kidney failure and the future prediction of kidney failure incidence. The 
distance between the RDC and patient homes and the topographical feature of the area has 
also to be considered. The patients should have an easy transfer to and from the RDC 
without exacerbating complications and should avoid unnecessary road traffic. 
Transportation is identified as one of the factors that can lead to non-compliance with the 
in-centre dialysis (Latham, 1998; Chan et al., 2014).  Therefore Oman’s MOH has to 
facilitate transportation for the dialysis sub-population to achieve the best outcomes of 
dialysis compliance. 
 
The overall incidence rates were fluctuating (Table  5-7) as also demonstrated by 
cumulative incidence of years 2010 and which were respectively 0.007% of RRT event in 
2010 and 0.004% of RRT event in 2013 across the total population. This study reports 
incidence rates for Oman’s RRT population, for example, 22.9 pmp/1986, 76.8 pmp/2003, 
75 pmp/2010, 43.6 pmp/2013, and 55.3 pmp/2015, and a mean incidence rate of 125 
treated kidney failure cases per year. Also, it was described that the recorded incidence 
peaked in the year 2009 with 247 treated kidney failure patients. It could be secondary to 
the peak in diabetic nephropathy incidence registered in the same year. The mean 
incidence figure found across the years up to 2015 was 135.8 treated kidney failure patients 
per annum. The overall described trend for incidence was an increase if described across 
the actual incidence figures (Figure  5-8); however, the increase was not linear because 
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there was fluctuation in the incidence of some years (Figure  5-8). In contrast, the USRDS 
reported Oman’s incidence rates respectively as 102.1 pmp/2008, 103 pmp/2009, 106 
pmp/2010, 108 pmp/2011, 110 pmp/2012, 120 pmp/2013 (United States Renal Data 
System – USRDS, 2015). Though, the trend line of USRDS about Oman’s RRT incidence 
rates show consistent increasing trend, this study incidence rates show an increase if 
described across the actual incidence figures (Figure  5-8); however, the increase was not 
linear because there was fluctuation in the incidence of some years (Figure  5-8), which is 
demonstrated by the cumulative incidence rates that were possible to calculate for some 
selected years (i.e. 0.004% in 2010 and 0.002% in 2013 RRT event). However, it is most 
likely that the incidence is under reported secondary to late presentation of these patients 
for medical care or no capture of these cases at the first instance due to pre-mature death or 
being treated in out of the country. 
 
This study reported mean incidence rate of 125 treated kidney failure per year per total 
population of Oman. On the other hand, the USRDS annual report (2015) reported 
incidence rate of 120 pmp in 2013 (if the total population in 2013 was 3.855 million, then 
the actual figure of incidence was 462.6 (120X3.855) per Oman’s population and not 168 
new cases (i.e. 43.6 pmp) per Oman’s population as reported in Figure  5-8. As a result, the 
two incidences are not exactly in agreement with each other, however the incidences 
reported by this study is believed to be more precise as they were gathered through on the 
spot field work and were gathered from an original source which is Oman’s RRT register.  
 
Similarly, this study results are compared to data published to any of the GCC countries’ 
data as available. Oman is part of the GCC countries which are all neighbouring countries 
whose population shares many characteristics with that of Oman, such as religion, 
language, borders, weather and more. Furthermore it is seen fruitful to compare Oman’s 
statistic with Italy or Poland as Oman’s land area is almost the same to that of Italy or 
Poland, though their population is far larger (~38 million in Poland vs. ~65 million in 
Italy/2013) than Oman’s population (~four million). Accordingly, Oman’s incidence rate 
(43.6pmp/2013) was the lowest when compared to KSA (127.3pmp/2013), Bahrain 
(207.5/2011 – no figure for 2013), Qatar (100 pmp/2013), Italy (162 pmp/2010 – this was 
the only reported incidence for Italy across years), Poland (126.2 pmp/2013), and UK 
(112.5 pmp/2013). Oman’s incidence rate is even lower than Bangladesh (45pmp/2013) 
which is the lowest reported incidence across the participant countries of the USRDS 
(2013). However, the actual figures of incidence could be higher if calculated across 
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Omani population only and not across the total population of Oman (Table  5-7). Also what 
all figures displaying here are only for the treated population and definitely there are some 
proportion of this population who are missed because of not being under treatment or 
having the disease and not yet detected. 
 
The incidence of Oman’s treated kidney failure due to diabetes (45%/2010, result of this 
study, and 46%/2013 reported by USRDS, 2015) was the highest if compared with KSA 
(38.8%), Kuwait (40%), Qatar (32%), UK (22%), and Poland (21%). The both figures 
regarding this aspect from this study and USRDS agree with each other. Oman has no data 
on hypertensive nephropathy to compare for example with KSA which has 39% of their 
treated kidney failure patients had hypertension. 
 
 
Similarly, the incidence and prevalence when described across the four RDCs and across 
the two subdivisions of the north region, it again showed rising figures. In particular, that 
the RDCs of subdivision 1 had a higher incidence compared to subdivision 2. The 
incidence of dialysis treatment in the four RDCs was not possible to calculate for the year 
2015 due to some shortage in the data provided. Furthermore, this study provides a closer 
observation to these rising figures, it is noticed that despite the lower population of 
subdivision 1 compared to subdivision 2, the incidence and prevalence of subdivision 1 
were higher. Also the comparison between the regions showed higher figures in the capital 
and west end and lower figures in the west and the north of Oman. Accordingly this data 
provide clues on treated kidney failure population mapping of Oman which could be 
secondary to many reasons represented by BEINGE model, for example, cross-population 
variations in age or gender, and variations in socioeconomic status of the population. This 
data on kidney failure occurrence across Oman signpost toward further studies to 
emphasise these data and explore the aetiology and risk factors led to the variations in 
occurrence across the regions of Oman. 
 
This study found that treated kidney failure male figure (54.5%) was higher compared to 
females (45.6%) which is compatible with KSA data (55% males to 45% females) and  
with all registries described in chapter one of this thesis (see p.36). USRDS (2015) had no 
data on genders ratio of Qatar and Poland, and for the UK it was 61.8% treated males to 
38.2% treated females. This data imply that there is a need to investigate the reasons 
behind having more kidney failure prevalence among males than females. Though the 
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difference was not high in Oman’s context and it could be as a result of having more male 
population compared to females in the general population census. Higher prevalence 
among males of Oman could be because they are at high risk of getting the kidney failure 
or it could be because they have long duration of disease and so they live longer and add 
up to the prevalence (cumulative), or it could be because the incidence of kidney failure is 
higher in men than woman. Also possible explanation could be that kidney failure among 
men is detected earlier secondary to their early attendance for the medical check-up 
compared to women in Oman and therefore men proportion of prevalence appears higher 
because they were being diagnosed earlier than women who are diagnosed late. However 
studying gender differences in a disease context can provide valuable understanding on 
differential susceptibility (Altevogt et al., 2011). Comparing different variables such as the 
role of genes or effect of identical treatments in males to females can discover valuable 
data such as the protective factors that exist in females that could protect them against 
diseases or how a treatment can be modified to best treat each gender (Altevogt et al., 
2011). 
 
Understanding the relationships between incidence, prevalence and case-fatality can 
provide a deeper description of the epidemiology of any disease. It is well known that 
prevalence is the function of two main factors which are incidence and duration (i.e.  Short 
or long term duration to death – LaMorte, 2016). In this case, the prevalence of RRT event 
found rising within population of Oman; incidence were fluctuating, mortality rates and 
case-fatality were fluctuating too. As a result, it is difficult to infer the existence of positive 
relationship between prevalence, incidence and case-fatality because of the fluctuation of 
the later. It is most likely that the duration of the disease is long and therefore the 
prevalence is rising as demonstrated for example by the morality rate in 2013 was 0.002% 
and the incidence was 0.004% (i.e. incidence figure is more than death figure). 
Accordingly only 0.002% died while the other remaining 0.002% of the incidence was 
added up to the prevalence of the next interval and causes rising of prevalence figures. The 
same can be applied on diabetic nephropathy incidence, prevalence and case-fatality. So if 
the trend of DN is described for the last five years from 2006-2010, it can be noticed that 
the DN increased from 38.6% in 2006 to 47% in 2009, then it dropped slightly in 2010 to 
be 45%. The data reported in the USRDS (2015) for Oman were similar, as the USRDS 
reported 46% (Oman was the top 8
th
 country in having diabetes among the participant 
countries of the USRDS) of DN among the incident cases of the year 2013. 
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The death profile for the RRT population was maintained very well in the Oman’s RRT 
register and helps to reveal that the most reported leading death factors among this 
population .The described trends show that the common three causes of death were: not 
recorded, infections or cardiac complications. However, the un-reported death causes were 
applied to a considerable number of these patients which, if reported, could change the 
present causes of death profile. For example for the years 2001-2010, there were 284 
(31.3%) deaths with no recorded cause of death, out of 906 (100%) patients who died in 
these years. It was known that most of the unreported death events took place at patients’ 
homes. However, it might be a good idea to advise the families to escort the patients 
immediately after death to the nearest hospital to report the cause of death before burying 
the body. This could improve the reporting statistics of death and causes of death. 
Furthermore, the data provided by literature showed that the cardiovascular factors were 
the most common causes of death for this population which suggests that this is most 
probably the cause of death for the unreported causes of death. However, this claim needs 
further testing in the context of Oman. 
 
It was described that the figures of all causes of death appeared to be higher in the 
haemodialysis (which is the main treatment modality provided for Oman’s RRT population 
since this treatment has started in Oman - Table  5-8) cohort compared to the kidney 
transplants and peritoneal dialysis cohorts (Table  5-8). The death figures appeared to be 
higher in males (n = 797) compared to females (n = 713) in all treatment modality cohorts 
except peritoneal dialysis cohort where female deaths (n = 16 = 59.3%) appeared to be 
higher compared to males (n = 11 = 40.7% - Table  5-8). This data is well-matched with all 
registries data. Males’ death figures were higher compared to females in all cohorts except 
in peritoneal dialysis cohort which suggest the need for further explorative and 
investigative studies to reveal the causes and risk factor behind these variations. 
 
There was a decline in death events described since 2009 which can have an important 
impact on both kidney failure patients (i.e. increased survival lifespan) and resource 
allocation (i.e. increased survival will cause increase demands for more resources). It is 
useful to study what were the strategies adopted in these years of death decline, so they 
could be studied further, modified if necessary and included in the care plans of the long 
term. 
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According to the data from this study, the prevalence of dialysis patients overall Oman in 
2013 was 58.9 dialysis patients per 100,000 Omani populations (i.e. 589.8 dialysis patient 
per million populations). This figure of prevalence is equal to 0.06% of the Omani 
population having dialysis treatment. However, the cost of dialysis treatment in 2013 was 
1.36% (i.e. 8,071,484 OMR) of the MOH budget (593.7 million OMR), which drains a 
considerable amount of budget; it is around 6,300 thousand OMR (direct cost only) per 
patient per year. This cost is recurrent as these patients have a chronic condition and are 
undertaking a lifelong treatment (i.e. dialysis). As discussed in chapter two, the 
epidemiological profile in Oman is shifting to have more of an elderly population as the 
life expectancy is high in Oman; also the diabetes prevalence is increasing which is most 
likely one of the leading causes of kidney failure in Oman. These figures predict that the 
cost of RRT will increase across the coming years and the country should be prepared to 
accommodate the growth in demand for this treatment. Therefore, it is important to secure 
funding to continue providing adequate renal care for the Omani population.  
 
 
Also, secondary to the increased demand for renal care, there will be a rise in related costs, 
for example increased demands on renal care staff that will need to increase in number 
with associated training and salary costs. This study results inform the renal care team, and 
especially renal nurses, to keep themselves up to date and be prepared for more load and 
challenges in dealing with the treated kidney failure population. The evidence from this 
research can be used to inform renal care leadership to undertake other cost-effective 
modalities, such as peritoneal dialysis, which may have better outcomes for the kidney 
failure population.  The current proportion of peritoneal dialysis patients in Oman is small 
and did not help to reduce the workload and cost very much. As reported earlier in the 
literature review, peritoneal dialysis is a patient self-managing treatment and is also a cost-
effective treatment. This should be a motivator for the Oman’s MOH to undertake this type 
of treatment to a greater extent. 
 
 
6.3  Kidney transplantation in Oman (1980-2013) 
Kidney transplantation care took a long time to launch in Oman; it was only started in 
1988. The number of transplantations conducted in Oman was only 23 in 2009; this is a 
limited success. The number of kidney transplantations has to be increased. The KSA and 
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Kuwait have successful programs of kidney transplantation which might inform the kidney 
transplantation program in Oman to adopt some changes to the existing system to make the 
program more successful. However, the MOH has provided all the resources for successful 
kidney transplantation program in Oman such as the transplant coordination unit and 
kidney donor clinic. The program was able to achieve the World Record for the youngest 
donor in kidney transplantation which imply that the program has the potential to perform 
the most difficult  kidney transplantation surgires. Also, the USRDS (2015) provided 
kidney transplantation statistics for Oman (18pmp/ 2013 kidney transplants per annum) 
which is comparable with KSA (18.6 pmp/2013), Kuwait (16.6 pmp/2013 kidney 
transplants per annum), higher than Bahrain (6.7 pmp/2012), but less than Poland (29 
kidney transplants per annum), and UK (51 kidney transplants per annum). This infers that 
there is no apparent problem within Oman kidney transplantation program but the main 
problem could be the shortage in the number of donated kidneys as there is no sufficient 
living or deceased donors at present for Oman’s kidney failure population.  
 
The USRDS (2015) reported many developed countries receiving more of donated kidneys 
from deceased donors compared to living, for the developing countries reported in the 
USRDS (2015) like Kuwait and Qatar, it was described that there were more living donors 
compared to deceased, in Oman in two thirds of the kidney transplant donors it is unknown 
if they are deceased or living (Figure  6-1). Also the general trend of the functioning kidney 
transplanted prevalence across the GCC reported by USRDS (2015), showed reduction, for 
example Bahrain had 52.7 functioning kidney transplant pmp/2011compared to 
53.5pmp/2010; Qatar had 332.4 pmp/2013 compared to 375.5 pmp/2012; KSA had 252 
pmp/2012 compared to 298.4 pmp/2010, and in Oman there were 297.4 pmp/2013 
compared to 331.1 pmp/2012. Therefore, the challenge is to disseminate the organ 
donation culture among Oman’s population, also to be transparent in telling the facts about 
the shortage of kidneys to the public and if possible ask the patients themselves to speak up 
about their difficulties and their need for organ donation. Many kidney failure patients on 
dialysis feel desperate for having no donors available to help them. In some instances, 
these patients travel abroad to seek commercial donation, which is considered by the 
international and national communities as unethical. This kind of transplantation plan is not 
supported by the MOH of Oman. Commercial kidney transplants expose the patients to 
higher risk of infections, organ rejections and death. 
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Figure ‎6-1 Distribution of kidney donor type across countries, 2013 
© United States Renal Data System. 2015  
 
Furthermore, the statistics of Oman’s kidney transplantation is not consistent as reported 
earlier because only few statistics for kidney transplantation were possible to be gathered 
by this study. So far, there is no national study covered the epidemiology of kidney 
transplantation in Oman and attempted to explore the facilitators and barriers of this 
important program in Oman. All renal registries and societies across the board agree on 
kidney transplantation as the best option for kidney failure patients. Therefore, the Oman’s 
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MOH can dedicate research manpower and resources to explore and examine this 
treatment in Oman and invest more if needed to increase the annual statistics of kidney 
transplants in Oman. Equally, the patients themselves should be educated about the best 
treatment option for them and allow them to have objective stance to choose what 
treatment of favour to them. 
 
 
6.4 Publications on Oman’s RRT population 
In general, most of the identified 44 publications were difficult to appraise because they 
lack some key information on the method conducted, on the missing data, and on the 
limitations encountered by these studies (see Appendix F on p.269). However, this again 
question the reliability of the research methods used in these studies and  emphasises the 
hypothesis of a quality knowledge shortage regarding the RRT population of Oman. 
 
The publications on kidney transplantation were relatively acceptable in number (n = 16 = 
36.4%) but limited in their scopes and methodologies because many of them were case 
reports where their reported data and their generalizability are limited. Similarly, the 
studies on the epidemiology of Oman’s RRT were limited in their number and 
methodologies. Only two studies with older dates (1985; 1998) contained some details of 
Oman’ RRT population.  Another five studies mentioned Oman’s RRT partially but most 
of them emphasise on the fact that there were limited data and studies coming from Oman. 
This shortfall applies not only to kidney failure research but to the overall situation of 
biomedical research in Oman, which is still considered of limited benefit (Ministry of 
Health - MOH, 2014). There were 141 countries assessed by SC Imago Journal and 
Country Rank portal for the number and citations of publications during 1996-2010. The 
study reported that Oman had only 1,522 publications with 7,357 citations; Oman was 
ranked ninth among 15 countries in the Middle East and North Africa region in research 
activity. Also, more than one-quarter of the biomedical publications (period 2005-2009) by 
Omani researchers were published in journals with no Impact Factor (IF) while more than 
half were also published in journals with IF value of less than one (Rohra et al., 2011). 
Therefore, the Omani research studies were found to be of limited practicality (Rohra et al., 
2011; Ministry of Health - MOH, 2014).  
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6.5  Conclusion 
This study found that the data archived in the Oman’s RRT register in the capital of Oman 
is worthwhile and clinically significant. So it can be argued that the data provided in this 
study and with a complementary data from Oman’s RRT register can have the potential to 
form the base for an Oman Renal Registry (ORR). The goal of ORR can be something 
similar to that of other registries such as the UKRR’s goal which is to improve the health 
of the kidney failure population through making the necessary changes to the renal health 
care system as a result of the registry data. Registry data can be useful in testing 
hypotheses and providing evidence of the need of research (United Kingdom Renal 
Registry - UKRR, 2016). Research can be of great benefit if utilised well. UKRR (2016) 
suggests adopting the “Translational Public Health Research” to achieve the maximal 
benefit from observational data and other data coming for example from international trials 
(Figure  6-2). On the other hand, if Oman’s MOH see difficulties in launching the ORR at 
present, then it is suggested if the ministry extend the existing published annual data about 
Oman’s dialysis population. For example to include distinct detailed statistics for all the 
three treatment modalities in Oman while distinguishing the statistics of Omanis and non-
Omanis, males and females, living and deceased especially for the kidney transplantation 
cohort, and  including the direct and non-direct cost for all modalities. Also it is 
worthwhile to improve the present reporting strategies by for example creating electronic 
renal network where all renal data can be entered and retrieved with a back-up plan in 
place. The entered data must be reviewed and ensure of its reliability and validity prior 
publishing them. 
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Figure ‎6-2 Translational Public Health Research 
© UKRR, 2016 
 
The data provided by this study are paving the road for further research studies needed in 
this field. For example, this study shows the geographical variations in incidence and 
prevalence of kidney failure between governorates, which highlights the need for 
conducting research to explore the causes and risk factors (BEINGS) responsible for these 
variations, which might be population differences or variations in the age structure of the 
population. Also, there is a need to conduct studies to measure the present situation of 
supply and demand of renal care so capacity planning will be signposted especially toward 
the urgency of creating more satellite RDCs. Also research studies’ results have to be 
published and accessible for the concerned parties. 
 
Also, the study found that the popular modality available for kidney failure Omani patients 
is haemodialysis (despite the higher death figures reported in this cohort) and few patients 
had the chance to be on peritoneal dialysis treatment, for example. This study’s data can be 
the base for further research to assess the equity of access to these modalities, and to assess 
whether patients are offered sufficient information and options to select from. So far organ 
donations culture needs to disseminate among Oman’s population through perhaps strong 
awareness program that reach all people of the country. 
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The study showed some dips in the prevalence of kidney failure like in 2003 and 2005 with 
no clear justification. This result may be explored further to see if they were actual dips 
and then to consider the explanation for them, to help in understanding the theory behind 
the dips, and then perhaps adapting some strategies to achieve a continuous decreasing 
trend for kidney failure in Oman. Also, it is known that the MOH had established a 
national screening program in 2010 and published the protocol of it under the title of 
“Operational and management guidelines for the national non-communicable-disease 
screening program”. This screening program targets all Omanis who fulfilled the following 
criteria: they are 40 years old and over and never diagnosed with chronic kidney diseases 
or diabetes or hypertension or even with obesity or elevated cholesterol. However, it is 
more than five years now since this program was established and there is no decrease in 
prevalence but a slight decrease in incidence since 2010. It is not known whether this 
program has resulted in this slight reduction or not, therefore, it is important now to 
evaluate the impact of this program on the epidemiology figures particularly the incidence 
of kidney failure in Oman, and on people’s awareness of kidney failure and RRT. 
 
Also, one significant result was the dramatic increase in the prevalence rate of kidney 
failure in between 2011 and 2015. This increase needs to be studied to explore if it 
happened secondary to the dramatic increase in the non-Omani population in these years, 
or secondary to the increase of diabetes incidence among Omanis, or maybe there is 
another theory explaining this observation. 
 
This study recommends secure funding to be sustained, it is very important to continue 
providing adequate renal care for the Omani population. Oman as a high-income country 
has to direct all income sectors (oil and non-oil resources) of Oman to participate in 
supporting the health sector services and research activities to maintain high standards, 
because these two are the main generators for the developments of the country. 
 
In conclusion, this study suggests that there is a great need to do further research in this 
field. The renal research field in Oman is starving for more data to be gained about the 
kidney failure and RRT population. The first step is to conduct research to uncover the 
characteristics of this population, to gain more understanding on what the kidney failure 
population in Oman looks like and if is it similar to other countries’ populations or is it 
unique with different characteristics. This recommended research was already conducted 
by the author, and it is reported in the next chapter as study two. 
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7 Methods of study two 
7.1 Introduction 
This cross-sectional study (i.e. survey research) was conducted mainly to identify and 
describe the kidney failure population undergoing dialysis in Oman, and their main 
characteristics. However, due to the high expense and limited resources and limited time, it 
was planned to describe a sectional representative population who live in the northern 
region of Oman instead of observing the entire Oman’s dialysis sub-population. Further 
exploratory analysis using the data collected in this cross-sectional study was conducted, 
for example exploring how the descriptive statistics obtained differ for the different 
locations in the northern region of Oman. This chapter presents all the information required 
to understand how the cross-sectional study was conducted and how its data was analysed. 
The cross-sectional study main objectives were as follows: 
5. To identify the demographics and characteristics of patients undergoing kidney dialysis 
in the northern region of Oman. 
6. To identify the common primary diseases, co-morbidities and risk factors associated with 
the kidney dialysis population in the north, and compare it with the neighbouring 
countries if data is available. 
7. To describe the present kidney dialysis modalities in the northern region of Oman. 
8. To describe briefly the characteristics of haemodialysis, and how haemodialysis impacted 
the quality of life of patients in this sub-population. 
 
 
7.2 Study design 
The cross-sectional design was selected for this study because it was the best match for the 
study’s research questions and objectives, as it was intended to study a sectional 
representative population of kidney failure patients in Oman. The cross-sectional design is 
used widely in studying diseases and their risk factors in a pre-defined representative 
population in a defined period of time (Bhopal, 2008). This design can be used to compare 
sub-groups within a geographically defined place based on their diseases, risk factors and 
other factors, because undertaking national studies can be expensive and difficult to 
manage (Bhopal, 2008). It can also be used to assess health needs or the burden of health 
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problems within societies. Cross-sectional studies can be descriptive, describing the 
frequency and distribution of health problems in the identified population, or they can be 
analytical, examining the relationships between some risk factors and health outcomes 
(Bhopal, 2008). This cross-sectional study is mainly descriptive.  
 
Cross-sectional studies are used across the literature to provide a snapshot of studied 
phenomenon such as health or disease (Bhopal, 2008). Most cross-sectional studies collect 
data in a very short time (a matter of days), or over a longer period of time (such as a year 
or two). Studies which extend over more than one year are preferable, as they can capture 
the seasonal effects and changes that take place in the studied phenomenon over a 
reasonable length of time (Bhopal, 2008). Cross-sectional studies are able to provide data 
on different aspects of diseases, such as the medical history and risk factors (Bhopal, 
2008). One of this design’s limitations is that it identifies only the known participants; for 
example, it includes the participants on disease registers and does not include people who 
have the disease but are not yet diagnosed or recorded in the register (Bhopal, 2008). 
Similarly with some other designs the generalizability of this design is limited as a result of 
problems that may take place for example in sampling, and susceptibility to bias in 
reporting or analysis (Bhopal, 2008). 
 
 
7.3  Study settings 
The four public renal dialysis centres (RDCs) in the northern region of Oman were 
approached for data collection. These four RDCs were chosen for a number of reasons:  
 
 The four RDCs together had around 28% (338 patients) of the treated kidney failure 
population in Oman (2012 census) out of 1,221 treated kidney failure patient on 
dialysis in Oman in 2012 (Ministry of Health, Oman, 2013). 
 
 This part of Oman is the most densely populated area in Oman with Omani citizens 
(with a population of 700 thousands Omani in the 2012 census – The National 
Centre for Statistics and Information, 2013), so it was expected to be a 
representative population.   
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7.4 Study population and sample characteristics 
The selection process began with the knowledge that the Oman had 18 RDCs distributed 
over ten governorates (Table  7-1). From the 2012 Oman’s MOH annual report, the census 
of patients on dialysis was identified. The dialysis patients identified by the end of 2012 in 
the four dialysis centres that were planned to be approached  for study two were as follows: 
114 patients in the first setting (will be called RDC1), 41 patients in the second setting 
(RDC2), 69 patients in the third setting (RDC3), and 114 patients in the fourth setting 
(RDC4 - Table  7-1). Thus the total number of patients expected to be in the sample prior to 
data collection were in excess of 338 patients in the northern region of Oman. 
Table ‎7-1 Oman’s‎MOH‎2012‎statistics‎for‎dialysis‎population‎across‎RDCs 
 
Governorate  Name RDC Name No.‎ of‎ patients’‎ on‎
dialysis on 31
st
 
December, 2012 
% of patients 
The north subdivision 1 RDC1 114 9.34 
The north subdivision 1 RDC2 41 3.36 
The north subdivision 2 RDC3 69 5.65 
The north subdivision 2 RDC4 114 9.34 
The capital The central RDC 310 25.38 
The capital RDC5 25 2.05 
The capital RDC6 17 1.39 
The west end of Oman RDC7 36 2.95 
The interior  RDC8 115 9.42 
The interior  RDC9 25 2.05 
The south  RDC10 125 10.24 
The west  RDC11 54 4.43 
The east subdivision 2 RDC12 46 3.77 
The east  subdivision 2 RDC13 44 3.60 
The east subdivision 1 RDC14 50 4.09 
The east subdivision 1 RDC15 25 2.05 
The peninsula RDC16 9 0.73 
The peninsula RDC17 2 0.16 
10 Governorates 18 RDCs 1221 100% 
Note that there are two governorates in the north (i.e. subdivisions 1 and 2); also two 
governorates in the east (i.e. subdivision 1 and 2); the west end of Oman is written in this 
manner to avoid the confusion with west end of other parts of the world like the West End of 
Glasgow. The RDCs highlighted in blue are the settings of this study. 
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This cross-sectional study covered all patients who underwent regular haemodialysis in 
four public sector dialysis centres in the northern region of Oman. For the cross-sectional 
study selecting a representative sample rather than an entire population was seen more 
realistic and less expensive (Polit and Beck, 2014).  The most suitable sampling method 
selected for this study was non-probability sampling (Robson, 2013). The principle of 
selection was convenience sampling because all the registered patients (who were on 
regular dialysis sessions) in the four approached RDCs were considered as representative 
and convienient to approach.  The northern region of Oman is considered to be 
representative of the Omani population because it is a large and densely populated area. In 
terms of Omani citizens, it is the most populated area of Oman, with 717,192 Omanis 
(Table  7-2), although when including non-Omanis the census population increases to over 
one million according to the census of mid-2014 (The National Centre of Statistics and 
Information – NCSI, 2015). In other words, it is the largest area, with the highest Omani 
population, and as a result the northern region’s four renal dialysis centres (RDCs) served 
more than a quarter of the total dialysis population in Oman (28%) by the end of 2012 
(Table  7-1). The sample selected was a convenience sample because it was convenient to 
include all the available patients on haemodialysis at the time of conducting the study in 
the northern region of Oman. The northern region of Oman is spread over a great length of 
Oman’s coastline, with an area equal to 25 thousands km2 (i.e. ~15.5 thousand miles). Due 
to its great size, it is therefore further sub-divided geographically and politically into two 
parts, which in this thesis will be referred to as subdivision 1 and subdivision 2. Each 
subdivision has two renal dialysis centres and covers all the population living  in that 
subdivision (i.e.catchment area). The distance between each individual RDC and the other 
is not standardized (Table  7-2). 
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Table ‎7-2 The breakdown of Oman's population across regions and districts 
© The National Centre of Statistics and Information/Oman, 2015 (statistics for 2014) 
Variables 
 
 
 
 
The northern region  
Omani 
 
 
 
 
Non-
Omani 
 
 
 
Total 
 
 
 
 
Distance from 
the main 
hospital to the 
named district 
in kilometres 
(km) 
Subdivision 1  districts 
District 7 
District 8 
District 9 
District 10 
District 11 
District 12 
 
Total 
 
19,357 
13,120 
82,628 
12,681 
62,018 
80,944 
 
270,748(37.8%) 
 
4,324 
2,923 
22,879 
2,021 
19,902 
37,724 
 
89,773 
 
23,681 
16,043 
105,507 
14,702 
81,920 
118,668 
 
360,521 
* 
68.9 
~65 
40.3 
62.4 
7  
37.7 
Subdivision 2  districts 
District 1 
District 2 
District 3 
District 4 
District 5 
District 6 
 
Total 
 
106,941 
94,892 
51,073 
29,400 
53,897 
110,241 
 
446,444(62.2%) 
 
90,576 
39,079 
14,192 
11,496 
11,983 
42,103 
 
209,429 
 
197,067 
133,971 
65,265 
40,896 
65,880 
152,344 
 
655,423 
** 
4.2 
28.7   
64.3  
35.1  
59.6  
96.7  
 
Total (both 
subdivisions) 
717,192(100%) 299,202 1,015,944  
* This is the distance from RDC1 which is located in District 11, to the other served districts; 
also the distance between RDC1 and RDC2 which is located in District 9, is around 40.3 km 
** This is the distance from RDC4 which is located in the District 1 hospital, to the other 
served districts; however, the distance between RDC4 and RDC3 (also located in District 1) is 
around 20 km 
 
In the northern region of Oman, the population of  males (50.4%) is relatively higher than 
females (49.6%), according to the mid-2014 census (Table  7-3), and this was the genreal 
ratio found later on within the study sub-population. 
  
138 
 
Table ‎7-3 Census of Omani males to Omani females across age groups in subdivisions 
of the northern region of Oman 
© The National Centre of Statistics and Information/Oman, 2015 (the statistics included 
are for 2014) 
 
Variables Males Females Total 
Subdivision 1(RDC1&2) 
0-19 
20-44 
45-64 
65-75 
>75 
 
Total  
 
61,379 
55,814 
12,665 
3,320 
2,434 
 
135,612 
 
60,204 
55,454 
13,885 
3,448 
2,145 
 
135,136 
 
121,583 
111,268 
26,550 
6768 
4579 
 
270,748 
Subdivision 2 (RDC3&4) 
0-19 
20-44 
45-64 
65-75 
>75 
 
Total  
 
102,378 
93,096 
21,123 
5,537 
4,060 
 
226,194 
 
98,122 
90,381 
22,631 
5,620 
3,496 
 
220,250 
 
200,500 
183,477 
43,754 
11,157 
7,556 
 
446,444 
Overall Total 361,806 (50.4%) 355,386 (49.6%) 717,192 (100%) 
 
The sub-populations served by the RDCs of subdivision 1 live in six catchment districts 
which are named in this thesis as District 7 to District 12 (Table  7-2). The total population 
living in subdivision 1 was 360,521, of which 270,748 were Omanis in mid-2014 (National 
Centre for Statistics and Information/Oman, 2015).  
 
Subdivision 2 is composed of six districts, which are named as District 1 to District 6 
(Table  7-2). The total population living in subdivision 2 was 655,423, of which 446,444 
were Omanis in mid-2014 (The National Centre of Statistics and Information – NCSI, 
2015). Note that part of the District 6 population is served by RDCs of Subdivision 1 
because this district is very large and need more than two RDCs to serve its population. 
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Figure ‎7-1 The Omani population of the northern region in relation to their RDCs 
sub-population 
* This is the number of patients who were on dialysis by end of 2012 
 
 
The target population was treated kidney failure patients on regular dialysis who were 
registered in any one of the four RDCs in the northern region of Oman. These patients had 
to undergo dialysis for at least three months in order to be identified as a definite kidney 
failure case according to the KDOQI definitions of CKD and kidney failure. The selected 
participants were Omanis because most of the expatriate population living in Oman were 
Indian or Bangladeshi and perhaps were included in their own countries’ renal databases, 
so to avoid duplication and contamination of the study data non-Omanis were excluded 
(for further justification see  6.2 on p.118). At the time of the data collection, 380 people 
were on haemodialysis treatment in the northern region of Oman. Of these, 341 met the 
inclusion criteria (Figure  7-2). Inclusion and exclusion criteria were the following: 
 
o Inclusion criteria: 
1.    Omani kidney failure patients (of any age) who live in the northern region of Oman. 
2.    On regular weekly dialysis for a minimum period of at least three months. 
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3.   Registered as a dialysis patient in one of the four selected renal dialysis centres selected 
in the northern region of Oman. 
  
o Exclusion criteria: 
1.    Had dialysis for less than three months. 
2.    Known to be dialyzing temporarily (e.g. acute renal failure following snake bite).  
3.   Non-accessible patients such as those who were not on regular weekly dialysis e.g. 
peritoneal dialysis (PD) patients and kidney transplanted patients. 
4.    Non- Omanis (expatriate) 
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Figure ‎7-2 Included and excluded participants 
  
Total Included 
N=341 (89.7%) 
Patients undergo regular dialysis in 
the northern region of Oman 
N=380 (100%) 
Had dialysis for less than 3 
months or known to be 
dialyzing temporarily 
Excluded, N=29 (7.7%) 
PD & kidney transplanted 
patients 
Excluded, N=7 (1.8%) 
Non-Omani 
Excluded, N=3 (0.8%) 
Total Excluded 
Excluded, N=39 (10.3%) 
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7.5 Recruitment 
After obtaining approval from the ethical committees of Oman and of the University of 
Glasgow to conduct this study, copies of the letters were taken by the author and given to 
the administration of the hospitals which the RDCs belonged to (i.e. RDC2 & RDC4), or to 
the person in charge of the RDC if the RDC was independent (i.e. RDC1 & RDC3). 
Permission from the hospital/RDC head was obtained verbally or in writing prior to 
approaching the participants. The RDC patient registers (with 380 patients) were inspected 
to identify the included (341) and excluded (39) patients. All the patients who complied 
with the inclusion criteria were recruited.  
 
The RDCs had either two or three duty shifts, so participants were approached depending 
on their availability during the shift attended by author, according to pre timetable made by 
the author on the day one of being in the RDC. Generally the participants were approached 
during their dialysis sessions at the RDC. However, sometimes participants preferred to 
take the researcher administered survey during their waiting time prior to the dialysis 
session, because, for example, they had arrived too early for their dialysis sessions and 
preferred to utilise their waiting time to complete the survey and then sleep at the time of 
the dialysis. The participants’ wishes were respected at all times. 
 
The research information sheet was handed to the participants and/or authorized person 
and explained by the author (see Appendix D-1 and D-2 on p. 253 & 254). The participants 
and/or authorized person then signed the informed consent (see Appendix D-3 and D-4 on 
p. 256 & 257). Afterwards, the author administered the researcher administered survey 
either face-to-face (15-20 minutes long), if participant available, or later by telephone call 
if they had not been available until the last days for the author in that particular RDC. In 
the case of the telephone calls, the information sheet was explained verbally, the consents 
were taken verbally, and the participants were asked to sign the informed consent sheet as 
soon as they were back for dialysis in their RDC.  
 
 
7.6 The study tool  
Quantitative research is a structured and controlled approach, where the data is collected 
using a formal, unified tool, administered using the same approach for all patients (Polit 
and Beck, 2012). The tool in quantitative research provides a measurement of pre-
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determined variables to eliminate the ambiguity of a studied health problem and provide a 
clear framework for data collection (Polit and Beck, 2012). The measurement outcomes 
provide precise information, usually in numbers, about such studied health problems. In 
this project’s context, one major challenge was to develop a reliable and valid tool to 
measure the variables of this cross-sectional study. Polit and Beck (2012) suggest that the 
task of developing a data collection plan and tool involves a lot of creativity and choices, 
which implies the complexity of this process.  
 
The tool developed for this cross-sectional study was a survey (see Appendix D-6 on 
p.263). The basic aim of the survey was to be able to gather data to assist in developing the 
first description of the characteristics of dialysis-treated kidney failure patients for the 
northern region of Oman. However, finding a ready-made validated survey tailored exactly 
to the purpose of this study was not feasible. This conclusion was reached after reviewing 
the literature and extracting similar studies, which used a tool similar to the one intended. 
One particular study conducted in Libya matched partially the aims of this cross-sectional 
study; however the tool was not published at that point of time and the Libyan author did 
not respond when contacted via email. 
 
Polit and Beck (2012) acknowledge that designing a “well-developed” data collection tool 
is time-consuming, and cannot be fulfilled in a short time. Therefore finding a rigorously 
validated tool from another source such as kidney registries and renal databases was 
considered feasible. All reviewed renal registry and database surveys were designed to 
measure many variables when compared to this project’s cross-sectional study. Therefore, 
items matching the aim of the cross-sectional study were extracted, slightly modified and 
re-used with maintainance of proper citation and copy right as indicated by each renal 
database. The process of building up the survey is explained step by step in the following. 
 
7.6.1 Survey development process 
The study tool was primarly a researcher administered survey. The survey had  61 items 
and was divided into five sections as follows: patient demographics, disease profile, risk 
factors at incidence, impact of kidney failure and dialysis on patient, and death profile (see 
Appendix D-6 on p.263).  
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As explained earlier, the survey items were extracted, slightly modified and re-used from 
different renal registries and renal databases. Three sections from the survey (i.e patient 
demographics, disease profile and death profile) were derived primarily from three renal 
survey forms. The first two forms were from the “centres for Medicare and Medicaid 
services or CMS forms”. First one  called “ESRD medical evidence report Medicare 
entitlement and/ or patient registration”, and the second one called  “ESRD death 
notification”, available for public and researchers via this link on the USRDS website: 
http://www.usrds.org/2015/appx/4_CMS_KF_Forms_15.pdf (for copy right permission, 
see p.248). The third form (called “kidney dialysis patient survey”) was from the  “annual 
audit census for haemodialysis”, available via the Scottish Renal Registry website link for 
SRR Projects A-Z: http://www.srr.scot.nhs.uk/Projects/PDF/2014/May-2014-Census-HD-
Form.pdf?1 (for copy right permission, see p.248). The section on the ‘risk factors’ was 
derived and based on the author reading for the Taal and Brenner (2006) article on 
“predicting initiation and progression of chronic kidney disease: developing renal risk 
scores” (see Reference list on p.225). The section on the ‘kidney failure impact on 
participants’ QoL’ was derived from the kidney disease and quality of live (KDQOL) 
survey (KDQOL-SF
TM
 1.3) which is available on 
http://www.rand.org/health/surveys_tools/kdqol.html (for copy right permission, see 
p.250).   
 
The patient demographic section contained variables such as residence, date of birth, 
gender, race, marital status, education level and occupation. The disease profile section 
identified variables such as the primary disease (i.e. the first chronic disease the patient got 
in his life, mainly looking for diabetes, hypertension and cardiovascualr disease), 
investigations done at that time to diagnose kidney failure, present co-morbidities at the 
time of data collection, dates of first diagnosis with kidney failure and first dialysis date, 
dialysis modality type, vascular access type, and kidney transplantation plan. The risk 
factor section had 21 listed risk factors, including the presence of diabetes, hypertension or 
intake of nephrotoxins; the participant was asked if any of these risk factors were present 
prior to the first diagnosis of kidney failure (see Appendix D-6 on p.263). Section four was 
measuring the impact of kidney failure. It comprised of four variables; namely kidney 
failure interferance with the patient’s life, feeling of being a burden on family or 
community, if having any frustrations and worries, and any effect of  kidney failure on the 
patient’s financial income. The final section of the survey was used to record the death 
profile of the patient, and this included variables such as the date of the patient’s death, 
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cause of death, and age of the patient at death. This last section was completed if the 
participant died during the data collection phase, which began in October 2014 and ended 
on 31
st
 December 2015. 
 
Most of the items of the survey had predetermined dichotomous answers (yes/no responses 
- Figure  7-3). A few questions were considered open-ended questions, which mean they 
needed a written answer: either a date (e.g. date of birth) or a short description (free-text 
question), as with the question ‘What do you think is the cause of your kidney failure?’ 
 
 
Figure ‎7-3 Capture of one part of the survey 
Finally, some of the concepts in the survey were believed to be by some means ambiguous 
and needed some sort of explanation to avoid confusion. For example, with the variable 
“parent dialysis unit”, which meant the dialysis centre where the participant is registered to 
undertake his/her favourite regular dialysis sessions, and which usually served the 
catchment area where the participant live in.  
 
Another variable was “race or ethnicity”, which was a difficult term to define because in 
Islam, the religion of most Omanis, all people are to be considered equal and it is 
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prohibited to categorize people based on their race/ethnicity. However, the idealism that 
Islam and most religions of the world call for is not always the reality. The reality is that 
most Omanis have the concept of race/ethnicity in their minds and sometimes speak out 
loud of how they think this concept should be defined. Omanis see race/ethnicity as either: 
White (people with fair skin and not Mongolian -Mongolian in this context indicating 
Chinese-like physical features such as flatter faces and smaller noses), Blacks (people with 
black or dark skin, very curly hair, wide noses, and not Mongolian), Asians (typical 
Omanis, with a skin colour in between white and black, and not Mongolian), and others 
(people who do not fit in any one of the above categories). This latter race/ethnicity 
categorisation was the ones followed in this study survey.  
 
Also, the meaning intended by the author for the variable ‘urban’ was to mean the highly 
populated cities, with good infrastructure and a high rate of employment; and ‘rural’ to 
mean the less populated places with developing infrastructure and low rate of employment. 
Any option that did not fit into these two categories (urban or rural), were identified as 
‘mixed’, meaning they have features of both urban and rural environments, or cannot be 
identified. 
 
Another issue is that some participants had a history of failed or sometimes recurrent failed 
renal transplantation. This means that those participants were returned to dialysis, so for 
such participants, the history collected was of the current dialysis while interviewing them 
and not for the previous dialysis. For example, if the participant was on dialysis in 1995 
and then  managed to have a successful kidney transplantation and was off dialysis for five 
years, but thereafter the transplanted kidney failed in 2000, and as a result he or she was on 
dialysis again until surveyed by the author. In such a case the date of 1
st
 dialysis recorded 
for this participant was 2000. 
 
Another concept to clarify is “primary diagnosis”, which is defined in this study as the first 
chronic disease the participants had first in their life, and mainly looking for diabetes, 
hypertension and cardiovascular diseases. Also, “limited access to RRT” refers to those 
who live in the mountains or places far from her/his parent RDC, or those with no nearby 
RDC serving her/him, or with no access for dialysis secondary to such reason, who 
therefore do not attend the dialysis sessions frequently. The final concept is “health care 
beliefs”, defined as any personal beliefs a patient has which influence her/his attitude 
towards health, usually negatively. 
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7.6.2 Justification of survey selection 
Across the literature, there is a consistent association between cross-sectional studies and 
surveys. In most of the descriptive cross-sectional studies or most descriptive research, 
survey is the primary tool for data collection (Public Health Action Support Team – 
PHAST, 2017; IARC, 2017).  The main aim of survey is to determine the current status of 
a phenomenon or a situation (Public Health Action Support Team – PHAST, 2017; 
International Agency for Research on Cancer - IARC, 2017).  Survey helps to collect data 
such as demographic, socio-economic, health characteristics of population and to estimate 
specific parameters in a population such as prevalence, and to describe association between 
different variables (e.g. in between gender and age – (Public Health Action Support Team 
– PHAST, 2017; IARC, 2017).  
However, selection of the survey should be based on the research question (Diem, 2002). 
In other words the survey should be the best method to answer the research question of a 
research project. For this cross-sectional study (i.e. survey research) there were two main 
research questions (see cross-sectional study research question on p.133). For the first 
research question, the survey was the best tool to gather data on variables measured by that 
question such as demographics and disease characteristics. These variables are quantitative 
and can be captured best by a survey tool rather than focus groups or semi-structured 
interviews which are most common tools in qualitative research. 
For the second research question, focus groups or semi-structured interviews were possible 
data gathering alternatives. This research question intended to have an initial measure only 
on absence or presence of negative impacts on the QoL of the participants of this study. 
Therefore, the predetermined dichotomous answers (yes/no responses) were used to 
identify the absence or presence of the impact. However, QoL is frequently explored in the 
literature by qualitative methods. On the other hand, the author selected a quantitative 
approach to answer this research question, and this was due to number of reasons. First, the 
author wanted only to determine the absence or presence of the negative impact on the 
participants. Subsequently, this determination will identify the size of population having 
negative impacts. Thereafter, it will be known if the answer to this research question is 
compatible with the global findings in order to make the suitable recommendations for the 
best research method to explore this aspect further. Second reason, the author is aware of 
the availability of disease-specific QoL tools such as KDQOL-SF
TM
. This tool was 
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developed to track kidney disease patients’ views about their health, about their feelings, 
and about their ability to maintain good activity of daily living . Also, this tool measures 
the burden of advanced kidney failure on patients using rating scale and not predetermined 
dichotomous answers (yes/no responses - Research and development – RAND, 1994-
2017). This tool is used by many scholars to mainly measure the QoL scope solely. 
However, this study is not solely exploring  QoL , but other aspects  such as the  presence 
of what risk factors existed prior to the occurrence of kidney failure. Yet assessment of 
quality of life can be controversial, it needs more than fixed response questions that are 
used in this study. It needs a separate and focused study using disease-specific QoL 
questionnaires. However, it was not intended at this stage of this research to focus on QoL . 
Also the tool for this study (see Appendix D-6 on p.263) had to be short because it was 
designed to be administered by the author during a researcher administered survey, usually 
with sick patients. It was essential and ethical to consider the tolerance of patients with 
chronic illness for questioning, which is usually low.  Iarossi (2006) suggests that higher 
response errors can take place if the questionnaire is long and overloads the participant’s 
time and memory. Therefore the items on QoL utilised closed questions rather than open. 
Finally, due to the tied timelines of this research study, having more than 300 patients, it 
was not feasible to explore their QoL in depth at this stage. 
 
7.6.3 Validity of the survey instrument 
The reliability and validity of any data collection tool are based on the internal quality of 
the data collection form and the degree of measurements the data collection tool is taking 
for the variables included in the research question (Polit and Beck, 2012). Reliability 
concerns the accuracy of data collected. The accuracy of the data collected in this research 
was ensured by first gathering the data from the primary source, that is, the patients; and 
secondly by verifying the accuracy of the patients’ answers by comparing them with 
additional sources such as patients’ medical records. Another reliability check on overall 
answers was performed by the author before and during data entry into the SPSS 
programme, to ensure the answers were coherent prior to the analysis stage (Iarossi, 2006). 
The survey (see Appendix D-6 on p.263), used in this research is believed to be of a good 
standard because it was based on evaluated surveys which were tested and retested by 
some of the international registries and databases of the world. Additionally, this study 
survey was evaluated by a panel of experts. Furthermore, the survey was tested during the 
pilot study, and a revised version was made thereafter. All the details of the survey’s 
149 
 
creation and amendments are described further under the study tool section (see section 
6.6, p.144). 
 
The survey was the instrument used to gather the data for this study. The quality of any 
research depends on the quality of the instrument used. One important measure to assess 
the quality of a quantitative study is the reliability measure, which simply means 
measuring the accuracy of an instrument to ensure the rigour of the gathered data (Heale 
and Twycross, 2015). It is difficult to give precise calculation of reliability of an 
instrument; however an estimate can be achieved by testing three major attributes of 
reliability. These attributes are homogeneity (internal consistency), stability (consistency of 
the results) and equivalence (consistency among the responses of participants). The 
internal consistency of an instrument can be tested using different statistical tests such 
item-to-total correlation, split-half reliability, the Kuder-Richardson coefficient and 
Cronbach’s α; the latter is the most popular test (Heale and Twycross, 2015). The stability 
of an instrument is assessed through the use of common test-retest measurements, which 
means giving a test score each time the instrument is completed by a sample participant, 
and repeating this procedure more than once under similar circumstances (Heale and 
Twycross, 2015). A statistical comparison is then made between the scores, to give an 
indication of the stability of the instrument. The equivalence attribute is measured via 
inter-rater reliability, which is a process whereby two or more describers test the same 
instrument and each give a score for that same instrument. The agreement between scores 
given by these describers can indicate the equivalence of the instrument, and enhance the 
reliability of the instrument.  
 
In this study, testing of the internal consistency, stability, and equivalence of the survey 
were not undertaken. However, the reliability of the instrument was ensured by other 
different strategies. First of all by the fact that most of the items used in this study survey 
were derived from trusted international renal registries and databases which are considered 
high quality clinical databases. For example, USRDS functions through a trusted steering 
committee and external expert panel which collaborate to ensure the best quality 
established tools are used and best quality data analysis are undertaken (United States 
Renal Data System – USRDS, 2016).  Secondly, the author was the one asking the 
survey’s questions, and at the same time recording the participants’ responses, rather than 
relying on research assistants - in order to reduce the risk of bias and conflicts in recording 
responses. Thirdly, the same structured survey was used for all participants, including the 
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same questions and following the same instructions, to maintain equivalence. Fourthly, the 
author did not involve other researchers in this process, so that the way the questions were 
asked and explained was consistent, and also to ensure that the intention behind each 
question was fully conveyed to the participants in a consistent way, that the responses 
recorded were the right ones for the relevant question, and also to ensure that those 
surveyed fit within the sampling frame of this study. Finally, the instrument was examined 
for any shortcomings in the pilot study. Despite all of this, no researcher can claim to have 
achieved 100% reliability, because of issues like participant error or bias, and describer 
error or bias (Robson, 2013). Furthermore, there are also some disadvantages to researcher 
administered survey, such as the high cost, and the difficulty in asking sensitive questions 
while facing the patient (Robson, 2013). 
 
Another criterion by which to judge the quality of data is by ensuring the validity of the 
instrument by making sure it measures what it is supposed to measure (Polit and Beck, 
2012; Robson, 2013). There are three main types of validity, which are content validity, 
construct validity and criterion validity (Heale and Twycross, 2015). Content validity 
examines to what degree the instrument measures the research variables (Heale and 
Twycross, 2015). Construct validity inspects the level to which the instrument measures 
the desired construct of the research (Heale and Twycross, 2015). Finally, criterion validity 
describes the extent to which the instrument is related to other instruments that measure the 
same variables (Heale and Twycross, 2015). Validity is difficult to measure because there 
is no ready-made equation or test to calculate the validity of an instrument (Polit and Beck, 
2012). However, triangulation can be helpful in this regard, using multiple sources of data 
to ensure that the data collected was accurate (Robson, 2013, p.158). Although the author 
used multiple sources to gather the information as explained earlier but the author did not 
undertake formal triangulation. For this study, the instrument used did measure what it was 
supposed to measure, and the data was gathered from multiple sources, that is, as far as 
possible, from patients, patient records, and the renal team caring for those patients. 
 
Most of the participants (n = 334, 98%) were present at the RDCs to undertake the 
researcher administered survey. The participants who were not available but matched the 
inclusion criteria were telephoned; seven (2%) participants had telephone interviews. The 
data regarding the death profile of the surveyed participants was followed up passively, so 
one core member of the renal staff was selected during the active phase of the data 
collection per RDC to assist in sending the information relevant to the death of any 
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participants directly to the author. A default date was set per month (5
th
 of the month) as a 
reminder to ask for any data available from the selected staff member. Moreover, the 
author re-visited the study settings during the passive period to complete the data for death 
profiles and double-check the accuracy of the information sent by the core staff member. 
     
7.7 Data collection process 
The process of data collection started after obtaining ethical approval of the study. The four 
data collection locations were visited consecutively by the author. The information sheets 
were distributed on the day one for the first half of the participants and on the day two for 
the remaining participants. Additionally the information sheet was explained verbally for 
most patients on an individual basis because most of them were illiterate. All volunteers to 
participate were informed about the research and then they signed the consent sheet before 
filling the survey. The researcher administered survey was used for all the participants and 
completed by the researcher herself. The primary source of the collected data was the 
participants. However all relevant survey data that could be counter checked with their 
medical records were checked after taking the participants' permission especially if the 
patient could not give specific answers such as the date of the first dialysis. The 
participants' permission was obtained verbally to access their medical records as this access 
was not clearly highlighted in the written informed consent and in the information sheet 
because this was not seen practiced in the clinical settings of Oman. However, the process 
of seeking data from the participants'' medical records were explained and mentioned 
clearly in the proposal, which was approved by the ethics committees (see Appendix A-4 
on p.247). Human participants in research must understand about the research they are 
involved in and they should freely accept participation (The Royal College of Nursing - 
RCN, 2011). However, the inclusion of access permission in the informed consent and 
information sheet was the best recommended to reassure that the participant is best 
informed and the researcher is legally and ethically protected. Also, the participants’ data if 
not found in participant's medical record were collected from the assigned staff if possible 
(for more specification on the sources of the collected data see Figure 6-1).  Also items 59 
to 61 were filled up only if the participant died during the data collection phase.  
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Figure 6-1 Sources of the collected survey data 
 
 
7.8 Ethical considerations  
All included participants were handed an information sheet in Arabic (see Appendix D-1 
and D-2 on p.253-254) and in case the participant was not able to read, the information 
about the research was explained verbally to ensure the participants’ understanding. The 
participant and/or authorized person then voluntarily signed a written informed consent 
(see Appendix D-3 and D-4 on p.256-257).  Also the medical records for the patient were 
accessed after taking verbal consent. (See section 6.7 on p.151, for details of the verbal 
consent and approval from the participants). The permission to access the patient’s medical 
records were obtained from MOH earlier as this was explained in the proposal approved by 
the ethical committees of MOH and UOG (see p.247) the participants had the right to 
accept or reject participation, or withdraw at any time of the study. This was explained to 
them. For vulnerable participants, such as children (in Oman adults are those aged 18 and 
above), the consent was taken from the responsible/authorized person. If any participant 
had any queries, they could ask before beginning or at any time during or after the 
interview. All participants were treated with equal respect, fairly, and their rights to 
privacy were safeguarded at all points in this study. The participants were not exposed to 
any potential risks during the time of data collection, the benefit of the study was explained 
to the participants, the participants were selected fairly and accepted participation 
Demographics 
Patient: 
Most 
Record: 
Item 4 
Staff: None 
Disease 
Profile‎
Patient: 
Some 
Record: 
Items 15-24 
& 26 
Staff: Items 
19, 22, 28, 
29 
Risk Factors‎
Patient: 
Some 
Record: 
Items 33-34, 
38-41, 43-46 
Staff: None 
Impacts‎
Patient:  
All 
Record: 
None 
Staff: None 
Death profile‎
Patient: 
None 
Record: 
None 
Staff: All 
items 
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voluntarily, and all the necessary measures were taken to protect privacy and confidentially 
for the participants (Beauchamp and Childress, 2009). Therefore, this study satisfied the 
principles of biomedical research ethics.  
 
The survey forms were kept secure during the data gathering stage and afterward were 
stored securely in a locked cabinet, within a locked room at the University of Glasgow. 
These forms and all relevant confidential documents will be destroyed after ten years of 
retention as per University of Glasgow policy of “data management and support for 
researchers” which is available at this link: 
http://www.gla.ac.uk/services/datamanagement/storageandcosts/. The data entered into the 
statistical analysis package was anonymous and completely coded. 
 
 
7.9 The pilot study 
The pilot study was undertaken prior to the main study and after receiving ethical approval. 
This was essential in order to determine if any part of the study required amendments. The 
general guideline on the size of the sample required for a pilot study is using 10% of the 
sample required for a full study (Hertzog, 2008). For this research, the estimated full study 
sample was around 400 participants, and accordingly 40 participants were adequate as a 
sample for the pilot study. However, the author approached one dialysis centre that 
estimated to have 40 patients, but on field visit, there were 47 participants who satisfied the 
inclusion criteria. Consequently, the structured survey was administered by the author with 
47 participants (about 14 % of the actual sample). The pilot interview sample was kidney 
failure patients under regular haemodialysis, but selected from a geographical area 
different from the main study settings.  At the pilot RDC, comments about the clarity of the 
survey, its logical flow, missing items, extra items, the burden of questioning, any 
offensive questions, and the actual time needed to complete the survey were considered.  
 
Thereafter, some amendments were made to the original protocol. The required 
amendments were minor, except one, which was the addition of telephone calls to the 
methods. The main data collection method was researcher administered survey, but on a 
few occasions some of the patients were not available at the pilot RDC during the active 
data collection period, for example when a patient was admitted to another hospital and 
could not be reached. So it was feasible to add the telephone call in order to contact such 
patients who were interested to participate in this research study but could not attend the 
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RDC. The author agreed with the telephoned participants to leave the study information 
sheet and the participant informed consent with their assigned staff nurse so it could be 
handed over to them whenever they were next in the RDC. Also, after the informed 
consent was signed by these participants, the author was informed, in order to collect them. 
The main amendments took place in the survey were as follows: 
 
o Some of the sentences in the original protocol on how to approach the participants 
were rephrased and expanded to make them more explicit, to give step-by-step 
guidance to the author (e.g. more detail on when and where to approach the patients 
for interviews). 
o The numerical coding for the survey was amended to be alpha-numerical, which 
was found to be more explicit to use, in order for the author to be able to identify 
not only the participant but also the participant’s RDC later on, if needed. 
o Two exclusion criteria were added to make clear identification of the population.  
o The consent form was amended to permit an authorized person to sign it on behalf 
of a vulnerable participant if needed. 
o Some amendments were made in the survey’s items to enable easy entry and 
analysis on SPSS software, e.g. redundant items were removed and more explicit 
coding and numbering were made, and also the general outline of the survey was 
made more organised and fluent. 
 
All the necessary modifications to the original protocol were carefully made, the protocol 
was resubmitted to the ethical committees, and all the necessary approvals were given for 
the second time (see Appendix-A on p.244-246). 
 
Meanwhile, the main results from the pilot study were not included in the analysis of the 
main study but reported in this section as follows.  There were 47 participants who had a 
definitive diagnosis of kidney failure and were on dialysis at the time of data collection. 
There were 32 males (68.1%) and 15 females (31.9%). Nineteen participants reported that 
they were illiterate (40.4%), 12 had a secondary education (25.5%),  seven had a primary 
education (14.9%), five participants did not follow formal education but could read and 
write (10.6%), three had a college education (6.4%); and one participant had a post-college 
education (2.1%).  About two thirds of the participants were without jobs (76.6%). Almost 
90% of the participants reported having diabetes or hypertension as a primary disease: 
46.6% diabetes and 43.1% hypertension. Most of the participants (70.2%) reported that 
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dialysis had not caused them stress or worry, and that it had little financial impact on their 
lives.  
 
 
7.10 Preparing the data for analysis 
The process of data preparation for analysis comprises checking, editing, coding, 
assembling, and transforming (Kent, 2015). The surveys were first checked for their 
usability after completion. Kent (2015) identifies unusable surveys by the pattern of 
responses: if the responses show some discrepancies, perhaps because the participant did 
not understand the question or the survey was completed by a non-member of the study 
population (such as non-kidney failure participants), the survey is weighted for its 
usefulness, and if shown to be unusable the survey is discarded. Upon collection of the 
inclusion and exclusion criteria, seven participants who matched at least one exclusion 
criteria were excluded, leaving 341 participants. In other words, the author identified 380 
(100%) participants on dialysis at the data collection time, 32 (8.5%) were excluded on the 
spot and seven (1.8) were excluded later, at the checking phase. The numbers of eligible, 
usable surveys were 341 (89.8%).  
 
The editing phase is the process undertaken to verify the consistency and accuracy of the 
responses (Kent, 2015). For this study, the accuracy of the responses was checked in the 
field by verifying the data obtained from the participants with their medical records. In a 
few instances some discrepancies were identified, such as the first dialysis start date.  So in 
such cases the response was verified by the staff assigned to that participant, either at the 
time or whenever the staff member was available. If the data was successfully verified it 
was recorded, and if not, then it was labelled as missed data. Also, some inconsistencies 
were identified in the responses of a single participant. All the inconsistencies, which were 
minor, were corrected.  Those which could not be resolved were treated as missing values. 
However, there was little missing data in this project overall (Table  7-4). 
 
All items on the survey were pre-coded prior to the data collection being initiated, except 
for the multi-response items which were coded later during the data entry phase. Each 
response from the multiple responses was entered as a separate variable (Figure  7-4). Also, 
some of the open-ended questions were coded when possible. 
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Figure ‎7-4 Example of a multiple response question 
*The top is a multiple response question captured from the survey; the bottom is how the 
same question been entered as a separate variable in the SPSS soft ware 
 
Usually researchers develop a codebook for the assistant researchers. The codebook may 
contain further details about the variables, further definitions or descriptions, or specific 
guidelines necessary for the same manner of data collection to be followed by all the 
research assistants (Kent, 2015). In this case, the author was the one who administered all 
the surveys. Also, a key document was developed to provide the necessary explanation 
whenever needed. This worked as a key reference to sufficiently remove any vagueness of 
terms or questions. For example, on the first page of the survey there was the term “parent 
dialysis unit”, so a note was written beside it to clarify what exactly was meant by this 
term. 
 
Kent (2015) defines ‘assembling’ as the step that comes after the checking, editing and 
coding, and which consists of assembling the data from all forms of record, such as surveys 
and diaries, and entering them into the data analysis software. This study data was 
assembled into the Statistical Package for Social Sciences version 22 (IPM SPSS, Chicago, 
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IL). The data was subject to double-entry validation - which means that the data was 
entered twice by the author - and it was checked a third time by a peer reviewer. The peer 
reviewer had anonymised samples of data to check their entry, and thereafter the author 
had a final check on the data entered. 
 
Although there was no transformation undertaken, but some categorisation or re-grouping 
of the variables was performed, for example re-grouping “date of birth” into five sub-
groups of age, in order to create fewer categories for the many variables responded, and 
enables comparison afterwards. The general rules used in handling the data on SPSS were 
as follows: 
 
o Aims/objectives of the analysis   
Firstly, the data analysis should describe the sample population as a whole. Secondly it 
should compare data across the sub-divisions or RDCs, and thirdly, it should compare data 
(i.e. sample population characteristics) from this study with the evidence available from the 
literature. 
 
o Handling‎of‎missing‎data‎and‎the‎“do‎not‎know”‎responses 
In the case of this project, most of the ‘do not know’ responses were received when one of 
the following happened: firstly, when the participant was not able to remember certain 
dates, such as the date of the first dialysis and also the date was not found in any other 
resource, and secondly, when there were discrepancies between responses and it was 
impossible to verify the correct answer. Consequently these types of responses were 
recorded as missed data. 
 
Some of the SPSS system’s missing data occurred as a result of the survey design itself 
(Table  7-4). For example, there was one item asking about the marital status of the 
participant. If the participant answered ‘divorced’, then he or she had to go to the next sub-
set question, and if not divorced the participant had to skip the next sub-set question. So all 
the skipped questions, the system then recognised them as missing values (Figure  7-5).  
However, in one specific instance, a participant who was divorced refused to answer the 
sub-set question regarding divorce, and therefore this particular case was coded as an 
“item-non-response” or “user-defined missed value” rather than “system missing value” 
(Kent, 2015). 
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Table ‎7-4 Summary of missing data on SPSS 
Type of missing data 
(items with missed data) 
N** % Rationale 
A.SPSS system missing values 
*9. If you are divorced, is it because of your KF 
& dialysis? (One participant refused to respond). 
 
*11. If you have no occupation, is it because of 
your KF & dialysis? 
 
*29. If yes, when were you transferred from 
another RDC to this RDC? 
 
*31. Had you any failed renal transplantation? 
 
 
320*** 
 
 
49 
 
 
333 
 
 
309 
 
93.8 
 
 
14.4 
 
 
97.7 
 
 
90.6 
All the listed 
questions were 
conditional 
questions (sub-
sets), which meant 
that the participant 
had to answer 
them if s/he 
satisfies the 
condition required 
for that 
question/item 
2.User-defined missing values 
*17. Co-morbidities 
*33. Risk factor: proteinuria 
*41. Risk factor: dyslipidaemia 
 
18 
34 
4 
 
5.3 
10 
1.2 
Participants do not 
know and data 
could not be found 
 
* serial numbers of items on the survey  
** number of missing data values  
*** 319 system missed values and 1 user-defined missed value  
KF, kidney failure; N, number; %, percent; RDC, renal dialysis centre 
 
 
Figure ‎7-5 Example of SPSS system missing values 
Kent (2015) recommends that if an item’s non-responses are more than 5%, then the author 
can use certain techniques to resolve the problem, for example ‘explicit imputation’, where 
the missing values will be replaced by other actual values such as the mean of that 
response. However, the non-response rate in this project for most items was less than 5%, 
so it would not affect the results of the data analysis and there was therefore no need to use 
such techniques.  
 
Regarding the entry of dates in the SPSS, the SPSS software requires the date to be entered 
in the form of day, month and year, and while participants usually remembered the years, 
they might not have remembered the exact month or date. Therefore, whenever necessary, 
the date was rounded off to the nearest convenient value for the participant’s dialysis 
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history, if agreed by the participant. The final issue in this regard is that most of the 
participants’ dates of birth were recorded as the 1st of January, which implies that the 
health agency’s medical records computed the 1st of January as a default date. This may 
have happened because participants were not carrying their birth certificate and/or could 
not recall the exact date of birth while registering at the health agency. Nevertheless, this 
issue occurred prior to receiving the data and therefore the data was recorded as received. 
However, if participants were certain about their accurate date of birth, then the recorded 
date of birth was the most reliable or accurate one according to the participant. 
 
Open-ended questions (free-text) can also be a source of missing data if the responses are 
not categorised and coded in the ideal way (Kent, 2015). In this study, the last question in 
the fourth section of the survey was an open-ended question, as the participants were asked 
about their thoughts on the cause of their kidney failure, and there were many responses 
recorded. The described pattern of answers was that most of the participants identified the 
cause as either diabetes combined with other reasons, or hypertension combined with other 
reasons, or both diseases, either singly or combined with other diseases. This was difficult 
to categorise and code, so it was left as it is and the analysis was carried out manually. 
 
o Statistical methods - descriptive statistics 
A profile of the sample population was computed using descriptive statistics on the SPSS 
version 22.  The mean, standard deviation (SD), median, and 25
th
 and 75
th
 percentile were 
calculated for continuous data (e.g. age based on date of birth). N and % have been 
provided for categorical data (e.g. overall number and % of participants undergoing 
dialysis). 
  
For nominal data, and where data was categorised or re-grouped - for example, when age 
has been measured at the continuous level but then categorised (i.e. in age groups) - a chi-
squared test was computed for comparisons between groups, or a Fisher exact test was 
computed if the total number of observations was less than twenty or any of the expected 
frequencies were less than five. Comparisons between groups were made using two sample 
t-tests or non-parametric equivalents (i.e. non-normally distributed data; Mann-Whitney U 
test), or parametric (i.e. normally distributed data; one-way ANOVA test) in comparing 
continuous variables between groups based on the distribution of the data. An appropriate 
univariate type of analysis was carried out according to the needs as follows: 
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- To test the relationship between two categorical variables, a chi-square test or 
Fisher’s exact test was carried out. 
- To test the relationship between one categorical variable of two levels (e.g. gender) 
and one continous variable (e.g. age) a t-test was carried out, because the data was 
normally distributed. 
- To test the relationship between one categorical variable of more than two levels 
(e.g. education levels) and one continous variable (e.g. age), a one-way ANOVA 
analysis was performed, because it was normally distributed data. 
 
Comparison was made between subdivisions and/or between RDCs, between districts, 
between genders, between race/ethnicity, between marital statuses, between education 
levels, and between employments whenever seen as significant. The decision for statistical 
significance was based on the alpha value (α) of 0.05 significance level, and the null 
hypothesis was rejected if alpha was less than 0.05.  
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8 Results of study two 
8.1  Overview 
The following section  presents the details of this study’s results, and is structured under 
the following sub-headings: participant demography and characteristics, participant 
distribution across districts, participant perception on the risk factors, participant primary 
diseases and causes, participant co-morbidities profile, participant haemodialysis 
characteristics, participant perception on the impact of dialysis treatment on their lives, 
participant death figures in 2014 and in 2015, and participant plans on kidney 
transplantation. The reported results satisfy one main aim, which is to develop the first 
description of the characteristics of dialysis-treated kidney failure participants in the 
northern region of Oman. 
 
8.1.1 Participant demography and characteristics 
The overall age across the subdivisions and across the RDCs was normally distributed. The 
average age for this population was 51.7 ± 15.8 (mean ± SD) years old, and the median 
was 54 years old (Table  8-1). The participants in subdivision 2 were slightly younger 
(mean age M = 50.6 years, SD = 16.3), compared with subdivision 1 (M = 52.9 years, SD 
= 15.3). However, when the mean age across the four RDCs is compared, RDC1 (M = 
51.9 years, SD =15.9) and RDC3 (M = 51.3 years, SD = 15.5) had almost the same mean 
age, while RDC2 appeared to have a slightly older population (M = 55.6 years, SD = 13.3) 
and RDC4 had a slightly younger population (M = 50 years, SD = 16.9). Statistically, there 
was no significant difference between the mean ages of the subdivisions (p-value of t- test, 
P = 0.177) and across the RDCs (p-value of one-way ANOVA test, P = 0.282). 
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Table ‎8-1 The statistical summary of the age variable across the northern region of 
Oman 
Variable 
All 
 
Subdivision 1 
 
Subdivision 2 
Age 
   
Total 
(n=341) 
All 
(n=167) 
RDC1 
(n=123) 
RDC2 
(n=44) 
All 
(n=174) 
RDC3 
(n=77) 
RDC4 
(n=97) 
 
Mean (SD) 
 
Med.(Q1,Q3) 
 
Mini.(max.) 
 
 
51.7(15.8) 
 
54(41,63) 
 
10(94) 
 
 
52.9(15.3) 
 
55(42,64) 
 
16(94) 
 
 
51.9(15.9) 
 
54(41,63) 
 
16(94) 
 
 
55.6(13.3) 
 
57(46,65) 
 
21(93) 
 
 
50.6(16.3) 
 
53.5(38,62) 
 
10(84) 
 
 
51.3(15.5) 
 
54(38,61.5) 
 
20(84) 
 
 
50(16.9) 
 
53(37,62) 
 
10(83) 
 
Age groups  
 
 0-17    n (%) 
     
18-45   n (%) 
 
46-64   n (%) 
 
65-75   n (%) 
    
 >75     n (%) 
         
 
 
6(1.8) 
 
102(29.9) 
 
164(48.1) 
 
52(15.2) 
 
17(5) 
 
 
 
1(0.6) 
 
49(29.3) 
 
79(47.3) 
 
30(18) 
 
8(4.8) 
 
 
 
1(0.8) 
 
39(31.7) 
 
57(46.3) 
 
19(15.4) 
 
7(5.8) 
 
 
 
0(0) 
 
10(22.7) 
 
22(50) 
 
11(25) 
 
1(2.3) 
 
 
 
5(2.9) 
 
53(30.5) 
 
85(48.9) 
 
22(12.6) 
 
9(5.1) 
 
 
 
0(0) 
 
27(35.1) 
 
37(48.1) 
 
8(10.4) 
 
5(6.4) 
 
 
 
5(5.2) 
 
26(26.8) 
 
48(49.5) 
 
14(14.4) 
 
4(4.1) 
 
N, number; RDC, renal dialysis centre, SD, standard deviation; Med, median; Q1, quartile 1; Q2, 
quartile 2;Mini, minimum; max, maximum 
In subdivision 1, the participant age range was 16-94 years old. The oldest (regarding 
dialysis duration) registered participant on dialysis who was still alive (at the time of data 
collection), and still on dialysis, started the dialysis in 1988. This participant was 69 years 
old at the time of data collection and spent 26 years of his/her life on maintenance 
haemodialysis. 
 
In subdivision 2, the participant age range was 10-84 years old, and the oldest registered 
participant on dialysis (who was still alive at the time of data collection) had started the 
dialysis in 1980. This participant was 44 years old at the time of data collection and had 
spent 34 years of his/her entire life on maintenance haemodialysis.   
 
Around 80% of the study population were aged less than 65 years old. Nearly half of the 
participants, regardless of the subdivisions, were in the 45-64 age groups Table  8-1). The 
males were apparently younger (M = 50.3 years) compared to females (M = 53.3 years), 
however there was no statistically significant difference between males and females in 
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relation to age. There were six children (1.8%) in the sample population, and 335 adults 
(98.2% - Table  8-1 and Figure  8-1). Five out of the six identified children were from 
subdivision 2. 
 
Figure ‎8-1 Overall age group distributions across the northern region of Oman 
There were more male participants than females (54.8% vs. 45.2% - Table  8-2), with no 
statistically significant differences between the subdivisions (P = 0.598) or RDCs (P = 
0.643). 
 
Table ‎8-2 Statistical summary of the gender variable across subdivisions and RDCs 
Variable 
All 
 
Subdivision 1 
 
Subdivision 2 
Gender 
   
Total 
(n=341) 
n (%) 
All 
(n=167) 
n (%) 
RDC1 
(n=123) 
n (%) 
RDC2 
(n=44) 
n (%) 
All 
(n=174) 
n (%) 
RDC3 
(n=77) 
n (%) 
RDC4 
(n=97) 
n (%) 
 
Males      
                
Females  
                 
 
187(54.8) 
 
154(45.2) 
 
 
94(56.3) 
 
73(43.7) 
 
 
69(56.1) 
 
54(43.9) 
 
25(56.8) 
 
19(43.2) 
 
 
93(53.4) 
 
81(46.6) 
 
 
45(58.4) 
 
32(41.6) 
 
 
48(49.5) 
 
49(50.5) 
 
 
Across the whole sample (i.e. in the northern region of Oman) there were significantly 
large numbers of Omani Asians (n = 237 = 69.5%), a lesser number of Omani Whites (n = 
55 = 16.1%), and Omani Blacks were the smallest group, represented by 49 participants 
1.8 
29.9 
48.1 
15.2 
5 
0
10
20
30
40
50
60
0-17 18-45 46-64 65-75 >75
%
 
Age groups 
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(14.4% - Table  8-3). Although the percentage of Asians was similarly high across the 
subdivisions and RDCs, however, it was higher in subdivision 1 as a result of higher 
percentages of Asians within RDC1 (n = 88 = 71.5%) and RDC2 (n = 37 = 84.1%). It was 
also described that the number of Whites was greater in subdivision 2 (n = 44 = 25.3%) 
when compared to subdivision 1 (n = 11 = 6.6%). In contrast, Blacks were relatively 
numerous in subdivision 1 (n = 31 = 18.5%) when compared to subdivision 2 (n = 18 = 
10.3% - Table  8-3). The p-value of the chi-square test was significant (P < 0.05) between 
subdivisions (P < 0.05) and between RDCs (P < 0.05), which indicates a significant 
statistical difference in race/ethnicity between the subdivisions and between RDCs. 
 
Table ‎8-3 Statistical summary of the race/ethnicity variable across subdivisions and 
RDCs 
Variable 
All 
 
Subdivision 1 
 
Subdivision 2 
Ethnicity 
 
Total 
(n=341) 
n (%) 
All 
(n=167) 
n (%) 
RDC1 
(n=123) 
n (%) 
RDC2 
(n=44) 
n (%) 
All 
(n=174) 
n (%) 
RDC3 
(n=77) 
n (%) 
RDC4 
(n=97) 
n (%) 
 
Asians     
 
Whites    
 
Blacks      
 
237(69.5) 
 
55(16.1) 
 
49(14.4) 
 
 
125(74.9) 
 
11(6.6) 
 
31(18.5) 
 
 
88(71.5) 
 
7(5.7) 
 
28(22.8) 
 
 
37(84.1) 
 
4(9.1) 
 
3(6.8) 
 
 
112(64.4) 
 
44(25.3) 
 
18(10.3) 
 
 
50(64.9) 
 
17(22.1) 
 
10(13) 
 
 
62(63.9) 
 
27(27.8) 
 
8(8.3) 
 
 
Of the female participants, 103 (66.9%) were Asians, whilst 134 (71.7%) of the male 
participants were Asians (Table  8-4). There were more White females (n = 26 = 16.9%) 
compared to White males (n = 29 = 15.5% - Table  8-4) and more Black females (n = 25 = 
16.2%) across the whole dialysis sub-population in the northern region of Oman compared 
to Black males (n = 24 = 12.8% - Table  8-4). Statistically, there was no evidence of 
statistical significant difference between gender and race/ethnicity, as the p-value was P = 
0.590. 
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Table ‎8-4 Statistical summary of the race/ethnicity variable in relation to gender 
across the northern region of Oman 
Variable 
Gender 
 
Ethnicity 
Total (n = 341) 
n (%) 
Female (n = 154) 
n (%) 
Male (n = 187) 
n (%) 
 
Asians     
 
Whites    
 
Blacks    
 
237(69.5) 
 
55(16.1) 
 
49(14.4) 
 
103(66.9) 
 
26(16.9) 
 
25(16.2) 
 
134(71.7) 
 
29(15.5) 
 
24(12.8) 
The majority of the participants were married (n = 214 = 62.8%), 54 (15.8%) were single 
(i.e. never married), 51 were widowed (15%) and 22 were divorced (6.4% - Table  8-5). 
The divorced sub-set were asked if their divorce happened because of their chronic kidney 
failure and their prolonged treatment (dialysis), as a result eight out of the 22 divorced 
participants reported that their divorce was an outcome of their chronic treatment 
(Table  8-5).  
Table ‎8-5 Statistical summary of the marital status variable across all subdivisions 
and RDCs 
Variable 
All Subdivision 1 Subdivision 2 
 
Marital status 
 
Total 
(n=341) 
n (%) 
All 
(n=167) 
n (%) 
RDC1 
(n=123) 
n (%) 
RDC2 
(n=44) 
n (%) 
All 
(n=174) 
n (%) 
RDC3 
(n=77) 
n (%) 
RDC4 
(n=97) 
n (%) 
 
Married       
 
Widowed    
 
Single          
 
Divorced     
 
Because of KF 
 
214(62.8) 
 
51(15) 
 
54(15.8) 
 
22(6.4) 
 
8(38.1) 
 
107(64) 
 
25(15) 
 
23(13.8) 
 
12(7.2) 
 
2(9.5) 
 
75(61) 
 
20(16.3) 
 
19(15.4) 
 
9(7.3) 
 
2(9.5) 
 
32(72.7) 
 
5(11.4) 
 
4(9.1) 
 
3(6.8) 
 
0 
 
107(61.5) 
 
26(14.9) 
 
31(17.8) 
 
10(5.8) 
 
6(28.6) 
 
47(61) 
 
11(14.3) 
 
13(16.9) 
 
6(7.8) 
 
5(23.8) 
 
60(61.9) 
 
15(15.5) 
 
18(18.5) 
 
4(4.1) 
 
1(4.8) 
KF, Kidney Failure 
It was described that the divorce figure appeared higher in subdivision 1 (n = 12 = 7.2%) 
compared to subdivision 2 (n = 10 = 5.8% - Table  8-5). The p-value was P > 0.05, 
showing no statistical significant difference in divorce rates between subdivisions (P = 
0.49) and between RDCs (P = 0.48). The divorce figure was higher among female dialysis 
participants (n = 13 = 8.4%) compared to male participants (n = 9 = 4.8%). Statistically, 
there was evidence of significant difference between gender and marital status across the 
whole sample (P < 0.05 - Table  8-6). 
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Table ‎8-6 Statistical summary of the marital status variable in relation to the gender 
variable across the northern region of Oman 
Variable 
Gender 
 
Marital Status 
 
Total (n = 341) 
n(%) 
Female (n = 154) 
n(%) 
Male (n = 187) 
n(%) 
 
Married    
 
Widowed 
 
Single 
 
Divorced 
 
214 (62.8) 
 
51(15) 
 
54(15.8) 
 
22(6.4) 
 
85(55.3) 
 
37(24) 
 
19(12.3) 
 
13 (8.4) 
 
 
129(69) 
 
14(7.5) 
 
35(18.7) 
 
9(4.8) 
 
 
The vast majority of participants were unemployed (n = 292 = 85.6% - Table  8-7), with 
only 62 (21.2 %) participants said that they were fired from their job because of their 
sickness. The employment status was almost the same across the subdivisions or RDCs. 
The p-value was P ˃ 0.05, showing no statistical significant difference between 
subdivisions (P = 0.537) or between RDCs (P = 0.942 - Table  8-7). The reported 
education level of the surveyed participants was as follows: illiterate (n = 164 = 48 %), 
read and write (n = 51= 15%), primary education (n = 47 = 13.8%), secondary school (n = 
58 = 17%), college degree (n = 18 = 5.3%) and post-college education (n = 3 = 0.9%). It 
was described that nearly half of the surveyed participants were illiterate (Table  8-7). 
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Table ‎8-7 Statistical summary of the educational level and employment status 
variables across the northern region of Oman 
Variable 
All 
 
Subdivision 1 
 
Subdivision 2 
 
Literacy status 
 
Total 
(n=341) 
n (%) 
All 
(n=167) 
n (%) 
RDC1 
(n=123) 
n (%) 
RDC2 
(n=44) 
n (%) 
All 
(n=174) 
n (%) 
RDC3 
(n=77) 
n (%) 
RDC4 
(n=97) 
n (%) 
 
Employed         
 
Unemployed   
 
  Because of KF 
 
49(14.4) 
 
292(85.6) 
 
62(21.2) 
 
22(13.2 
 
145(86.8) 
 
28(9.6) 
 
16(13) 
 
107(87) 
 
15(5.1) 
 
6(13.6) 
 
38(86.4) 
 
13(4.5) 
 
27(15.5) 
 
147(84.5) 
 
34(11.6) 
 
12(15.6) 
 
65(84.4) 
 
18(6.2) 
 
15(15.5) 
 
82(84.5) 
 
16(5.4) 
 
Illiterate           
 
Read & write  
     
Primary           
 
Secondary       
 
College            
    
Post-college    
         
 
164(48.1) 
 
51(15) 
 
47(13.7) 
 
58(17) 
 
18(5.3) 
 
3(0.9) 
 
72(43) 
 
31(18.6) 
 
28(16.8) 
 
28(16.8) 
 
7(4.2) 
 
1(0.6) 
 
55(44.7) 
 
21(17.1) 
 
18(14.6) 
 
24(19.5) 
 
5(4.1) 
 
0(0) 
 
17(38.6) 
 
10(22.7) 
 
10(22.7) 
 
4(9.1) 
 
2(4.5) 
 
1(2.4) 
 
92(52.9) 
 
20(11.5) 
 
19(10.9) 
 
30(17.2) 
 
11(6.3) 
 
2(1.2) 
 
32(41.6) 
 
14(18.2) 
 
9(11.7) 
 
15(19.5) 
 
6(7.8) 
 
1(1.2) 
 
60(61.9) 
 
6(6.2) 
 
10(10.3) 
 
15(15.5) 
 
5(5.1) 
 
1(1) 
The literacy status in general was similar across the subdivisions and RDCs. The p-value 
also showed no evidence of statistical significant difference between subdivisions (P = 
0.174) or RDCs (P = 0.084). However there were more illiterate females compared to 
males, with 103 (66.9%) illiterate females compared to 61 (32.6%) males across the whole 
sample of the dialysis sub-population of the northern region of Oman Table  8-8). The post-
college cohort was all males, with no females in this category (Table  8-8). Statistically, 
there was a significant difference between the variables of education and gender (P < 
0.05). The statistics showed that the 18-44 age groups were a more educated population, 
while the over 75 age group was less educated (Table  8-8). The p-value was (P < 0.05), 
showing a significant difference between education and age groups. 
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Table ‎8-8 Statistical summary of the education variable in relation to gender and age 
group variables across the northern region of Oman 
Variable 
Gender Age group 
Education 
Total 
n(%) 
Female 
n(%) 
Male 
n(%) 
0-17 
n(%) 
18-45 
n (%) 
46-64 
n (%) 
65-75 
n (%) 
>75 
n (%) 
 
 
Illiterate          
 
Read &write   
     
Primary           
 
Secondary       
 
College   
          
Post-college               
 
 
164(48.1) 
 
51(15) 
 
47(13.7) 
 
58(17) 
 
18(5.3) 
 
3(0.9) 
 
 
 
103(66.9) 
 
15(9.7) 
 
14(9.1) 
 
19(12.4) 
 
3(1.9) 
 
0 
 
 
 
61(32.6) 
 
36(19.3) 
 
33(17.6) 
 
39(20.9) 
 
15(8) 
 
3(1.6) 
 
 
 
1(16.7) 
 
1(16.7) 
 
3(49.9) 
 
1(16.7) 
 
0 
 
0 
 
 
 
13(12.7) 
 
4(3.9) 
 
21(20.6) 
 
45(44.1) 
 
17(16.7) 
 
2(2) 
 
 
 
99(60.4) 
 
31(18.9) 
 
22(13.4) 
 
10(6.1) 
 
1(.6) 
 
1(0.6) 
 
 
 
38(73.1) 
 
11(21.2) 
 
1(1.9) 
 
2(3.8) 
 
0 
 
0 
 
 
 
13(76.5) 
 
4(23.5) 
 
0 
 
0 
 
0 
 
0 
 
No participants were living alone, but all were living in families, either in rural (n = 239 = 
70.1%) or urban areas (n = 99 = 29% - Table  8-9). It was observed that the number of 
participants living in rural areas was higher compared to those in urban areas, across all 
RDCs (Table  8-9) except RDC2 (n = 16 = 36.4%), where it was the opposite (i.e. more 
lived in urban areas). However, most of the participants surveyed were not sufficiently 
certain as to whether the area they lived in was rural or urban. Statistically, there was a 
significant difference in the variable of residential status between subdivisions (P < 0.05) 
and between RDCs (P < 0.05). 
Table ‎8-9 Statistical summary of residential status across subdivisions and RDCs 
Variable 
All 
  
Subdivision 1 
 
Subdivision 2 
Type of 
area lived 
in 
 
Total 
(n=341) 
n (%) 
All 
(n=167) 
n (%) 
RDC1 
(n=123) 
n (%) 
RDC2 
(n=44) 
n (%) 
All 
(n=174) 
n (%) 
RDC3 
(n=77) 
n (%) 
RDC4 
(n=97) 
n (%) 
 
Urban      
 
Rural        
 
Mixed    
 
99(29) 
 
239(70.1) 
 
3(0.9) 
 
 
45(26.9) 
 
120(71.9) 
 
2(1.2) 
 
 
17(13.8) 
 
104(84.6) 
 
2(1.6) 
 
 
28(63.6) 
 
16(36.4) 
 
0 
 
 
54(31) 
 
119(68.4) 
 
1(0.6) 
 
 
27(35.1) 
 
50(64.9) 
 
0 
 
 
27(27.8) 
 
69(71.1) 
 
1(1.1) 
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8.1.2 Participant distribution across districts 
The four RDCs of this study served the sub-population on maintenance dialysis from 12 
districts (Figure  8-2). The largest number of participants came from District 1 (n = 62 = 
18.2%), followed by those from District 6 (n = 58 = 17%), and those from District 11 (n = 
55 = 16%). The smallest number of participants came from District 8 and District 9 (n = 8 
= 2.4%) and District 7 (n = 5 = 1.5%).  
 
Figure ‎8-2 Dialysis sub-population‎across‎the‎northern‎region‎of‎Oman’s‎districts 
 
It was noticed that the figures for males were slightly higher than for females across the 
districts (e.g. in District 6 - males were 9.4% vs. 7.6% females), except in District 1 (males, 
8.8% vs. females, 9.4%) and District 3 (males, 2.3% vs. females 3.3%): where the figures 
for females appeared slightly higher than for males (Figure  8-3). However, the p-value of 
the chi-square test showed no evidence of statistical significant difference in gender across 
the districts (P = 0.682). 
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Figure ‎8-3 Treated dialysis sub-population across districts of the north in relation to 
gender 
The distribution of the age groups was similar across all districts, and the chi-square test 
presented no significant difference in distribution (P = 0.859). The only difference was that 
paediatric participants were coming from only four districts (i.e. Districts 1, 2, 5, and 6) out 
of the 12 districts of the northern region of Oman. Furthermore, when the education status, 
compared across the districts, was almost the same, and the chi-square tests showed no 
evidence of significant difference (P = 0.924).  
 
8.1.3 Participant perception on the risk factors 
All the surveyed participants were asked to identify the risk factors apparent to them at the 
phase preceding their diagnosis with kidney failure, or at the time of their diagnosis with 
kidney failure. Most of the listed risk factors had no clinical evidence in the patients’ 
profiles when compared except for hypertension or diabetes which were well evidenced in 
most of the patient medical profiles. The participant had to select any or all of the 21 risk 
factors listed in the survey that was applicable to them. Hypertension was the most 
common risk factor, reported frequently by the participants (14.2%). Second was obesity 
(11.5%) and third was diabetes (8.6%). Cultural factors came fourth (8.4%), low socio-
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economic status fifth (6.9%), and limited access sixth (6.5%) and few participants chose 
the remaining risk factors on the list (Figure  8-4). 
 
 
Figure ‎8-4 participants perceived top nine risk factors across the northern region of 
Oman compared to gender 
It was noticed that when compared to males, females had slightly higher percentages for 
five risk factors: first was nephrotoxins (males, 2.4 % vs. females, 3.7%), second was 
proteinuria (males, 2.9% vs. females, 3.2 % - note: the missing responses for this variable 
were more than 5% which may give this statistics less reliability), third was dyslipidaemia 
(males, 2.3 % vs. females, 2.4% ), fourth was late diagnosis (males, 2.1 % vs. females 
2.4%), and fifth was anaemia (males, 0.9 % vs. females,1.1% - Figure  8-4). Another result 
was the higher percentages of hypertension in District 6 (18%), District 1 (15.2%) and 
District 2 (10.6%), and the low percentages in District 7 (1.4%), District 8 (1.4%), and 
District 10 (0.5%). Also the highest percentage of obesity was described in District 1 
(24.4%), and the lowest in District 7 (0.6%). Comparing the risk factors across 
subdivisions revealed that subdivision 1 participants appeared to have more hypertension 
(55.8%) compared to subdivision 2 (44.2%). However, subdivision 2 appeared to have 
more obesity (63.6%) and diabetes (52.7%) compared to subdivision 1 which had obesity 
at 36.4% and diabetes at 47.3%.  
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8.1.4 Participant primary diseases and causes  
Overall, the top four primary diseases reported by participants were hypertension (n = 161 
= 47.5%), diabetes (n = 77 = 22.7%), diabetes and hypertension combined (n = 55 = 
16.2%), and finally other medical problems such as polycystic kidneys, heart problems, 
hyperthyroidism and anaemia (n = 88 = 26% - Table  8-10). It is described that more than 
half of the surveyed participants reported diabetes, hypertension or combined as the 
primary disease. Also, these primary diseases were counter checked by the patients’ 
medical records. 
Table ‎8-10 Statistical summary of the primary diseases variable across all 
subdivisions and RDCs 
Variable 
All 
 
Subdivision 1 
 
Subdivision 2 
 
Primary 
diseases 
 
Total 
(n=341) 
n (%) 
All 
(n=167) 
n (%) 
RDC1 
(n=123) 
n (%) 
RDC2 
(n=44) 
n (%) 
All 
(n=174) 
n (%) 
RDC3 
(n=77) 
n (%) 
RDC4 
(n=97) 
n (%) 
 
DM         
 
HTN    
 
DM & HTN     
 
Genetics           
 
   SLE                 
 
Urological        
 
Others              
 
 
77(22.7) 
 
161(47.5) 
 
55(16.2) 
 
10(2.9) 
 
20(5.9) 
 
9(2.7) 
 
88(26) 
 
23(13.9) 
 
81(48.8) 
 
39(23.5) 
 
4(2.4) 
 
13(7.8) 
 
7(4.2) 
 
42(25.3) 
 
8(4.8) 
 
60(36.1) 
 
39(23.5) 
 
3(1.8) 
 
11(6.6) 
 
6(3.6) 
 
28(16.9) 
 
15(9) 
 
21(12.7) 
 
0 
 
1(0.6) 
 
2(1.2) 
 
1(0.6) 
 
14(8.4) 
 
54(31.2) 
 
80(46.2) 
 
16(9.2) 
 
6(3.5) 
 
7(4) 
 
2(1.2) 
 
46(26.6) 
 
22(12.7) 
 
40(23.1) 
 
2(1.2) 
 
2(1.2) 
 
4(2.3) 
 
0 
 
17(9.8) 
 
32(18.5) 
 
40(23.1) 
 
14(8.1) 
 
4(2.3) 
 
3(1.7) 
 
2(1.2) 
 
29(16.8) 
DM & HTN, diabetes and hypertension; SLE, systematic lupus  erythematous 
 
There was no evidence of significant statistical difference in primary diseases across the 
subdivisions and RDCs, except with diabetes (P < 0.05) or diabetes and hypertension 
combined (P < 0.05 - Figure  8-5), both of which had evidence of significant statistical 
difference.  
  
173 
 
 
Figure ‎8-5 Primary diseases distribution across subdivisions 
 
It was described that the male figures for primary diseases are higher than those for 
females, except in RDC4, where females reported more diabetes compared to males (males 
43.8% vs. females 56.3%). Males have also reported less systemic lupus erythematous 
(SLE) and glomerulonephritis (GN) compared to females. These results follow the normal 
trends reported by the literature, as SLE is more prevalent in females than in males, which 
may be due to differences in sex hormones and gonadotropin-releasing hormone (Wasef, 
2004 - Table  8-11).  
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Table ‎8-11 Statistical summary of the primary diseases variable in relation to the 
gender variable across the whole sample in the north of Oman 
Variable 
Gender 
 
Primary diseases 
Total 
n(%) 
Female 
n(%) 
Male 
n(%) 
 
DM  
 
HTN 
 
*DM & HTN 
 
SLE  
 
*GN 
 
Urological 
 
Others 
 
77(22.6) 
 
161(47.2) 
 
55(16.1) 
 
10(2.9) 
 
20(5.9) 
 
9(2.6) 
 
88(25.8) 
 
32(41.6) 
 
76(47.2) 
 
27(49.1) 
 
5(50) 
 
10(50) 
 
2(22.2) 
 
41(46.6) 
 
45(58.4) 
 
85(52.8) 
 
28(50.9) 
 
5(50) 
 
10(50) 
 
7(77.8) 
 
47(53.4) 
*DM & HTN, diabetes and hypertension; GN, glomerulonephritis 
 
Participants were also asked to express their thoughts on what might be the cause of their 
kidney failure. Many participants perceived it might be hypertension (n = 112 = 32.8%), 
diabetes (n = 67 = 19.6%), diabetes and hypertension combined (n = 44 = 12.9%), or other 
mixed causes (34.7%), which included nephrotoxins (e.g.NSAIDs, 1.2%) and medical 
errors (e.g. medication errors and misdiagnosis, 0.6% - Figure  8-6). It was also observed 
that while reporting their diabetes, hypertension or other causes, participants frequently 
combined other problems with their primary cause. Examples of this were diabetes and 
non-compliance, or hypertension and ignorance (3.5% of the participants reported non-
compliance and ignorance, mainly because of denial of the problem or lack of trust in the 
success of the treatment).  
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Figure ‎8-6 Participant perceptions on their kidney failure causes 
 
8.1.5 Participant co-morbidities profile 
The most common co-morbidities reported by participants (and counter checked by their 
medical records) were, firstly, diabetes and hypertension combined (n = 156 = 45.7%), 
followed by hypertension only (n = 136 = 39.9%), then other mixed co-morbidities (n = 90 
= 26.4%) such as anaemia, hyperparathyroidism, asthma and neurogenic bladder, then 
cardiovascular disease (n = 83 = 24.3%), diabetes only (n = 9 = 2.6%), and finally SLE (n 
= 7 = 2.1% - Table  8-12).  
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Table ‎8-12 Statistical summary of the co-morbidities variable across all subdivisions 
and RDCs 
Variable 
All 
 
Subdivision 1 
 
Subdivision 2 
 
Co-
morbidities 
 
Total 
(n=341) 
n (%) 
All 
(n=167) 
n (%) 
RDC1 
(n=123) 
n (%) 
RDC2 
(n=44) 
n (%) 
All 
(n=174) 
n (%) 
RDC3 
(n=77) 
n (%) 
RDC4 
(n=97) 
n (%) 
 
DM & HTN*     
 
HTN  
 
Others               
 
CVD*                 
 
DM         
 
SLE         
 
 
156(45.7) 
 
136(39.9) 
 
90(26.4) 
 
83(24.3) 
 
9(2.6) 
 
7(2.1) 
 
 
69(20.2) 
 
72(21.1) 
 
45(13.2) 
 
27(7.9) 
 
6(1.8) 
 
5(1.5) 
 
 
51(15) 
 
56(16.4) 
 
32(9.4) 
 
17(5) 
 
2(0.6) 
 
3(0.9) 
 
 
18(5.3) 
 
16(4.7) 
 
13(3.8) 
 
10(2.9) 
 
4(1.2) 
 
2(0.6) 
 
 
87(25.5) 
 
64(18.8) 
 
45(13.2) 
 
56(16.4) 
 
3(0.9) 
 
2(0.6) 
 
 
30(8.8) 
 
34(10) 
 
21(6.2) 
 
24(7) 
 
2(0.6) 
 
1(0.3) 
 
 
57(16.7) 
 
30(8.8) 
 
24(7) 
 
32(9.4) 
 
1(0.3) 
 
1(0.3) 
 
*DM & HTN, diabetes and hypertension; CVD, cardiovascular disease; SLE, systemic lupus 
erythematous 
 
Across the northern region of Oman, males appeared to have more of all reported co-
morbidities compared to females, except for SLE. For SLE, females had higher 
percentages (85.7%) compared to males (14.3% - Table  8-13). 
 
Table ‎8-13 Statistical summary of the co-morbidities variable in relation to the 
gender variable across the northern region of Oman 
Variable 
Gender 
 
Co-morbidities 
Total 
n(%) 
Female 
n(%) 
Male 
n(%) 
 
DM & HTN           
 
HTN 
 
Others  
 
CVD        
 
DM 
 
  SLE          
 
156(45.7) 
 
136(39.9) 
 
90(26.4) 
 
83(24.3) 
 
9(2.6) 
 
7(2.1) 
 
76(48.7) 
 
61(44.9) 
 
46(51.1) 
 
38(45.8) 
 
3(33.3) 
 
6(85.7) 
 
80(51.3) 
 
75(55.1) 
 
44(48.9) 
 
45(54.2) 
 
6(66.7) 
 
1(14.3) 
DM & HTN, diabetes and hypertension; CVD, cardiovascular disease; SLE, systemic lupus 
erythematous 
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8.1.6 Participant haemodialysis characteristics 
o Diagnostic investigations 
Participants were asked to identify how their kidney failure was diagnosed, by selecting 
one or more of the following diagnostic tests: blood, urine, imaging tests, eGFR, kidney 
biopsy, nephrologist’s opinion or perhaps other tests performed.  
All participants (341) underwent blood tests and received nephrologists’ opinions to 
confirm their kidney failure diagnosis. Imaging tests were reported by 95.3% (n = 325 
participants) and urine tests by 90.9% (n = 310 participants). Kidney biopsies were 
reported by 8.2% (n = 28 participants) and eGFR was reported by 0.3% (n = one 
participant). Other investigations such as MRI (magnetic resonance imaging) were reported 
by only 0.3 % (n = one participant - Figure  8-7). There was no statistical evidence of 
difference across subdivisions or across RDCs, as the p-value was for both at  P > 0.05. 
 
Figure ‎8-7 Kidney failure diagnostic tests reported by participants across the 
northern region of Oman 
 
o Vascular access for haemodialysis 
The most common vascular access was the permanent arteriovenous fistula (AVF - n = 
272 = 79.8% - Table  8-14). In comparing types of vascular access across the subdivisions, 
it was noticed that subdivision 1 participants reported only three types of vascular access, 
arteriovenous fistula, arteriovenous graft and P-cath, while subdivision 2 participants 
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reported more types of vascular access, including femoral venous catheter and jugular 
venous catheter (Table  8-14). The p-value was P > 0.05, which indicates no significant 
statistical difference in types of vascular access across subdivisions (P = 0.130) and RDCs 
(P = 0.174). 
 
Table ‎8-14 Statistical summary of the vascular accesses variable across all 
subdivisions and RDCs 
Variable 
All 
 
Subdivision 1 
 
Subdivision 2 
 
Vascular 
access 
 
Total 
(n=341) 
n (%) 
All 
(n=167) 
n (%) 
RDC1 
(n=123) 
n (%) 
RDC2 
(n=44) 
n (%) 
All 
(n=174) 
n (%) 
RDC3 
(n=77) 
n (%) 
RDC4 
(n=97) 
n (%) 
 
AVF           
 
AVG           
 
P-cath         
 
FVC            
 
  JVC            
 
272(79.8) 
 
23(6.7) 
 
41(12) 
 
1(0.3) 
 
8(1.2) 
 
140(41.1) 
 
11(3.2) 
 
16(4.7) 
 
0 
 
0 
 
103(30.2) 
 
7(2.1) 
 
13(3.8) 
 
0 
 
0 
 
37(10.9) 
 
4(1.2) 
 
3(0.9) 
 
0 
 
0 
 
132(38.7) 
 
12(3.5) 
 
25(7.3) 
 
1(0.3) 
 
4(1.2) 
 
64(18.8) 
 
4(1.2) 
 
7(2.1) 
 
1(0.3) 
 
1(0.3) 
 
68(19.9) 
 
8(2.3) 
 
18(5.3) 
 
0 
 
3(0.9) 
AVF, arteriovenous fistula; AVG, arteriovenous graft; P-Cath, permicath; FVC, femoral venous 
catheter; JVC,  jugular venous catheter 
 
 
o Haemodialysis dose, duration and timing 
All the participants (n = 341) surveyed were on haemodialysis modality. Most of this study 
population started the dialysis either immediately or within three months after their definite 
diagnosis of kidney failure (n = 267 = 78.3%). However, six patients from RDC4 were on 
peritoneal dialysis, so were excluded from the study. RDC4 was the only RDC that had 
patients on peritoneal dialysis modality at the time of data collection. At the time of data 
collection nearly half of the participants had survived on dialysis for an average of five 
years (48.4% - Table  8-15).  
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Table ‎8-15 Duration of survival on dialysis in years across the whole sample at the 
time of data collection 
Years on dialysis N % 
0-1 51 15 
1-5 165 48.4 
5-10 87 25.5 
10-20 34 10 
20-30 3 0.9 
>30 1 0.3 
Total 341 100 
 
Nearly two thirds (62.5%) of this study population were on three dialysis sessions a week, 
or a minimum of nine dialysis hours per week. Two sessions of dialysis per week was the 
rate for 36.1% of participants, which is a minimum of five hours of dialysis per week. Only 
1.5% was following a non-fixed schedule (i.e. sometimes two sessions a week and other 
times three sessions a week - or one session per week in a few cases). Less than half of the 
participants (41.9%) were attending their dialysis sessions in the afternoon or evening. 
Some of the participants were attending dialysis sessions at differing times: sometimes in 
the morning, sometimes in the afternoon or evening. The remaining participants (22.9%) 
were attending morning sessions.  
The majority of participants (n = 296 = 86.8%) were comfortable with their dialysis 
timing; however, 45 participants (13.2%) said they did not like the timetable of their 
weekly dialysis. There were some variations between RDCs regarding frequency and 
timing of haemodialysis, and to illustrate this further each RDC is described separately in 
appendix G (see p.272). 
  
180 
 
 
Figure ‎8-8 Participant satisfaction regarding haemodialysis frequency and timing 
across the four RDCs 
8.1.7 Participant perceptions on the impact of dialysis treatment 
on their lives 
The overall findings of this item showed that most participants (n = 288 = 84.5%) felt that 
dialysis treatment caused no interference to their lives, and the difference across 
subdivisions (P = 0.227), and between RDCS (P = 0.007) was not statistically significant. 
Many participants did not feel that they caused a burden on their family or the community 
(n = 283 = 83%) with no statistically significant difference between subdivisions (P = 
0.907) or RDCs (P = 0.009 - Table  8-16). The majority felt psychologically stable, with 
few worries or frustrations (n = 291 = 85.3%) with no statistically significant difference 
between subdivisions (P = 0.446), but with statistically significant difference between 
RDCs (P = 0.003). Most of the participants (n = 286 = 83.9%) had no financial difficulties 
secondary to their commitments to the dialysis treatment with statistically significant 
difference between subdivisions (P = 0.003), and between RDCs (P < 0.05).  
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Table ‎8-16 Statistical summary of the reported impact of dialysis treatment on 
participant lives across subdivisions and RDCs 
Variable 
All 
 
Subdivision 1 
 
Subdivision 2 
 
Dialysis 
impact 
   
Total 
(n=341) 
All 
(n=167) 
 
RDC1 
(n=123) 
 
RDC2 
(n=44) 
 
All 
(n=174) 
 
RDC3 
(n=77) 
 
RDC4 
(n=97) 
 
54. My 
kidney 
disease and 
its treatment 
interfere too 
much with 
my life. 
Yes 15.5 
% 
Yes 8.8 
% 
Yes 5.3 
% 
Yes 3.5 
% 
Yes 6.8 
% 
Yes 1.2 
% 
Yes 5.6 
% 
No 84.5 
% 
No 40.2 
% 
No 30.8 
% 
No 9.4 
% 
No 44.3 
% 
No 21.4 
% 
No 22.9 
% 
55. I feel 
like a 
burden on 
my family 
and the 
community. 
Yes 17 
% 
Yes 8.2 
% 
Yes 5.0 
% 
Yes 3.2 
% 
Yes 8.8 
% 
Yes 1.8 
% 
Yes 7.0 
% 
No 83 
% 
No 41.0 
% 
No 31.3 
% 
No 9.7 
% 
No 42.2 
% 
No 20.8 
% 
No 21.4 
% 
56. I feel 
frustrated 
and worried 
when 
dealing with 
my disease.    
Yes 14.7 
% 
Yes 6.4 
% 
Yes 2.9 
% 
Yes 3.5 
% 
Yes 8.2 
% 
Yes 2.3 
% 
Yes 5.9 
% 
No 85.3 
% 
No 42.5 
% 
No 33.1 
% 
No 9.4 
% 
No 42.8 
% 
No 20.2 
% 
No 22.6 
% 
57. I do not 
have 
sufficient 
income 
because of 
my dialysis 
treatment. 
Yes 16.1 
% 
Yes 5.0 
% 
Yes 1.8 
% 
Yes 3.2 
% 
Yes 11.1 
% 
Yes 2.3 
% 
Yes 8.8 
% 
No 83.9 
% 
No 44.0 
% 
No 34.3 
% 
No 9.7 
% 
No 39.9 
% 
No 20.2 
% 
No 19.6 
% 
 
 
8.1.8 Participant death figures in 2014 and in 2015 
The overall death figures in the four RDCs combined was 42 dialysis patients in 2014, with 
13 females (31%) and 29 males (69%). In 2015, 57 dialysis patients died: 29 females 
(50.9%), and 28 males (49.1%). Therefore the total death figure for both years combined 
was 99 deaths, however for 22 (22.2%) of these – all from RDC4 in 2014 - the cause was 
not reported. The causes of death overall, for 2014 and 2015, were cardiovascular  (CVD -
n = 41 = 41.5%), infection (n = 10 = 10.2%), unknown or unreported causes (n = 5 = 
5.2%), respiratory (n = 4 = 4%), and other causes such as: cancer (n = 1= 1.2%), 
cerebrovascular (CVA - n = 1= 1.2%), gastrointestinal bleeding (n = 1= 1.2%), and poly-
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trauma (n = 1= 1.2% - Figure  8-9). The average survival rate for those on dialysis from 
their start of dialysis treatment and until death across three RDCs (this was not possible to 
calculate for RDC2 – see next paragraph for details) was 6.9 years per survivor. As there is 
some missing data in this domain and there were some variations between the individual 
RDCs, the death profiles for individual RDCs are illustrated next. 
 
Figure ‎8-9 Comparison of causes of death between the years 2014 and 2015 across the 
whole sample the northern region of Oman 
 
RDC1 had 15 deaths in 2014, with 11 (73.3%) males and 4 (26.7%) females. The most 
common cause was cardiovascular diseases (n = 9 = 60%), followed by infection (n = 4 = 
26.6%), respiratory arrest (n = 1 = 6.7%), and cerebrovascular accident (n = 1 = 6.7% - 
Figure  8-9). In 2015, there were 11 deaths, five (45.5%) males to six (54.5%) females. The 
causes of death reported were cardiovascular (n = 8 = 72.7%), respiratory (n = 1 = 9.1%), 
and cancer (n = 1 = 9.1%). The range of survival on dialysis treatment for the 11 
participants who had been surveyed and died during data collection was 3-19 years. The 
average survival rate on dialysis for the same cohort was 7.3 years of dialysis per patient. 
In RDC2 nine participants died in 2014 (Figure  8-10), six (66.6%) males and three (33.4%) 
females. The causes of death as reported were cardiovascular (n = 3 = 33.3%), unknown or 
unreported causes (n = 3 = 33.3%), infection (n = 2 = 22.3%), and respiratory (n = 1 = 
11.1%). In 2015, there were 14 deaths (Figure  8-10) during the year, eight (57.2%) males 
to six (42.8%) females. The reported causes of death were cardiovascular (n = 8 = 57.2%), 
infection (n = 2 = 14.3%), unknown or unreported (n = 2 = 14.3%), respiratory (n = 1 = 
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7.1%), and gastrointestinal bleeding (n = 1 = 7.1%). The range of survival on dialysis was 
not possible to calculate because only one participant found his/her data, and it seemed the 
others  were not captured by this study because they started after the interviews (i.e. they 
were not included in the sample) and died during the year 2015, which was confirmed later 
by the RDC’s staff.  
 
Figure ‎8-10 Death figures across RDCs in 2014 
 
RDC3 reported the deaths of six participants in 2014 (Figure 5.17), with five (83.3%) 
males and one (16.7%) female. The reported causes of death were cardiovascular for five 
participants (83.3%), and infection for the other (16.7%). In 2015, ten participant deaths 
were reported, seven (70%) males to three (30%) females (Figure  8-11). The reported 
causes of death were cardiovascular (n = 8 = 80%), infection (n = 1 = 10%), and poly-
trauma (n = 1 = 10%). The range of dialysis survival for the ten participants who had been 
surveyed and who died during data collection was 2-14 years. The average survival rate 
was 5.75 years on dialysis per patient. 
RDC4 had 12 deaths in 2014, seven (58.3%) males and five (41.7%) females 
(Figure  8-10). The causes were not reported for 2014. In 2015, the reported death rate was 
22 patients, eight (36.4%) males to 14 (63.6%) females (Figure  8-11). This RDC only 
reported the causes of death for ten participants, nine of which died because of 
cardiovascular complications and one because of multi-organ failure. The range of dialysis 
survival for the 11 participants who had been surveyed and died during the data collection 
was 1-7 years. The average survival rate on dialysis treatment was 7.9 years per patient. 
11 
6 
5 
7 
4 
3 
1 
5 
0
2
4
6
8
10
12
RDC1 RDC2 RDC3 RD4
N
 o
f 
p
at
ie
n
ts
  i
n
 2
01
4
 
RDCs 
Males
Females
184 
 
 
Figure ‎8-11 Death figures across RDCs in 2015 
  
8.1.9 Participant plans on kidney transplantation 
In summary, slightly more than half of the participants (n = 173 = 50.7%) were hoping to 
have kidney transplantation in the near future. Similarly, nearly half of the participants (n = 
163 = 47.8%) were not planning to have a transplantation. Only 1.5 % of the participants 
were not sure about their transplantation plan (Table  8-17).  
 
Table ‎8-17 Participant responses regarding their plans for kidney transplantation 
across the whole sample compared to gender 
Variable 
 
Are you planning to have kidney 
transplantation? 
Gender 
Total 
n (%) 
Male 
n (%) 
Female 
n (%) 
Yes 104(30.5) 69(20.2) 173(50.7) 
No 80(23.5) 83(24.3) 163(47.8) 
         Not Sure 3(0.9) 2(0.6) 5(1.5) 
   Total 187(54.9) 154(45.1) 341(100) 
More males wanted to have kidney transplantation compared to females (60.1% males vs. 
39.9% females - Table 5.21), with no statistical significance difference across subdivisions 
(P = 0.124) or RDCs (P = 0.124 – Table  8-18). 
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Table ‎8-18 Statistical summary of kidney transplantation plans in relation to the age 
gender and groups variables across the northern region of Oman 
Variable 
All 
  
Subdivision 1 
 
Subdivision 2 
 
Age 
   
Total 
(n=341) 
n (%) 
All 
(n=167) 
n (%) 
RDC1 
(n=123) 
n (%) 
RDC2 
N=(44) 
n (%) 
All 
(n=174) 
n (%) 
RDC3 
(n=77) 
n (%) 
RDC4 
(n=97) 
n (%) 
 
Males    
 
 
Females   
 
 
104(60.1)* 
80(49.1)** 
 
69(39.9) 
83(50.9) 
 
50(28.9) 
44(27) 
 
28(16.2) 
45(27.6) 
 
39(22.5) 
30(18.4) 
 
19(11) 
35(21.5) 
 
11(6.4) 
14(8.6) 
 
9(5.2) 
10(6.1) 
 
54(31.2) 
36(22.1) 
 
41(23.7) 
38(23.3) 
 
22(12.7) 
22(13.5) 
 
17(9.8) 
14(8.6) 
 
32(18.5) 
14(8.6) 
 
24(13.9) 
24(14.7) 
Age groups  
 
0-17   
 
 
18-45   
 
 
46-64  
  
 
65-75  
  
    
>75     
 
 
 
4(2.3)* 
2(1.2)** 
 
58(33.6) 
43(26.4) 
 
85(49.1) 
75(46) 
 
22(12.7) 
30(18.4) 
 
4(2.3) 
13(8) 
 
 
1(0.6) 
0 
 
24(13.9) 
25(15.4) 
 
39(22.5) 
40(24.5) 
 
11(6.4) 
19(11.7) 
 
3(1.7) 
5(3) 
 
 
1(0.6) 
0 
 
20(11.6) 
19(11.7) 
 
26(15) 
31(19) 
 
8(4.7) 
11(6.8) 
 
3(1.7) 
4(2.5) 
 
 
0 
0 
 
4(2.3) 
6(3.7) 
 
13(7.5) 
9(5.5) 
 
3(1.7) 
8(4.9) 
 
0 
1(0.5) 
 
 
3(1.7) 
2(1.2) 
 
34(19.7) 
18(11) 
 
46(26.6) 
35(21.5) 
 
11(6.3) 
11(6.7) 
 
1(0.6) 
8(5) 
 
 
0 
0 
 
15(8.7) 
12(7.4) 
 
19(11) 
16(9.8) 
 
4(2.3) 
4(2.5) 
 
1(0.6) 
4(2.5) 
 
 
3(1.7) 
2(1.2) 
 
19(11) 
6(3.6) 
 
27(15.6) 
19(11.7) 
 
7(4) 
7(4.2) 
 
0 
4(2.5) 
* all first rows are for yes responses ** all second row in each item are for no responses 
 
It was described that about half (49.1%) of the participants who wanted to have kidney 
transplantation were in the 46-64 age group. Participant plans across age groups were 
almost identical across the subdivisions and RDCs. The p-value showed the same 
conclusion, with no evidence of significant difference between RDCs (P = 0.174) or 
subdivisions (P = 0.381) in relation to age groups. 
Kidney transplantation plan in relation to education level were tested statistically showing 
positive relationship. However, the p-value was P > 0.05 across subdivisions and RDCs, 
which indicates no significant statistical difference in this variable in relation to education 
level between subdivisions or RDCs. 
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Table ‎8-19 Statistical summary of kidney transplantation plans in relation to 
education level 
Are you planning to do kidney 
transplantation? 
Yes No Not Sure Total 
Variable  
 
 
Education 
level 
Illiterate n 68 92 4 164 
%  39.3 56.4 80 48.1 
Read and Write n 26 25 0 51 
%  15 15.3 0 15 
Primary (1-9) n 27 19 1 47 
%  15.6 11.7 20 13.8 
Secondary (10-12) n 39 19 0 58 
%  22.5 11.7 0 17 
College n 10 8 0 18 
%  5.8 4.9 0 5.3 
Post-College n 3 0 0 3 
%  1.7 0 0 .9 
Total n 173 163 5 341 
%  100 100 100 100 
% of 
Total 
50.7 47.8 1.5 100.0 
It was noticed that across the subdivisions, smaller proportion of participants in subdivision 
1 (45.1%) wanted to have kidney transplantation compared to subdivision 2 (54.9%), but 
with no statistically significance difference (P = 0.124).  The highest percentages of 
participants who planned for kidney transplantation were in District 1 (20.2%), District 2 
(13.4%), and District 6 (12.7% - Figure  8-12), with no statistically significant difference (P 
= 0.183). 
 
Figure ‎8-12 Participant plans for kidney transplantation across all districts 
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9 Discussion of study two 
9.1 Participant demography and characteristics 
The first objective of this study is answered in this section and sections 8.1.1 by identifying 
the demographics and characteristics of patients undergoing regular dialysis treatment in 
the northern region of Oman. In general, both subdivisions and the four RDCs share 
common similarities, such as having a middle-aged population; nearly half of the 
population falling within the 46-64 age group, with a mean age of 51.7 (Table  8-1). A 
recent study from Oman published in 2016, found the mean age of the included treated 
kidney failure patients overall Oman as 50.1 years old, which agrees with this study’s 
results (Al-Ismaili et al., 2016). In comparison, the common age group prevalence 
described globally were commonly older groups, especially in the USA (65-74 years) and 
the UK (70-79 years); in Australia and New Zealand (55-74 years), and in Africa, the 
common age group was younger (20-50 years). In KSA, dialysis is common in the 26-65 
age groups (70%), which include a younger population in comparison to Oman’s dialysis 
sub-population. The higher prevalence among the older age group might be explained  as 
the older age is found to be  related to greater decline in kidney GFR and therefore may act 
as initiating factor of chronic kidney disease but not necessarily a perpetuating factor 
(Eriksen and Ingebretsen, 2006; Taal and Brenner, 2006). Furthermore, this common age 
group identified by this study is the upper half of the working age group and the country’s 
economy relies on their contribution. However, the dialysis sub-population identified in 
this study constitutes only 0.04% of the general population of the northern region of Oman, 
which is a small proportion. According to mid-2014 statistics, 86% of the general 
population of the north of Oman is under 45 years old. It is likely that this young educated 
population can respond positively to an active education program if implemented on them 
early and frequently. 
The general population of both subdivisions had more males than females; however, 
subdivision 2 had a greater number of males compared to females (Table  8-2).  The only 
two studies published recently about Oman’s RRT population had close results with this 
study’s results as follows; this cross sectional study identified 54.8% males vs. 45.2% 
females, timeline is 2014 – 2015, population is dialysis patients in the northern region of 
Oman); Al-Ismaili et al. (2016) reported 52% males vs. 48% females, timeline is 1980-
2013, population is overall Oman RRT population); Al-Alawi et al. (2017) reported 57.1% 
males vs. 42.9% females, timeline is 2001-2015, population is overall Oman RRT 
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population. Though the results of Al-Ismaili et al. (2016) and Al-Alawi et al. (2017) agree 
and validate this cross sectional results, however, the comparison is handled with caution 
because of the differences in the timelines and the population covered. Similarly, among 
the dialysis population of the world and KSA, the number of males was relatively higher 
than females. Males on dialysis in KSA were 55% compared to 45% females, where 86% 
of this population were Saudi and the remaining 24% were non-Saudi, in the  UK male 
incidence was 64.6% compared to females, 35.4%. The unexpected part about this part of 
this study results was that the males who underwent dialysis in subdivision 1 were greater 
in number than the males of subdivision 2, despite the fact that subdivision 2 had a larger 
general population and also a larger male population than subdivision 1. This might be 
investigated in the future to explore the causes and risk factors behind this result, and also 
behind RDC4 having slightly more females on dialysis than males, and in general having 
younger males on dialysis compared to slightly older females. However, the general trend 
for most countries reporting the characteristics of their kidney failure population on 
dialysis was that the incidence in males is higher compared to females (United States Renal 
Data System – USRDS, 2013). Taal and Brenner (2006) discussed that there are some 
contradictions regarding the role of gender in human renal risk. They identified many 
studies that suggest that worse renal outcomes were seen in the male gender, a higher 
incidence of proteinuria and chronic kidney disease in males, a higher risk of decline in 
renal function among hypertensive males, a lower risk of kidney failure among females 
with chronic kidney disease stage 3, and males with chronic kidney disease had shorter 
time to start RRT compared to females (Weller et al, 1985; Shulman et al, 1989; Isek et al, 
1996; Haroun et al, 2003; Evans et al, 2005; Eriksen and Ingebretsen, 2006).  
One study found that women during their reproductive age are less likely to have kidney 
failure compared to men, and the kidney failure risk start to rise 10 years later in women 
compared to men (Iseki, 2008). On the other hand, Taal and Brenner (2006) identified a 
meta-analysis that had 11,345 chronic kidney disease patients from 11 RCTs, which 
concluded that no increased risk of doubling of serum creatinine or kidney failure alone 
among men using angiotensin-converting enzyme inhibitor,  However, after adjusting the 
baseline variables such blood pressure and urinary protein excretion, women demonstrated 
a significantly higher risk of doubling of serum creatinine or kidney failure (Jafar et al, 
2003).  
189 
 
Gender differences present in many diseases including renal diseases. Gender differences 
are identified in the underlying pathophysiology of the disease, in its complications, in 
presenting variable symptoms of the disease, in responding to the therapy and in tolerance 
of disease between men and women (Cobo et al., 2016). Gender differences are most likely 
to be due to some biological or psycho-socioeconomic factors that’s need further 
explorative studies (Cobo et al., 2016). However, the data on this aspect from Oman are 
limited and therefore needs further exploration and research. 
Subdivision 1 had a general population of 61,379 which was nearly half the population of 
subdivision 2 (102,378). The data showed that 83.3% of the paediatric dialysis patients 
were from subdivision 2. When the data for the paediatric population is described, it can be 
seen that 60% of this sub-population reported low socio-economic status, and either kidney 
problems, SLE, or sometimes both as the primary disease; 80% were males and 50% were 
from District 6. All of this data requires further investigation to discover the reason 
underpinning all the paediatric dialysis population coming almost from the same area. The 
data on paediatric nephrology are limited in general and there were no specific data 
comparable to this result found; the only piece of information found recently was that the 
leading cause of paediatric kidney failure in Oman was inherited kidney disease as reported 
recently by Al-Alawi et al. (2017). However, there are also potential different reasons 
could explain why most paediatric patients were coming from the same area, such as the 
type of diet practices that parents follow in this area,  or may be biological or socio-
economic factors. Also, the main reported causes for kidney failure in the USA for this 
sub-population were cystic, hereditary or congenital disease, which is almost similar to this 
study results. 
It was expected that there would be more Omani Asians in the dialysis population, because 
they form the largest portion of the wider population of Oman. However, as explained 
earlier in the methods of this study, there is no available or reliable data on Omani ethnicity 
types or characteristics for Oman and for even the Middle East or Arab World. Throughout 
the literature it was claimed that kidney failure is more common among African-Americans 
in USA, among Whites/ Caucasians in the UK, and among Caucasians in Australia and 
New Zealand. A higher incidence of kidney failure was reported by number of population 
–based studies which was attributable partially to socio-economic and other possible risk 
factors. This latter might explain the higher prevalence of kidney failure in subdivision 1 
(62 kidney failure patients in 100,000 in 2013) compared to subdivision 2 (39 kidney 
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failure patients per 100,000 in 2013), as subdivision 1 had a higher number of Omani 
female blacks. Taal and Brenner (2006) discussed that African American race could not act 
as initiating factor of chronic kidney disease but it could act as a risk factor for chronic 
kidney disease progression. However, the association between race and kidney failure is 
not fully elucidated and it could be that some differences in BEINGE factors in relation to 
the race attributed to the higher incidence of kidney failure among American African for 
example. 
The data shows that the majority of this study dialysis sub-population was able to maintain 
their marriage, which agreed with the Al-Ismaili et al. (2016) study. Al-Ismaili et al. (2016) 
reported around 65% out of 4066 Omani RRT registered patients that they were married,  
and this almost agree with a study from Ghana i.e. 55.7% out of 203 participants were 
married (Amoako, 2014). Divorce was represented by only 22 patients, eight of whom said 
they were divorced because of their sickness. This can be understood in relation to the 
Omani culture, which has strong ties between families and between the members of the 
same family. This also explains why all of the study population were living with their 
families, not alone or with friends. This belief is supported by the Islamic guidance toward 
preserving marriage and family relationships at any cost, and the belief that successful 
marriage is blessed by God. In general, females tend to maintain their marriages even if 
they have a sick partner but usually not vice versa. This theory might explain the higher 
divorce rate among kidney failure females compared to males. The data found in the 
literature for comparisons on this issue was limited. However, having a chronic illness is a 
major change on couple’s life and surely will have an impact on them. The Caregiver 
Action Network (it is a nation’s leading family caregiver organisation) identified six times 
higher rate of depression or anxiety symptoms occurrence for family caregiving spouse 
(Caregiver Action Network – CAN, 2017). Also in a couple of studies, patients with 
kidney failure showed marital disruption and psychological distress and 20% of dialysis 
patient spouses showed significant depressive symptoms (Chowanec and Binik, 1989; 
Cukor et al., 2007). Cukor et al (2007) specified that strain of having a couple with chronic 
disease may place strain on different marital roles of the couple. Accordingly, this result 
contradicts the common evidence available in the literature as this study found 62.8% of its 
population were able to maintain their marriage. Also one study conducted on 116 dialysis 
patients found that only 38% of the sample were married (Gillespie, 2014), and this again 
contradicts our results. This implies that the impact of kidney failure on marriage of 
Omanis could be different due to different culture, different self-behaviour or different set 
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of socio-economic factors; or happened because some selection bias as the included sub-
population is not a nationwide surveyed population and though if this study could include 
all treated Omani kidney failure overall Oman, there is the possibility of getting some 
different results. 
It was expected that more of the unemployed population would be found in the study 
population (Table  8-7), but it was unexpected to find that only 21.2% of this population 
said that they lost their job because of their sickness and commitment to dialysis sessions 
which could mean that there were other factors that contributed to their unemployment 
other than their kidney failure problem. Some patients admitted that they received enough 
support from their employer but were not able to carry on with their work duties due to 
persistent fatigue and sickness. In the literature, multiple studies with variable degrees of 
evidence quality (e.g. Lakshmi et al., 2017; Huang et al., 2017; Al-Ismaili et al., 2016; 
Gillespie, 2014; Amoako et al., 2014; Helantera et al., 2012; Muehrer et al., 2011), 
reported  a high rate of unemployment, especially among dialysis patients. The only study 
from Oman which reported the employment status of RRT population had almost similar 
results as one half were unemployed, and less than one-fifth were retired, and others were 
disabled or unknown status with only less than one-fifth  employed (Al-Ismaili et al., 
2016). In comparison, one American study found 97% of its haemodialysis sub-population 
was unemployed and 53.5% of them were disabled (Gillespie, 2014). This cross sectional 
study did not measure the disability variable which, if measured, would give some rational 
for the proportion that were not employed because of disability for example. In one large 
retrospective study including 102,104 American dialysis patients, the study found that the 
rate of unemployment of kidney failure patients is high compared to the working-age of the 
general population (Muehrer et al., 2011). In a Finnish study, which included data from  
2,637 RRT patients, found 19% of haemodialysis patients were employed, 30% peritoneal 
dialysis patient were employed and 40% of the functioning kidney transplant were 
employed (Helantera et al., 2012). In a Chinese study, which included 231 patients, 49.3% 
were unemployed (Huang et al., 2017). In an Indian study included 226 dialysis patients, 
the loss of job was reported in 44% of haemodialysis cohort and reported in 51.2% of the 
peritoneal cohort (Lakshmi et al., 2017). In another study conducted in Ghana, the 
unemployed rate was 37.9% out of 203 total participants (Amoako et al., 2014). Factors 
associated with unemployment status were patient demographic, comorbid conditions, 
kidney failure cause, insurance status, and predialysis use of erythropoietin and dialysis 
modality (Muehrer et al., 2011).  The participants in this study had an average age of 51 
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years old which means they did not reach the retirement age, so a potential explanation for 
their unemployment could by the multiple comorbid conditions, anaemia or disability and 
or haemodialysis complications. 
Nearly half of the study population were illiterate (Table  8-7), with more illiterate females 
than males. It was expected to have a proportion of illiterate participants but to have 48.1 
% illiteracy, this was a high percentage.   The degree of illiteracy identified in this research 
is high compared with some other studies in the literature. One study from Oman did not 
report illiteracy status specifically but reported education status for overall RRT of Oman 
which was that around 65% of them had less than 12 years of education, 25% has 
secondary school and only 10% has a college education (Al-Ismaili et al., 2016). In an 
American study, there was no illiteracy were reported but the participants who had grade 9 
education or less were only 16.8% (Gillespie et al., 2014). In an Indian study the illiteracy 
reported was 18.6% for the haemodialysis cohort and 15.9% for the peritoneal cohort 
(Lakshmi et al., 2017). In a study conducted in Ghana, the illiterate proportion was 12.3% 
of the participants (Amoako et al., 2014). This high illiteracy rate within my study 
participants could be because the average age of this population was 51.7 years old, which 
means that many patients were born before the Omani Renaissance (before 1970), before 
which there was almost no education. Females tend to be illiterate because many of them 
were married at the era when females were raised to get married and give birth; education 
was complementary and not essential for females at that time. Males were more educated 
because that is a requirement to obtain a good job. This is also elucidated by the result that 
the 18-44 age group in this study were found to be more educated compared to the other 
groups and this because this group was born after the Omani Renaissance.  In the literature 
there is growing and convincing evidence showing that limited health literacy is common 
among kidney disease patients and it is linked with number of adverse effects such as 
higher frequency of missing dialysis treatments and more frequent emergency department 
visits (Green et al., 2013; Jain and Green, 2016). Accordingly, it is highly recommended 
that renal health provider be aware of any red flags of limited health literacy (e.g. non 
adherence with medications or treatments) and at all instances use a clear health 
communication principles with their patients (e.g. explain things clearly in plain language 
– Jain and Green, 2016). 
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9.1.1 Participant distribution across districts  
The data from this study showed variations in kidney failure distribution across regions and 
districts as of the northern region of Oman, also similar results demonstrated in many renal 
registries’ data. Similarly, a study included 719 Australian kidney failure patients from 
January 1993 to December 1998, found marked regional variation in the incidence of 
kidney failure across indigenous Australians (Cass et al., 2001). The study revealed 
inequitable access to dialysis facilities for remote patients and even in urban patients if age 
and gender were standardised (Cass et al., 2001). Another study conducted in Libya found 
higher rate of kidney failure incidence in the South of Libya compared to the other regions 
of Libya. The possible explanation underpinning regional variation in Libya was that the 
South of Libya is a remote, populated and deprived area with hot and dry weather and 
occupied by a mixture of different minorities (Alashek et al., 2012). Also potential 
differences between remote and rural contexts were reported in some studies such as  rural 
areas have  lower health levels due in general to differences in demographics, health needs, 
geographical isolation, type of social relations within rural locale and local health actions, 
social structures and power (Home Parliamentary Business Committees, 2007; Mariolis et 
al., 2008; Bourke et al., 2012). A German study, identified that CKD is higher in Northeast 
than in Southern Germany, due partly to the higher presence of risk factors such as obesity, 
type 2 diabetes and hypertension in Northeast than Southern Germany (Aumann et al., 
2015). In another large scale study conducted in Taiwan in 2009 (n=1,544,82) and 2010 
(n=1,669,436), the study concluded that the existence of substantial geographic variations 
across 368 townships in Taiwan could be the reason behind the presence of regional  
variations, however, this were not very clear and needed further investigations (Yap et al., 
2015).  
Geographical or regional variations in incidence and prevalence of kidney diseases and 
failure are presented widely in the literature and this study results agree with these 
variations. The reasons behind these variations were variable too, from inequitable access 
to treatments to variations in the presence of risk factors.  There is insufficient data on the 
reasons for the regional variation in Oman and, this needs further studies to explore them/. 
However, there are two Omani studies published recently (i.e. Al-Ismaili et al., 2016 and 
Al-Alawi et al., 2017) which highlighted the epidemiological status of kidney failure in 
Oman in less depth than in this present research study and so both studies had no regional 
data provided  to compare this research study data with. Also, it is important to note that 
regional variations presented in this present cross-sectional study do agree with the data 
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presented earlier in the study one (i.e. the secondary data analysis study) of this thesis (see 
section 4.3.1 on p.97). accordingly the sample recruited to this study appears to be 
representative of the larger kidney failure population of Oman and the role of the statistical 
chance to deviate the data in this study from the truth is low. However, the chance of 
having underreported cases of kidney failure into the renal health of Oman is possible, 
which means that the included sample of this study could be an estimate and the real 
number is obscured. 
The data on the Omani population living in the north region of Oman showed that the 
Omani population of subdivision 2 was about two thirds of the entire population of the 
north region of Oman (n = 446,444 = 62.2% -Table  7-2). This could be the reason behind 
sending some of the District 6 patients to the subdivision 1 RDCs, especially as the highest 
Omani population among all the districts of the north region of Oman were living in 
District 6 (Table  7-2). District 6 is also the last district in subdivision 2 on the map, and it 
is the adjacent district to subdivision 1 area. Nevertheless, this raises doubts over why the 
population of District 6 did not have their own dialysis centre. The data shows that the 
highest numbers of dialysis patients were coming firstly from District 1, and secondly from 
District 6. As a result, there were two dialysis centres in District 1, but none in District 6.  
Accordingly, there is more to be done, the dialysis patients are in need of more dialysis 
centres close to their place of residence as some of these patients were travelling a more 
than 100 km (about 62 miles) return trip three times a week. The dialysis population are 
known for their high co-morbidities and dialysis complications, which means that these 
patients are at risk if they drive on their own, especially after their dialysis session. This 
again means that the patient will need somebody, a relative or a friend, to take him/her to 
and from the dialysis centre, which is very difficult to accomplish if the distance to the 
RDC is far. The paediatric population also needs a nearby RDC to be able to keep up with 
their school attendance and duties. Some patients also need a nearby RDC because they 
live in remote and difficult to travel places; otherwise they need to be afforded alternatives 
such as training to do peritoneal dialysis or haemodialysis at home. There is no known 
protocol or policy governing the distance allowed for patients to travel from home to a 
dialysis centre, but the UK can be taken as a good example where there is satellite RDCs 
close to patients’ homes and even transportation is offered in some instances by the RDC 
itself to its population in UK. 
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9.1.2 Participant risk factors, causes, primary diseases and co-
morbidities 
This section is answers the study objective related to identifying the common risks factors, 
causes, primary diseases and co-morbidities of dialysis sub-population of the northern 
region of Oman. Accordingly, hypertension and diabetes were notable risk factors, causes, 
primary diseases and co-morbidities across the board in this study. The data from the 
Omani Ministry of Health agree with this study data. The MOH non-communicable 
diseases (NCDs) detection programme (testing 15,241 persons above 40 years old in 2013) 
shows that 18% had increased blood pressure (BP) of more than 140/90 mm/Hg, and 4.1% 
had missed data; 9.5% had a fasting blood sugar level of ≥7 mmol/ml, and 5.9% had 
missed data; 4.9% had an eGFR of less than 60 (ml/min/1.73m
2
), and 7% had missed data. 
The same data shows that the highest detected BPs were in the west end (24.8%), the west 
(21%), and east 2 (20%); the highest fasting blood sugar levels were in the west end 
(14.8%), middle (12.3%), and north 2 (11.6%). Also, the highest body mass index (+30) 
were recorded in the south (60.1%), west end (44.1%), and middle (37.5%). However, the 
generalisation of this MOH study results should be handled with caution, as the sample 
used in this programme was a convenience sample (i.e. not randomly selected but people 
who were available and persuaded to approach the health institution for the screening 
programme). The MOH, as reported in the Vision 2050 report (see Health sector in Oman, 
p.73), is aware that NCDs are increasing, knows that such risk factors as 
hypercholesterolemia, and being overweight or obese, are increasing among Omani 
population, and knows that 52-75% of the hypertensive diabetic population do not know 
their increased levels of BP and blood sugar (Ministry of Health/Oman - MOH, 2014). 
However, the issue now is to know where the lack is and why, despite the efforts of the 
MOH to fight NCDs, the population is still denying their NCDs and reluctant to approach 
health institutions for treatments.  
Different risk factors should be investigated in the Omani context, such as the congenital 
and genetic predisposition of the Omani population, nephrotoxin use, cultural factors, 
socio-economic status, limited access and late referral to health institutions, health beliefs, 
and why males are reporting more NCDs. All this will help to identify the risk factors and 
their relationship to the NCDs so that proper plans can be put in place to reduce them, such 
as preventive programmes and perhaps also curative programmes. Taal and Brenner (2006) 
discussed the role of number of risk factors in either initiating or perpetuating chronic 
kidney disease/ kidney failure. The main roles identified were as follows: diabetes was 
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related to a substantially increased risk of kidney failure or death related to chronic kidney 
disease; in many large population-based studies, hypertension was predictive of kidney 
failure; micro puncture studies have evidenced the relationship between obesity and 
glomerular hyper filtration and glomerular hypertension which can aggravate the 
progression of chronic kidney disease; some studies suggest the role of genetic factors in 
increasing the vulnerability to early manifestation of chronic kidney disease; a substantial 
body of evidence exists in supporting the theory of that low nephron endowment 
predisposes individuals to chronic kidney disease by escalating the single nephron GFR, 
and therefore, reduce renal function; GFR can be increased by protein feeding and 
thereafter accelerating renal disease progression; nephrotoxins such as cigarette smoking 
which were identified as an independent factor for different manifestation of chronic 
kidney disease (Zatz et al, 1985; Bosch et al, 1986; Iseki et al, 1996; Haroun et al 2003; 
Luyckx and Brenner, 2005; Hsu et al, 2005). These main roles can be investigated further 
in the Oman context and so then this will contribute to the knowledge base of renal disease 
and will help to pave the road for further improved health care. 
This study shows higher percentages of hypertension, obesity and diabetes in District 6, 
District 1 and District 2, and this was expected, as the highest populations of treated kidney 
failure come from these districts which imply a relationship between these causes or risk 
factors (i.e. diabetes, hypertension and obesity) and occurrence of kidney failure in these 
particular districts. However, it was noticed that hypertension is higher in subdivision 1, 
which has less population, and this unexpected result should be investigated further. This 
result agrees with the data of the KSA and European populations. 
In the literature, there was wide agreement across the board on diabetes and hypertension 
as the primary causes for kidney failure (among the KSA dialysis sub-population 38.8% 
had diabetes and 39% had hypertension). In comparison to the data from Oman, one recent 
study (i.e. Al-Ismaili et al., 2016) reported that the primary causes of RRT the Omani 
population were respectively glomerular nephritis (35%); diabetes (28%), hypertension 
(18%) and other causes (19%) while the same study reported the main leading causes 
among dialysis sub-population were respectively diabetes (46%) and hypertension (22%) 
which support this study results. 
In the literature, the most common co-morbidity was cardiovascular diseases, which was 
the third most common co-morbidity after diabetes and hypertension in this study. The 
common co-morbidity among Omani kidney failure patients are the same as most renal 
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registries population. Al-Ismaili et al. study (2016) reported the same co-morbidities as 
hypertension (87%), diabetes (58%), ischemic heart diseases (27%), and cardiovascular 
diseases (3%) among Omani Kidney failure patients. However, there are some variations in 
the percentages of the two studies because the measurement scale is different as they 
measure (i.e. Al-Ismaili et al., 2016) for the whole country and this present study measure 
the co-morbidities of the dialysis sub-population for the northern region of Oman only. 
Also this present study conducted in 2014-2015 while their study covered a different 
timeline, which was 1980-2013. Furthermore, this present study had an option for 
combined diabetes and hypertension while Al-Ismaili et al. (2016) measure each disease 
individually. Also multiple co-morbidities are a common characteristic among dialysis sub-
population. Yet the control of the multiple co-morbidities for the dialysis population is 
extremely challenging, and it requires a multidisciplinary team to coordinate and control 
them. Finally, the kidney failure risk factors, causes and co-morbidities are not studied 
with rigorous research designs such as randomised control trials, so further evidence is 
needed to enhance these conclusions. 
 
9.1.3  Participant haemodialysis characteristics 
This section answers the study objective related to describing the present dialysis 
modalities and the characteristics of haemodialysis modality of the sub-population of the 
northern region of Oman. This study’s data shows that the appropriate investigations for 
detecting kidney disease in the current diaylsis sub-population of the north region of Oman 
were in place and accessible for all patients. However, there were many patients who did 
not know what eGFR test is, or if it was done for them or not. Also, many participants said 
that their urine was taken for kidney disease diagnosis, but no result was reported back to 
them. The participants would have welcomed any information if they had been told. This is 
again is linked to the health literacy issue discussed earlier. Increasing health literacy of the 
patients is a paramount pillar toward improving compliance and accordingly treatment 
outcomes. 
The common vascular access in the KSA dialysis sub-population was AVF (65%), which 
is similar to what was found by this study. In KSA, there were 16,897 dialysis patients 
(547 pmp) by the end of 2015, 15,560 patients on in-centre dialysis and 1,307 on peritoneal 
dialysis. In the north region of Oman nearly all the surveyed participants were undergoing 
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in-centre haemodialysis because there was no other alternative offered to them. Since there 
is insufficient evidence to support convective dialysis (HF, HDF, and AFB) over 
traditional haemodialysis, it is convenient for the MOH of Oman, at present, to keep 
running the same regimen of traditional haemodialysis.  However, conducting research to 
test these different modalities and their outcomes on Oman’s dialysis population could 
contribute to the evidence and help the MOH to make better decisions on patients’ 
treatment plans.  
 
Currently, the dialysis population of Oman have one common dialysis option, which is in-
centre haemodialysis.  Similarly, greater than 80% of dialysis sub-population of the 
USRDS (2015) participant countries (53 countries) was following in-centre haemodialysis 
except in Hong Kong and New Zealand. Peritoneal dialysis is an emerging option which 
can grow if a training team is made available for the different RDCs of Oman to train and 
describe patients; this could be the best option at present for the dialysis population in 
Oman. Peritoneal dialysis patients should be prescribed with a personalised, adequate dose 
of peritoneal dialysis and with observation for infections. Home haemodialysis is not yet 
offered for this sub-population in Oman. This option, if offered, would open a door of 
hope, especially for the young population on dialysis to have more freedom and control 
over their lives.  
 
This study found that 78.3% of dialysis patients started their haemodialysis immediately, 
or within three months after diagnosis, because these patients sought medical attention only 
after progressing to a critical condition where they could not tolerate the symptoms any 
longer and accordingly had to start dialysis as soon as possible. Many patients reported 
their numerous medical consultations either in Oman or in other countries to confirm their 
kidney failure, as they were denying having kidney failure.  
Nearly two thirds of the patients were attending three haemodialysis sessions per week. 
Subdivision 1 had more patients attending three sessions and subdivision 2 had more 
attending two sessions, because this latter had more dialysis sub-population and therefore 
less capacity to accommodate three dialysis sessions for all patients. Despite the 
recommendation of the three haemodialysis sessions per week for the average patient 
protocol, this area needs further investigation to confirm that this is an adequate and safe 
dialysis dose. Furthermore, the nephrology team should be careful to base a patient’s 
dialysis dose on a comprehensive assessment of the patient using monthly blood tests, pre- 
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and post- dialysis parameters, and the general health status of the patient as explained in 
chapter one. 
 
Across all the RDCs, nearly two thirds of the dialysis patients had AVF vascular access, 
which is the one recommended for this population because of its better outcomes. The 
interesting thing is that the AVF and AVG patients were the most patients who expressed 
their comfort with their type of vascular access, while all remaining patients with other 
vascular access reported discomfort (13.5% - Table  8-14). This results guide the 
nephrology team to try their best to provide AVF access whenever possible for their 
dialysis patients, and to try to create the vascular access 3-4 months prior to initiating 
dialysis, as recommended.  However, these patients should be always watched for 
complications of AV access such as infection. 
 
The participants were comfortable with morning or afternoon dialysis sessions, but they 
were upset if shifted to night sessions. This was the reason behind the less than 90% 
satisfaction rate at RDC1 and RDC4, because these two RDCs were the ones offering night 
dialysis sessions. 
 
 
9.1.4 Participant perceptions on the impact of dialysis treatment 
on their lives 
It was unexpected that over 80% of this study participants reported that dialysis had not 
caused them stress or worry and that it had little financial impact on their lives which 
imply better QoL for this study population. In contrast to this study results, the literature 
has repeatedly reported a reduction in QoL of CKD and kidney failure patients. A study 
conducted on 155 patients’ stages 1-5 of CKD and 36 patients on haemodialysis concluded 
that QoL reduced in all stages of kidney disease (Cruz et al., 2011). Another cross-
sectional study was performed on CKD patients stages 4-5 (151 patients) who receive 
either peritoneal or haemodialysis treatment concluded that the sample studied 
demonstrated compromised QoL scores (Abdel-Kader et al., 2009). One more cross-
sectional study assessed for health-related QoL for 535 patients with CKD stages 2-5 and 
55 controls found significant deterioration in health-related QoL with the lowest scores in 
CKD patients stage 5 (Pagels et al., 2012). Though the concept of QoL is controversial, the 
WHO (2009) has defined it as "an individual perception of their position in life in the 
context of the culture and value systems in which they live and in relation to their goals, 
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expectations, standards and concerns". Accordingly, possible explanation for this study 
population showing better QoL compared to other studies from literature could be because 
these participants had psychologically and mentally reached the adaptation and comfort 
stage. It could be that they have strong faith (religious/spiritual) that this is their destiny 
and nothing better can be done, and therefore perceive the reduced of QoL as something 
good though. Santos et al. (2017) in their evaluation for 161 patients undergoing 
haemodialysis provided an evidence suggesting the association of religious/spiritual coping 
methods with QoL and depression among haemodialysis patients. This evidence identified 
positive correlations between religious/spiritual coping scores and general health and 
vitality scores (Santos et al., 2017). The Santos et al. (2017) evidence supports the finding 
of this research that  implies positive religious/spiritual status can positively affect the QoL 
of haemodialysis patients. However, is the religious/spiritual factor is the main factor can 
affect the QoL of Omani haemodialysis patients or there are a collection of factors (e.g. 
family and friends support that if stands all together, they can  improve the overall QoL of 
the Omani participants of this study. Families in Oman provide great support to their sick 
members, which may be a factor that helped many patients in improving their mental and 
psychological status. Also, his majesty Sultan Qaboos provides a monthly allowance for 
this population that is around £200/month. This allowance helped to sustain the financial 
status of these participants. On the other hand, the participants of this study who reported a 
greater impact of kidney failure and RRT on their lives should not be neglected 
(Table ‎8-16Table  8-16), and the support needed must be provided to them. Also, the 
proportion who reported lower QoL should be investigated to understand their perception 
of QoL and the reasons underpinning their QoL reduction so these reasons could be 
resolved in the future (Figure  8-8). At all instances the perspective of QoL for Omani 
kidney failure patients is not explored sufficiently in this study and needs further study and 
exploration. 
This section aimed to explore the haemodialysis treatment impacts briefly on the 
haemodialysis patients in the northern region of Oman. It is only to have a flavour if there 
is a presentation of negative impacts on the QoL of this population and thereafter 
recommend doing further research on this aspect depends on the findings. It is unlikely that 
the contradicting results of this present study are due to chance, bias or such confounding 
factors but it is more likely that the contradictory results obtained were as a result of some 
limitations in the survey design itself. The usage of the scale of yes or no helped apparently 
to obscure the real truth and provided contradicting results to the reality. The original 
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questions from the KDQOL-SF
TM 
1.3 use a Likert rating scale distributed into five degrees 
(i.e. definitely true, mostly true, don't know, mostly false, and definitely false). The use of 
the same Likert rating scale could give the obtained results more of normal distributed 
values and also would validate this part of the survey. Also, researchers can debate that the 
author may have some impact on the participants' responses and therefore, they may 
answered positively to please the author. However this perspective is greatly affected by 
the size of distance/closeness of the author with the participants, and how much 
information (e.g. race, class) and relationship, the researcher shares with their participants 
(Al-Natour, 2011). In general,  relationships and closeness are usually developed inside 
qualitative research and since this research was purely quantitative  so the contact time 
with participants was short and did not allow for deep impacts on the participants 
responses. 
  
9.1.5 Participant death profile in 2014 and in 2015  
Due to the high vulnerability of dialysis patients, death is an expected outcome. Although 
efforts are being made to increase the lifespan of the general population as well as that of 
kidney failure patients in Oman, this however could increase the size of the kidney failure 
population (prevalence) without guaranteeing a decline in the death figures. This perhaps 
explains the increase in death figures in this study population, which was 42 in 2014 and 
then 57 in 2015.  Cardiovascular disease was the major cause of death in this population, 
which agrees with the data of many countries. A systematic review identified 39 studies 
that included 1,371,990 participants concluded that individuals with CKD are at high risk 
for cardiovascular disease and all-cause mortality (Tonelli et al., 2006). These review 
findings were consistent across all studies despite differences in design and study 
population (Tonelli et al., 2006). In 2013, kidney disease killed more than 47,000 
Americans (National Institute of Diabetes and Digestive and Kidney Diseases, 2016). In a 
Swedish study that included 3040 CKD patients’ stages 4-5, 725 peritoneal dialysis 
patients, 1791 haemodialysis patients, and 606 transplanted patients; the study concluded 
that the dialysis patients were at the highest risk of mortality, peritoneal dialysis patients 
had considerably lower mortality risk compared to dialysis patients, and least mortality risk 
was for kidney transplanted patients (Neovius et al., 2014).  
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On the other hand, dialysis treatment can prolong survival of kidney failure patients if 
compared to conservative management despite dialysis treatment’s poor prognosis 
(Thadani, 2013). Survival duration is affected by number of factors such age, functional 
status, co-morbidities status (Thadani, 2013). Survival duration of Omani kidney failure 
patients’ cannot be improved and extended unless all-factors relevant to this population 
treatment are improved and consequently improving their QoL. Accordingly, there is an 
urgent need to gather in depth data regarding these population treatments, treatment 
outcomes, survival durations and life expectancy and QoL status. 
 
9.1.6 Participant plans on kidney transplantation 
This study identified an association between the education level of the participants and 
their desire for renal transplant, which was interesting to explore further and is therefore 
discussed individually in the following   chapter.   
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10 Participant plans on kidney transplantation 
More than half of this study’s participants wanted to have kidney transplantation, which is 
expected (Table  8-17). Papers published on testing the desire of kidney transplantation of 
dialysis patients found either limited or of older dates. The limited available evidence agree  
that the desire for kidney transplantation decreases in aged patients (Fukunishi, 1993), and 
African American women tend to have less desire to undergo live donor kidney 
transplantation compared with African American men (58.5 % females vs. 87.5% males – 
Gillespie, 2014). The literature evidence supports what this study found as most of those 
who wanted to undergo kidney transplantation were males (60.1%), and also the desire for 
kidney transplantation declined with aging (12.7% yes response vs. 18.4% no in the age 
group 65-75 years old, and 2.3% yes vs. 8% no in the age group over 75 years old). The 
possible explanation is that men are most likely to take more operational approach toward 
their health care compared to women (Hunt et al., 1999; Baines and Jindal, 2003). Also 
low self-esteem and lack of strong social support among women could contribute to the 
lower desire of kidney transplantation among women (Hunt et al., 1999; Baines and Jindal, 
2003). Omani women are usually had good self-esteem and good social support but it 
could be because they are less health conscious of kidney transplantation optimal 
outcomes. The older age patients tend to say no for kidney transplantation because of their 
psychosocial defence mechanism mainly denial (Fukunishi, 1993). Also one more possible 
explanation which the author described while in clinical practice for 18 years was that 
older patients tend to reject any treatment involving major surgery because they fear that 
they are going to die during the surgery. 
When kidney transplantation desire was associated with education level, it was noticed that 
as the education level increased, the desire for kidney transplantation increased 
(Table  8-19). For example, every single participant in the post-college group wanted 
transplantation. However, in the illiterate group the proportion of participants who reported 
no desire for kidney transplantation was higher (56.4%) than those who wanted to have 
kidney transplantation (39.3%). In the literature, there were no studies found to examine 
specifically the association between the dialysis patient's level of education and their desire 
for kidney transplantation. However, there were some studies which tested the association 
between education level or health literacy and some other outcomes such as chronic 
diseases. Overall the evidence testing the relationship of education or literacy level with 
other outcomes under investigation is mixed in their conclusions, and varied in their 
evidence degree of strength. However more weight of evidence support the positive 
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association between the high level of education and good health.  In an observational 
cohort study included 61,457 participants; the study found the higher educational level was 
independently associated with lower prevalence of chronic diseases (Choi et al., 2011). In a 
systematic review included 111research articles; the review found low health literacy is 
associated with poorer health outcomes and poorer use of health care services (Berkman et 
al., 2011). The evidence coming from the research articles included in the systematic 
review (i.e. Berkman et al., 2011) were rated as good or fair evidence after two reviewers 
independently rated the quality of the evidence using predefined criteria. In another study 
included 62 Black and White haemodialysis patient aged 18-75 years old, the study found 
inadequate health literacy among them; also 78% lower hazard of referral for transplant 
evaluation were reported among the participants who has inadequate health literacy 
(adjusted hazard ratio [AHR] 0.22; 95% confidence interval 0.08, 0.60; P = 0.003- Grubbs 
et al., 2009). Also in one literature review paper, the review reported limited health literacy 
as one barrier to kidney transplantation (Jain and Green et al., 2016).  
One potential mechanism of positive relationship between high education level and 
willingness to undergo kidney transplantation could be that these patients are more likely 
to educate themselves about the best treatment options (in this instance kidney 
transplantation) available to them even in the absence of the medical advice. Therefore, the 
higher education participants made a decision to undergo kidney transplantation based on 
their higher level of health literacy that related to their higher education level. However the 
high level of education could appear independent factor of association, statistically, while 
in reality it is not because of presence of other confounding factors that were not measured 
in this present study such as young age. In a study included 295 dialysis participants who 
were 71.5% of them were male and the mean age of the all participants was 44.53 ± 12.09 
years, the study identified some factors associated with renal transplantation desire namely 
younger age (<45 years) (OR = 2.14 CI: 1.12 - 4.06 p = 0.02), longer median duration on 
dialysis (>34 months) (OR = 2.12 CI: 1.15 - 3.88 p = 0.01) and the Christian religion (OR 
= 0.43 CI: 0.20 - 0.92 p = 0.03 (Lagou et al., 2017). Also, the incorrect estimate of 
association can happen because of selection bias of participants, those participants who are 
not representative can deviate the results from the truth. The selected participants of this 
study are representative because all patients on dialysis were included. However, it is hard 
to claim that this result is generalizable to the entire population of the country because of 
the geographical limitations of this study to the north of Oman only. The statistical chance 
to estimate incorrect association is present because the unclear effect of the confounding 
factors which were not explored by this present study such as young age. 
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However, kidney transplantation success is not sustained in Oman at the moment because 
mainly the variation in incidence and prevalence and organ availability. The major barrier 
toward the increasing success of kidney transplantation in Oman, described by this study, 
is kidney shortage. Therefore organ donation campaign should be launched in Oman 
though making active educational programs to spread all necessary information about 
organ donation across the public. It is important to start organ donor register that accessible 
by public and be transparent about the organ donation and transplantation through 
publishing the main statistics and the main activities of this aspect. 
Additionally, not all patients are eligible for kidney transplantation, and this should be 
explained very clearly for non-eligible patients. The UK has succeeded in providing more 
than half of the kidney failure population with kidney transplantation; Oman can learn 
from their experience to increase the number of kidney transplantations annually. It was 
expected that young age patients and highly-educated patients would have a higher demand 
for kidney transplantation, and this is what the data from this study verifies. Patients of 
subdivision 2 wanted kidney transplantation more than those in subdivision 1, and this is 
because the population living in subdivision 2 are generally younger and better educated. 
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11 The comprehensive discussion on the 
significant results 
This quantitative mixed method study was mainly conducted to have a deeper 
understanding of the Oman RRT population. The main aim was to identify the 
epidemiological variables of the Oman RRT population, and status of publishing on this 
population. Two designs were used to gather the necessary data, which were secondary 
analysis of existing data coming from RRT register and published resources, and cross-
sectional design. Most of the data from the first design were retrospective data covering 
aspects such as the nephrology care development, publishing status, and epidemiological 
variables of Oman RRT population from 1980 and until 2015. The second design was used 
to gain initial understanding of the characteristics of the Oman dialysis sub-population 
through surveying a cross-sectional sample that on dialysis in the northern region of Oman 
on years 2014 and 2015. Most of this design’s data were prospective gathered through 
researcher administered survey. 
 
The main conclusions of this thesis are mainly tied to answering the six major research 
questions of this thesis. First research question was related to the development of Oman 
renal replacement therapy. From the data gathered by the secondary data analysis study, it 
is known that nephrology care in Oman began in 1980, initially through the efforts of non-
Omanis and thereafter by Omani nephrologists. The first RDC opened in 1983 in Al-Nahda 
hospital with seven haemodialysis machines, treating 35 patients. The first remote RDC 
was established in District-1 in 1991. The main central RDC in the capital was established 
in 1998. The RRT services had developed in a steady and good manner in Oman to reach 
18 active RDCs and 217 dialysis station across the country by the time this study was 
concluded at end of 2015. However, the comparison of the dialysis station ratio to the 
served patients showed that the load of the performed dialysis sessions per week in the 
described RDCs are more than recommended by the ASN dialysis curriculum and 
accordingly this imply that the demand for dialysis is more than the available supply. 
Another conclusion is that if the Oman MOH plans for further RDCs, it would be helpful 
to consider that these RDCs should be closer and accessible by patients, especially in the 
most densely parts of Oman like the capital and the northern region. In consideration of the 
complex geography of Oman, it is supportive from Oman’s MOH to facilitate 
transportation if possible for this sub-population and to offer them life insurance as they 
utilise the traffic more frequently than normal people.  
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Further to answering the first research question, a kidney transplantation program was 
absent in Oman until 1988. From 1980-1988 the patients eligible for kidney transplantation 
were sent abroad to receive the surgery and kidney transplantation care. In 1988, the Oman 
transplantation program was established. In 2005, the transplant coordination unit and 
kidney donor clinic were launched and as a result the average of 6.5 kidney transplants per 
annum was increased to 23 kidney transplants in 2009. Also sometimes these 
transplantation rates are not sustained and can be less than these rates. However, the data 
from USRDS annual report (2015) show that Oman had transplantation rates of 18 pmp per 
annum, which is again the same conclusion of this study, that Oman has one of the lowest 
rates of kidney transplantation in the world compared to best rates of kidney 
transplantations performed by countries like Croatia (59 pmp), Netherlands (56), USA 
(56), and UK (51). However, and to be realistic, Oman MOH has secured the fund and the 
kidney transplantation infrastructure in place (see Kidney transplantation in Oman (1980-
2013). The shortage appeared in the number of kidney donors and this needs hard work 
toward increasing the awareness of the public regarding the importance and goodness of 
kidney donations. The literature review revealed that only 35 % (304 participants) of 
Omanis would donate organs after death in Oman. The literature and this study 
recommended an urgent education and awareness program about organ donation especially 
among school and university students. 
 
The second research question was regarding Oman dialysis and kidney transplantation 
statistics. There were 2,069 RRT (i.e. both dialysis and kidney transplant treatments’ 
cohorts) treated patients’ alive on 31st December 2013 and 2,192 alive patients on 4th 
November 2014 distributed as follows: haemodialysis cohort had 1,161 patients (52.9%), 
the peritoneal dialysis cohort had 76 patients (3.5%), and the cohort who had functional 
kidney transplants had 955 patients (43.6% ). The RRT prevalence was 549 pmp in 2014. 
The first comprehensive statistics available were for dialysis treatment for the years 1983, 
1985 and then from 1998 to 2015 (Figure  5-3). The dialysis treatment increased from 35 
dialysis patients in 1983 to 1,439 dialysis patients in 2015, which is a 4,010% increase in 
the 32-year- range (i.e. 1983-2015). The mean prevalence for dialysis treatment across the 
years of 1983-2015 was 724.9 treated patients per annum. This study found the prevalence 
rate for dialysis treated patients in 2015 was 61.4/100,000 (i.e. 614 pmp) per Omani 
population or 34.6/100,000 (i.e. 346 pmp) if calculated across the total population. In 
comparison, the prevalence rate for dialysis treated patients was 59/100,000 (i.e. 590 pmp) 
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Omani population or 33.2/100,000 (i.e. 332 pmp) per total population in 2013, which 
showed an increase in the prevalence of dialysis treatment in between 2013 to 2015.  
 
As has been said, it is favourable if the MOH consider publishing precise statistics on 
different categories like Omani under RRT (while separating statistic of dialysis from 
kidney transplantation), non-Omani under RRT, kidney transplantation in total, kidney 
transplantation from living kidney donors and from deceased kidney donors, number of 
patients under different modalities like haemodialysis and peritoneal dialysis, incidence, 
death figures and causes of death, paediatric statistics under RRT, and the rough cost of 
RRT treatment per annum. These statistics will help future research to grow and will aid 
renal researchers in planning for further research beyond the observational designs, for 
example, experimental designs. Other suggestions are first to activate the research studies 
department in the MOH by providing training for those concerned on the best research 
topics and designs needed by the MOH and the best research quality assurance practices 
that should be maintained by researchers while conducting research studies. Also, to create 
an expert editorial panel, on Oman MOH level, to review and professionally edit health 
research articles in the shortest time prior sending to high impact factor scientific journals. 
The panel should undergo regular training and assessment of their skills. Also, the panel 
can be in affiliation with other rigorous experts from high impact journals. This act will 
improve the quality of health publication coming of Oman and will improve the Oman 
MOH publication standard and rate.   
 
Further results answering the second research question is that in 2010, the highest 
prevalence rate for dialysis treatment was in the capital at 71.3 dialysis-treated patients per 
100,000 Omanis or 37.4/100,000 per total population, and the lowest was in the west at 
30.3 dialysis-treated patients per 100,000 Omanis or 23.7/100,000 dialysis-treated patients 
per total population. In 2015, the highest prevalence was in the west end at 99 dialysis-
treated patients per 100,000 Omani populations, or at 49.5 per 100,000 total populations. 
The lowest prevalence was different for the Omani population compared to the total 
population. For the Omani population the lowest prevalence was in the north at 46.8 
dialysis treated patients per 100,000 Omani populations, and for the total population for the 
lowest prevalence was in the capital at 30 dialysis treated patients per 100,000 total 
populations. The statistics of RRT incidence were available for the years 1983 to 2015. 
The number of new patients registered in 1983 was 34, and in 2015 were 230 patients for 
Oman, which is a 576% increase in incidence in the 32-year range. The incidence rate 
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increased from 2.29/100,000 (22.9 pmp) treated kidney failure patients in 1986 to 
4.36/100,000 (43.6 pmp) treated kidney failure patients in 2013 to 5.5/100,000 (55.3 pmp) 
treated kidney failure patients in 2015. The Oman’s RRT register reported a grand total of 
3,504 new kidney failure patient since 1983-2010 (28 years), which gives mean incidence 
rate of 125 treated kidney failure patients per year per total population of Oman.The 
diabetic nephropathy incidence for Oman was only two patients in 1983 and 94 patients in 
total by 2010. Diabetic nephropathy increased from 38.6% in 2006 to 47% in 2009 and 
then dropped slightly in 2010 to 45%. There were no data on the incidence of hypertensive 
nephropathy in the register. 
 
From these results and from the USRDS annual report (2015), it is concluded that the 
incidence and prevalence of treated kidney failure in Oman is considered among the lowest 
rates. On the other hand, the rates of diabetes, which is a major risk factor and cause of 
chronic kidney diseases is alarming in Oman, Oman is among the 8
th
 highest countries (i.e. 
among 53 participant countries of the USRDS, 2015) having diabetes. The diabetes rates if 
not reduced and managed well in Oman, logically will lead to increasing figures of treated 
kidney failure in Oman and will increase the direct cost to be more than 9,543,572 OMR 
(~20 million GBP) that’s reported in 2015, which is 325% increase over a 17-year period 
in Oman. Also, the predisposing factors of diabetes in Oman need to be explored. In theory 
and in relation to chapter two, the high rates of diabetes in Oman could be related to one or 
more than one of the PESTLE or BEINGS factors. For example, Oman is high in-income 
with rapid economic growth and this may affect people’s attitude toward many life 
practices, for example, reduction in physical activity due to use of mobile vehicles and 
employing house maids and the increase in using mobile phones and increasing on-hands 
use of technologies. Also other impacts of environmental and other factors on Omanis need 
to be investigated such as the impacts of the topographical nature (e.g. do the population 
living across the coastlines have higher rates of CKD compared to the interior 
population?), climate, dry weather and purification of water on Omanis health; the impact 
of the progressing health technologies on patients’ rates of mis-diagnosis or late referral. 
 
The number of RRT treated patients who died between 1983 and 2013 was recorded as 
four deaths in 1983 and 77 deaths in total by 2013. The highest death figure reported at 114 
deaths in 2009. The overall trends were showing fluctuating increase in death figures with 
common reported cause of death as cardiovascular diseases. The main reported causes of 
death across this population were cardiovascular disease (24.5% in 2001-2010) and 
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infection (26.6% in 2001-2010), however, there were many cases where the cause of death 
was unknown (31.3% in 2001-2010) as the patients died at their homes and the disease 
register did not capture the cause of the death. The non-reported causes, cardiovascular 
disease, and infection account for 82.4% of death in 2001-2010 of this population in Oman. 
The common cause of death of RRT population in the world was also cardiovascular 
diseases. It was described that prevalence of all causes of death appeared to be higher in 
the dialysis cohort (88.5% in 2001-2010) compared to kidney transplantation (9.2% in 
2001-2010) and peritoneal dialysis (2.3% in 2001-2010) cohorts. On the other hand, the 
percentage of deaths within the kidney transplantation cohort decreased from 32.5% in 
1983-1990 to 27.1% in 1991-2000 to 9.2% in 2001-2010. Also, the overall death 
percentages increased from 66% in 1983-1990 to 72% in 1991-2000 to 88.5% in 2001-
2010. This observation agrees with the all results reported by all major registries such as 
UKRR and USRDS. The death figures appeared to be higher in males (n = 797) compared 
to females (n = 713) in all treatment modality cohorts except the peritoneal cohort where 
female deaths (n = 16 = 59.3%) appeared to be higher compared to males (n = 11 = 
40.7%). The cost of dialysis treatment increased 325% from 1998-2015.  
 
The third research question was about the pattern that emerged from the gathered statistics. 
Accordingly, the described pattern showed increase in prevalence; an overall increase in 
incidence but slight reduction of incidence in 2015 with no clear reason for this reduction 
but it could be secondary to the national efforts towards fighting the chronic diseases 
occurrence in the country. Nearly half of the patients in 2015 had diabetes as a primary 
disease, which alerts the country to the increasing in chronic kidney diseases and kidney 
failure if diabetes figures are not reduced and managed well.  
 
The fourth research question was about Oman RRT publishing status since 1980 to 2013. 
So, among the databases searched, 44 articles (see Appendix-F on p.269) focused on or 
mentioned RRT, kidney failure or chronic kidney disease in Oman. However, the 
epidemiology of kidney failure was the focus of two (4.5%) national studies only, which 
are both from the past century. There were five (11.4%) other international studies which 
mentioned epidemiology of kidney diseases in Oman briefly. Kidney transplantation was 
the most popular researched topic in relation to this population in Oman (n =16 studies = 
36.4%). The remaining articles (n = 21 = 47.7%) were either exploring the risk factors of 
chronic kidney disease or handling general topics related to RRT, kidney failure or chronic 
kidney disease in Oman. This data showed that the status of kidney failure publication 
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coming from Oman is limited. Also, the quality of the past research studies in this field and 
in the biomedical research in Oman is questionable as most Omani researcher found 
publishing in journals with either no impact factor of impact factor of less than one. 
 
The fifth research question (see chapter 7 on p.161)  identified the following variables: the 
demographics, distribution across sites, primary diagnosis, risk factors, co-morbidities, and 
death profile of kidney failure patients undergoing regular dialysis in the northern region of 
Oman. The cross-sectional study revealed that the average age of this population was 51.7 
± 15.8 (mean ± SD) and more than 80% of this population were less than 65 years old at 
the time of the data collection. The greatest frequency of treated kidney failure was in the 
age group 45-64 years old, but the greatest prevalence was exhibited in patients aged more 
than 75 years old which is most likely due to improving in survival of these patients. There 
were more males (n = 187 = 54.8%) to females (n = 154 = 45.2%), males appeared 
younger with a mean age of 50.3 years compared to the female mean age of 53.3, although 
this was  not a statistically  significant difference (P > 0.05). However, the general trend for 
most countries reporting their kidney failure on dialysis population characteristics was that 
males are higher in number compared to females. Though, the difference in ratio of treated 
kidney failure Omani males to females is relatively close which go with the Omani grand 
total population census where   Omani males (n = 1,143,579 = 50.6%) are more than 
Omani females (n = 1,117,126 = 49.4%, 2014 census).  Among the 341 participants of the 
cross-sectional study, there were 335 adults (98.2%) and six children (1.8%).  The majority 
of the participants were married (n = 214 = 62.8%).The vast majority of the participants 
were unemployed (n = 292 = 85.6%) with only 62 (21.2 %) participants saying that they 
lost their job because of their sickness. Forty-eight percent of the participants were 
illiterate compared to 6.2% who had further education (i.e. college education) or higher 
education (i.e. university education), with more females illiterate (n = 103= 66.9%) 
compared to males (n = 61= 32.6%). This data showed most of the surveyed patients were 
married, unemployed and illiterate. Most of married patients got married before they had 
their kidney failure diagnosed and it was most likely that their marriage survived because 
of the strong rapport already existed between spouses before the sickness of one of the 
spouses. On the other hand, the patients who had their kidney failure diagnosed while they 
are still not married, they mostly stayed un-married. The high rate of illiteracy among the 
treated kidney failure population of the cross-sectional study may imply that kidney failure 
is most likely to happen among people who have no or limited education. This can direct 
the effort to target students in schools and universities to increase their awareness and 
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knowledge about diabetes and chronic kidney diseases methods of prevention and 
encourage them to educate their parents and grandparents (i.e. target illiterate people) and 
therefore wider sector of illiterate people will be reached through the young educated 
population. 
 
Further to answering the fifth research question, among the 12 districts of then region of 
Oman, the highest number of participants came from District 1 (n = 62 = 18.2%), then 
from District 6 (n = 58 = 17%), and third from District 11 (n = 55 = 16%). The smallest 
number of participants came from District 8 and District-10 (n = 8 = 2.4%) and District 7 
(n = 5 = 1.5%). The proportion of male participants were slightly higher than females 
across all districts except in District 1 and District 3 which had no statistical significant 
difference (P = 0.682). This data indicates that the prevalence of treated kidney failure 
across the districts were variable due may be to the variations in populations numbers and 
characteristics. However, this data are important for Oman MOH to view and analyse the 
variation in number of prevalent patients across the national, regional and district levels to 
aid the Oman MOH in their capacity planning process. For example, this data showed that 
there are no RDC serving District 6, which has the second highest number of treated 
kidney failures among the 12 districts of the northern region of Oman. The patients of 
District 6 expressed their need for having a closer RDC to their residence area while 
surveyed in 2014.  
 
The three primary diseases most reported were the following: hypertension (n = 161 = 
47.5%), diabetes (n = 77 = 22.7%); and diabetes and hypertension combined (n = 55 = 
16.2%). Hypertension was the risk factor reported most frequently by the participants 
(14.2%); second was obesity (11.5%); third was diabetes (8.6%). The most common co-
morbidities reported by these participants were hypertension and diabetes together (n = 
156 = 32.4%). The death figures for 2014 and 2015 respectively were 42 and 57 patients in 
total per annum across the four RDCs. The main cause of death reported by the four RDCs 
of the northern region of Oman were cardiovascular diseases (n = 41 = 41.5%) and 
infection (n = 10 = 10.2%). Nearly half of the participants had been on dialysis for five 
years at the time of data collection (n = 165 = 48.4%).  The most popular vascular access 
was the permanent arteriovenous fistula (AVF). All the surveyed participants were on 
haemodialysis modality and 62.5% of them were receiving dialysis three times a week. 
These data show that hypertension and diabetes are the leading factors toward kidney 
failure in Oman and the most common co-morbidities exists in the surveyed sub-
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population which agree with the data coming from most of the world’s countries (e.g. UK 
and KSA) who reported their kidney failure figures.  
 
Most of the world registries were able to measure the survival of the RRT patient due to 
having the record of when these patients started the treatment and when they died while 
they were on treatment. For example, in the UK the survival of kidney failure patients on 
RRT improved up to 10 years post RRT start for the past 14 years. For Oman RRT 
population this was never calculated and it is not yet known the survival span of Omani 
RRT population, but this study revealed that nearly half of the surveyed patients survived 
on dialysis at least for five years. Prolonged survival is an indicator of the improvement 
and good management of the patients’ care.  
 
Most of the participants had the vascular access recommended by the kidney associations 
and followed the most common treatment modality across the world, which is in centre- 
haemodialysis modality. In-centre haemodialysis is the most costly treatments among all 
RRT, therefore if Oman MOH wants to decrease the expenditure; the ministry has to adopt 
more kidney transplantation and peritoneal dialysis.   Adopting these later treatments will 
lead to improvements in patients’ quality of life, improve the survival span and decrease 
the cost of RRT care. Also, for how long will the country continue providing a free RRT 
service for their patients may be it is now the time to delegate part of the service to the 
private sector in order to provide patients with options of where they prefer to be treated. 
 
The sixth and last research question answered by this project was related to an attempt to 
identify if there were major psychological and financial impacts on the surveyed sub-
population lives. The overall findings reported by most of the participants (84.5% - n = 
288) in all RDCs of the northern region of Oman showed that dialysis treatment had not 
caused them stress or worry. Many participants reported that they did not feel they were 
causing a burden on their family or the community (n = 283 = 83%). The majority reported 
that they were psychologically stable with few worries or frustrations (n = 291 = 85.3%). 
Most of the participants reported that dialysis treatment had little financial impact on their 
lives (n = 286 = 83.9%). However, studying QoL is controversial and beyond the scope of 
this study and therefore this population needs more in depth studies to understand their 
perception of their disease and treatments and how health care team can help them improve 
their quality of life e.g. by recommending adapting psychosocial workers in RDCs who 
help this population to better adapt and manage their lives. 
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12 Conclusion  
 
12.1 Contribution of the study 
Prior research has shown limited data on Omani treated kidney failure especially with 
absence of Omani Renal registry. Thus, this research is the first epidemiological study 
conducted in Oman by an Omani researcher of this depth and size. The results of this study 
fill a gap in the knowledge about the treated RRT patients in Oman as the information on 
this subject was limited; it contributes to the knowledge of renal care in the Middle East or 
developing countries, as well, since Oman is part of these co-operations. This study 
communicated the evidence of the increasing prevalence of treated RRT patients in Oman 
through a scientific research using scientific methods and designs. The data generated by 
this research can contribute to forming an Oman renal registry because this current 
research provides quantitative data on Oman RRT population since its beginning in 1980 
and until 2015 and it also provides data on the characteristics of a cross-sectional sample 
on dialysis from the northern region of Oman. Otherwise if it is inconvenient for MOH to 
create Oman Renal registry now, then the Oman MOH can expand the statistics published 
on the annual MOH report to cover more vital statistics such as incidence and death 
figures.  
 
The results of this study showed how the Oman RRT services developed from having no 
renal care provided in the country to having developed and modern RRT services across 
the country and also it is a free of charge service. Accordingly, for how long Oman MOH 
can secure funds for this accelerating costly treatment, especially this study indicates that 
there is a need to increase the current number of RDCs or increasing the number of renal 
transplantations, which imply the need for further funding. Also, some of the main 
characteristics of the dialysis sub-population of the northern region of Oman revealed that 
most of these patients were illiterate and unemployed. The illiteracy is a challenge in 
improving the patients’ compliance with the treatment and therefore it might be helpful to 
introduce an electronic website or phone apps that contain audio visual materials to educate 
these patients and also people at risk about how to improve compliance or prevent chronic 
kidney diseases. 
 
215 
 
Furthermore, this research contributes to the knowledge such as that there are variations in 
the treated RRT patients across regions and districts of Oman and this indicates the need 
for further research to investigate the rational for these variations and so to provide the 
proper recommendations to overcome the deficiency. Also some more efforts are needed to 
improve the death register of this population to have more known reported reasons for the 
deaths in this population as the results from this research showed that many patients under 
RRT treatments died without known reason recorded. Also, this research can be considered 
as a base for future research to further explore and study kidney failure in Oman and its 
population as has been said, the publishing status is limited and also the past research 
published on renal care of Oman was of questionable quality. 
 
In summary, the major contributions of this study is producing an insight of the 
epidemiological variables of Oman RRT populations and having an understanding of the 
major characteristics of a representative sample of one region of Oman, this provided an 
understanding of the present public health strategies and gives a foundation for the 
development of future more effective public health strategies for this population. Though 
the epidemiological variables found by this study concluded that the prevalence and 
incidence of treated kidney failure in Oman is relatively low but yet the cost is still high 
and predicted to increase which grab the attention to adapt more effective public health 
planning particularly at the primary health level. The presentation of this study results 
helped to raise the awareness of both government and Oman MOH towards the substantial 
value of prevention, early detection as well as proper management of diabetes mellitus, 
hypertension and chronic kidney disease. The data presented in this study created a 
published base for Oman’s RRT population, which was not available in this depth and 
quality. This study signposts the research agenda, especially in Oman, to highlight this 
topic, enriches the present research knowledge with more updated data through conducting 
further up-to-date and high quality research studies. This later is very important take home 
message, all renal care personnel needs to work in collaboration to provide up-to-date 
information and also published data on this population to help giving deeper insights on the 
best strategies to improve this population care. 
 
12.2 Limitations of the study 
One of the common limitations of this research design is that it identifies only the 
participants known, for example, it includes the participants on disease registers and misses 
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people who have the disease but are not yet diagnosed or recorded in the register. This 
implies that the number of RRT treated patients reported by this research is under reported 
and so the actual numbers of kidney failure patients are most probably higher in Oman. In 
general, there are many reasons for under-reporting, for example, the register misses the 
patients who progress quickly to kidney failure and never visit the hospital for diagnosis or 
treatment; also, patients who never visit the national medical system and prefer to be 
diagnosed and treated in the private sector or treated overseas are most likely to be missed; 
also there are patients who are not followed up after diagnosis with kidney failure so their 
disease outcomes or the outcome is never known. 
 
Also relying on patient reported data could be one of this study's shortcomings, though this 
was resolved by counter checking the patient medical records. However, there are some 
items that relied mostly on patients reported data such as the risk factors existed prior the 
kidney failure; such as the causes of kidney failure and the impact of kidney failure on 
participants’ lives. The reliability of patients’ reported items of this study could be 
improved if adequate data were found in patient medical records. Well documentation of 
the patients’ medical history since the first visit to the medical agency is essential to 
integrate a comprehensive picture of patient medical stance. Also, it is of importance to 
connect all health agencies in a network that show all the patient medical data in a 
comprehensive profile, especially connecting the primary health institutions records with 
the other health institutions levels. Also, one of the RDCs was relying on paper-based 
records and therefore some of the hand-written documents were challenging to read. Also 
absence of reliable filling system in some of the RDCs led to more time consumptions 
when looking for some records. 
 
One important limitation was in the survey instrument by using a limited scale of yes or no 
to measure the QoL of dialysis patients which provided contradictory results to what were 
reported by most of studies measured the same variable. Focus groups or semi-structured 
interviews were possible alternatives to measure QoL but thought not applicable at this 
stage of this research. The reasons for not utilising any one of these strategies to measure 
QoL are presented in section 6.6.2 page 147. 
 
Another limitation was accessing the participant’sparticipants’ medical records with only 
verbal consent. Although the author ensured that the patients were fully informed it would 
have been more ethically appropriate if consent was obtained in writing.  
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Another limitation in general is that similar designs to this research are usually encounter 
some difficulties in inferring changes over time. This would be true for this study if the 
data was collected at one point of time and not over a period of time. However, this study 
attempted to overcome this limitation through gathering data over a year time (the 
prospective part was from October, 2014 until 31
st
 December 2015 and the retrospective 
from 1980-2013).  
 
12.3 Implications and recommendations for practice, 
service delivery and policy 
This research provided an initial understanding of epidemiological variations in the pattern 
of kidney failure in Oman. The results of this research emphasise the awareness of both the 
Oman government and the health care systems towards the substantial value of prevention, 
early detection as well as proper management of both chronic kidney disease and diabetes 
mellitus (hypertension as well) and to develop an active relationship (i.e. partnership) 
between all care levels, especially the primary care teams in health institutions and in the 
community, and people at risk of kidney failure. The data produced by this research has 
created a published database for Oman, which was not previously available to this degree. 
It can be used to guide the academic nursing, medical, and health-allied disciplines to 
highlight topics on kidney failure epidemiology with the latest available statistics for their 
students. This research contributed to the national and international research database, and 
provided the insight for further research projects based on this research.  
The author thinks that this research is considered timely as its conduction responds to the 
calls that the renal societies are sending across the globe toward increase the knowledge 
about kidney failure and chronic kidney disease populations across the world, especially 
the populations of developing countries including Oman.  
At all stages, policy-makers need to listen to the evidence provided by qualified research 
studies and try to modify the existing policies (i.e. public health care policies) to satisfy 
population needs and global trends. Specifically, the utilisation of research is supported by 
vision 2050 of Oman MOH (see Health sector in Oman); also the satisfaction of Omani 
citizens is an ultimate goal of the Oman top leadership. Therefore, it is believed that 
policy-makers will not reject the formation of a national renal registry. Renal registries 
have proven their practicality and usability across the world. The time has now come for 
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the MOH in Oman to upgrade the current kidney failure and RRT register to a renal 
registry. Creation of a renal registry needs funding, resources and a committed - quality 
data collection team. It needs people to value data as power and to take the belief that no 
health system can be upgraded or act efficiently unless they invest in research. This puts a 
responsibility on all the countries of the world including Oman to gather data about their 
kidney failure population and make it accessible and available as published material for the 
patients, the research society, and all concerned public in renal care. 
 
The world is now in a digital era, so it is of urgency to move from the phase of record-
keeper (paper-based) to publishers (e-form). Digitalisation of the government’s work in 
Oman is supported by the top leadership; a higher authority of technologies has already 
been formed in Oman (see Technological Status). This research suggests the development 
of a nationwide survey utilising the tools in this study, which needs further review and 
improvements, to gather information about incidence variables and other epidemiological 
variables of importance, from the time the patient is registered into the system as a chronic 
kidney disease patient and until the patient is deceased.  Renal care in Oman needs an e-
form portal (website) hosting all essential information relevant to the people at risk, 
patients and renal multi-professional teams to share knowledge and sustain professional 
networking about kidney failure problems.   For people who cannot access the website, a 
renal care campaign can reach them through TV advertisements and social media apps like 
texting, Whatsapp, Facebook and twitter. It is very important to educate and increase the 
awareness of the population who are at risk of chronic kidney disease or already have 
chronic kidney disease in early stages. The fight against chronic disease including chronic 
kidney disease, diabetes, and hypertension should be undertaken in partnership with all 
sections of the community, starting with the lay people and ending with the highest 
leadership in the country. All people in the community should value prevention, as it is the 
main approach that preserves health and saves lives and saves the economy as well.  
   
Some participants of this research raised concerns on the road distances they travel every 
week, especially patients coming from District 6. It was suggested that more satellite and 
nearby dialysis centres were needed to overcome this obstacle, and offer a better chance of 
treatment compliance for these patients. It is now time to initiate satellite haemodialysis 
centres, which are community based and closer to patients’ homes, and they are managed 
on a daily basis by renal nurses. The Oman’s MOH need to examine the feasibility of home 
haemodialysis, so it can be offered to patients if found feasible. Also, the Oman’s MOH 
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can offer transportation to their patients and this may be of practical support for some 
patients who do not have relatives to escort them. All these requirements by patients are 
linked to the economic capacity of the country and whether the government can increase 
the budget of Oman’s MOH, so the latter can spend more on improving the health services 
of renal sector. Other option is to shift more patients to use peritoneal dialysis treatment 
which is more cost-effective, and does not need travelling as it is conducted at home.  
 
The overall findings reported by most of the participants of the cross-sectional study in all 
RDCs of the northern region of Oman showed, for example, that 84.5% (n = 288) of the 
participants reported that dialysis treatment had not caused them stress or worry. However, 
this result does not mean to neglect the 15.5% who had worries and stress because of their 
dialysis treatment impact on their lives. This population might need social workers, who 
are not incorporated in the current renal multi-disciplinary team in Oman. Renal social 
workers should be made available for treated kidney failure patients especially the dialysis 
treatment cohort; they should be available for the patients to provide the social and 
psychological support the patient’s need. These workers can make the patients and their 
families more aware about all kinds of support offered to them by the Oman’s MOH and 
the government. Patients should find somebody to listen to their problems and complaints. 
The social workers can be the medium to inform the other renal professionals and renal 
policy makers about these patients’ needs. For example, many participants especially 
females were not comfortable to undertake their dialysis treatment in a big hall shared with 
males, which informs the MOH to make separated dialysis halls for each gender.                              
 
The Oman’s MOH made resources available for kidney transplantation when the program 
launched in 1988. It is possible to perform kidney transplantation in two major hospitals in 
Oman which are the Royal Hospital and the Sultan Qaboos University Hospital. And, since 
2005 the transplant co-ordination unit and the kidney donor clinic have been running 
smoothly.  Although more than half of the cross-sectional participants wanted to have 
kidney transplantation (50.7%), but could not find donors. Acceptance of the practice of 
organ donation needs to be built on within public attitudes to increase the organ donations 
and reduce the number of patients who might need to wait for years until they get a donor. 
Kidney transplantation figures need to be increased further in Oman and without increasing 
the figures of organ donation, this will be impossible to accomplish. What is needed is a 
campaign on a national and regional level to make people aware of the advantages and 
risks of organ donation, raising awareness of how it can save many lives. People need to 
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know that organ donation is a practice approved and supported by Islam. In addition, the 
experience of KSA in this perspective can be learnt as they have a website published in 
Arabic language and can be accessed by the public. The website provides significant 
information on kidney transplantation in KSA. It provided the opinion of Islam on kidney 
transplantation, which permits organ donation. It allows people to read and understand the 
policies of kidney transplantation and how they can register themselves as donors within 
the website itself (http://www.scot.gov.sa/). This makes the kidney donation offer 
accessible and available for Saudi people and the same can be done for Omanis as well. 
 
Finally, the time has arrived to re-activate the national preventive and screening program 
or initiate a dialogue with the public on all levels, governorates, districts, communities and 
schools, to increase their awareness on the best ways of modifying their lifestyles to fight 
kidney diseases. Furthermore, the demographic for this study showed that many patients 
were likely beyond school age, so strategies to reach this group and similar age groups in 
the wider community might be incorporated such as reaching them in the community 
though community-support group, making health education open days and invite them, and 
reach them through media and phone apps. 
 
 
12.4 Recommendations for future research 
The declaration of Helsinki 1964 set a number of principles for medical research. One of 
them was to emphasise the importance of ultimately involving human subjects in medical 
research to ensure medical research progress. Also, the declaration emphasises the 
importance of “understanding the causes, development and effects of diseases and 
improving preventive, diagnostic and therapeutic interventions (methods, procedures and 
treatments) so through these strategies, the patients care standards will ultimately improve. 
Also, the best proven interventions must be evaluated continually through research for their 
safety, effectiveness, efficiency, accessibility and quality”. 
 
In relation to what has been said, there are many aspects of kidney disease in Oman that 
have never been explored or are underexplored. Therefore, there is a space for further 
research in this field. First, studies on exploring causes of chronic kidney disease in Oman 
using, perhaps, the triangle of causation to see whether it is agent, environment or host 
which have caused kidney failure to increase in Oman; also how PESTLE or BEINGS 
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factors have impact on people at risk and how these factors can be modified to prevent 
kidney failure incidence. Also, the knowledge produced by this research highlights that 
diabetes is one of the significant causes of kidney failure in Oman as 47% of the RRT 
population of Oman in 2009 had diabetic nephropathy leading to kidney failure. Also 
USRDS (2015) reported that Oman ranked 8
th
 country out of the 57 participant countries of 
the registry, which had higher percentages of diabetes.  
 
Other studies could be conducted on how chronic kidney disease progresses among 
Omanis and how it affects the Omani population and who are the people who tend to 
progress to kidney failure faster and why that is. For example, ‘are Omani men more likely 
than Omani women to report kidney failure?’ or ‘do Omani men have worse complications 
and progress faster to death than Omani women following dialysis?’, since the evidence 
from this research says that the incidence of kidney failure is slightly higher among Omani 
males. Also the death event is higher among the male haemodialysis cohort compared to 
the female cohort. For example, there were 425 males died in the haemodialysis cohort 
compared to females (377 female) in 2001-2010. This information will help to examine the 
differences (RCT design could be used) in the progress towards death in between males 
and females and therefore develop further understandings to slow this progress and manage 
the predisposing factors better. 
 
This research revealed some geographical variations in the prevalence of treated kidney 
failure among the governorates of Oman. For example, the observational cohort study 
which reported the highest prevalence of dialysis sub-population was in the capital 
(71.3/100,000) in 2010, and then in 2015, the highest prevalence changed to be in the west 
end (99/100,000). So why these variations took place and if there were set of factors helped 
increasing the prevalence in some parts of Oman, how can these factors are reversed to 
decline the incidence and prevalence. Also, it was noticed that subdivision 2 had less 
prevalence of dialysis treatment and more educated population so are these two variables 
(i.e. prevalence and education) linked with positive or negative relationship and if, for 
example, the relationship was negative then this mean more education should be provided 
for the public because this will decrease the incidence and then later the prevalence of 
kidney failure in Oman.  Also there were some dips in dialysis treatment in the years 2003, 
2005 and 2006, which need to be explored if there were any justification behind this 
phenomenon and why there is a big difference between the prevalence in the Omani 
population when compared to the total population?  Is it because the high census of non-
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Omanis, which helped in changing the figures of treated kidney failure of Oman, if so then 
further studies needs to be done to confirm or reject this idea. Furthermore, it is 
recommended that the MOH distinguish the prevalence, when publishing these data, to 
specify whether individuals belong to the Omani or the total population and also if the 
dialysis figures are for haemodialysis only or both. The year 2009 showed, higher 
incidence of dialysis, and of diabetic nephropathy and higher death figures and so further 
exploration research on this area could be undertaken. 
 
Another study may be needed to evaluate the impact of the current screening program that 
Oman’s MOH is delivering at present. Future studies evaluating the present interventions 
and treatment for chronic kidney disease and kidney failure patients are needed, to evaluate 
their effectiveness, usefulness and safety and if they are the best proven interventions. 
Studies are needed to evaluate the patient on RRT’s quality of life, and satisfaction on 
treatments and care. Also it would be good to explore the effect (short term and long term 
effects) of less than three dialysis sessions on the Omani dialysis sub-population, as the 
cross-sectional study found that more than one third (37.5%) of the studied population 
were undertaking less than three dialysis sessions per a week. 
 
More epidemiological studies are needed to identify the specific determinants of the 
epidemiological changes found by this research. It is good to study different aspects of the 
dialysis sub-population especially infections, hospitalisation, survival, causes of death and 
others to develop further understanding of this population and thereafter recommend the 
best way to improve their care and their quality of life. Also, the paediatric population 
needs some research studies conducted on them, and also to explore the experience of their 
parents in dealing with a kidney failure child. The cost given by this study was for the 
direct costs for dialysis sessions, so it would be good to conduct future a study to explore 
and calculate the direct and the indirect expenses of dialysis and kidney transplantation in 
Oman. All this information will add to the body of knowledge and will help for better 
understanding of the real situation of treated kidney failure in Oman and also predict the 
future and modify health strategies and plans accordingly. 
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12.5 Summary 
 Local and national initiatives in Oman will face a hard job in fighting chronic kidney 
disease, because it is too difficult to change people’s unhealthy habits in a short time, 
however, it is worthwhile to undertake such initiatives. The people of Oman need a lot of 
assistance to make them aware about the healthier choices available for them. However, to 
change the kidney failure trajectory in Oman, the Oman’s MOH needs to work harder on 
all levels to address the increasing burden of risk factors leading to kidney failure such as 
diabetes, hypertension, and obesity. Also, the care of the Oman’s RRT population is 
complex and needs a multi-professional team to help this population optimise their quality 
of life. Nowadays, renal nurses are taking the lead in managing the dialysis patients’ care. 
Accordingly, renal nurses have to provide the dialysis support that patients need; allow 
patients to express their needs and help in satisfying them; renal nurses are the main 
advocates for this sub-population, so they have to encourage decision-making, care-
reviewing and share the latest best evidences of good care with the renal care multi-
professional team in order to achieve the best holistic care. Also, renal care remains a 
multi-disciplinary care and all health professionals involved need to contribute in 
improving these population health outcomes. 
 
Finally and to summarise, this research addresses the lack of research evidence on the 
epidemiology of kidney failure population of Oman. Accordingly, this research was 
conducted to communicate the evidence available on the epidemiology of treated kidney 
failure in Oman and the characteristics of a representative sub-population, which was the 
dialysis cohort of the northern region of Oman. The evidence presented by this research 
showed part of the picture and not yet the full picture on the status of kidney failure in 
Oman. Conducting the recommended research as outlined earlier will help to complete the 
picture of the kidney failure of Oman. The complete picture will provide the renal carers 
and renal care concerned with the necessary knowledge on strengths and weaknesses of 
existing health plans and of different treatments so they can alter existing plans and 
ultimately improve these population health outcomes. These improved population health 
outcomes (i.e. renal health outcomes) can be achieved if working on five pillars as this 
research concluded. First pillar is to work on national prevention programme to orient the 
population on the best health practices that can protect them from non-communicable 
disease such as diabetes. Second pillar is to activate the current detection and screening 
programme for NCDs, it should be packed with thorough documentation and referral 
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system. Third pillar is to design an education and awareness program to improve the public 
knowledge about organ donation. Fourth pillar is to initiate the Oman Renal Registry 
aiming to improve the volume and quality of renal data about Oman. Fifth pillar is to fund 
and guide the renal research to widening the knowledge base of renal disease about Oman. 
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Appendix F - Published articles on Oman's RRT 
population (1980-2013) 
 Title Authors & published 
in 
Date of 
publication 
Design 
1. Al-Nahda Hospital Milestones No nominated authors - 
Hospital Newsletter 
published in OMJ 
1984 R 
2. Health services in Oman: the past 15 years Al-Mughairy - Post 
graduate medical 
education committee -
Oman Newsletter 
1985 R 
3. Chronic kidney failure program March 
1983- July 1985 
Woods and Prabhakar 
– Post graduate 
medical education 
committee -  medical 
newsletter 
1985 OC 
4. High mortality among recipients of bought 
living-un-related donor kidneys 
Salahudeen and et al.- 
Lancet  
1990 OC 
5. Prevalence of antibodies to hepatitis C 
virus among Omani patients with kidney 
disease 
Al-Dhahry and et al. - 
Clinical Microbiology 
and Infection 
1993 CS 
6. Omani experience with a heterogeneous 
group of kidney transplant recipients over 
a 10-year period 
Aghanashinikar and et 
al.-Transplant 
Proceedings. 
1993 NA 
7. Hepatitis B, delta and HIV infections 
among Omani patients with kidney 
diseases: a seroprevalence study 
Al-Dhahry and et al. 
- Annals of Saudi 
Medicine.  
1994 CS 
8. Echocardiographic findings in ESRD on 
regular haemodialysis 
Marei and et al. - OMJ 1995 CS 
9. Left ventricular filling patterns in ESRD 
and the impact of haemodialysis 
Marei and et al. - OMJ 1995 CS 
10. Defective clonidine-induced growth 
hormone secretion and normal thyroid and 
kidney functions in prepubertal children 
with chronic kidney insufficiency (CRF) 
Soliman and et al. - 
Journal of tropical 
paediatrics  
1995 CS 
11. Pregnancy in kidney transplantation 
recipients: outcome and complications in 
44 pregnancies 
Al-Hassani and et al. - 
Transplant Proceedings 
1995 NA 
12. Kidney failure and transplantation activity 
in the Arab World. Arab Society of 
Nephrology and Kidney Transplantation 
Abomelha - 
Nephrology Dialysis 
Transplantation 
1996 CS 
13. Attitude to cadaveric organ donation in 
Oman: preliminary report 
Kehinde and et al. - 
Transplan proceedings  
1998 NA 
14. Renal replacement therapy in Sultanate of 
Oman 
Al-Marhuby - 
Saudi Journal of 
Kidney Disease 
transplant  
1998 R 
15. Malignant disease in patients with long-
term kidney transplants 
Saifudeen and et al.- 
OMJ 
1999 CR 
16. The first glycopeptides- intermediate 
Staphylococcus aureus in Oman  
Elhag and et al. - 
Clinical Microbiology 
and Infection 
2000 CR 
17. Current issues and problems of 
transplantation in the Middle East: the 
Shaheen and et al. 
- Transplantation 
2001 NA 
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Arabian Gulf Proceedings 
18. Living kidney donation for the mentally 
impaired. A case report 
Mohsin N. and et al. - 
Transplantation 
Proceedings 
2003 CR 
19.  Hypomagnesemia as a cause of severe 
cardiac arrhythmias in the immediate 
postoperative: a kidney transplant case 
report 
Mohsin N. and et al. - 
Transplantation 
Proceedings 
2003 NA 
20. Rapid resolution of mycophenolate 
associated diarrhoea with a small dose of 
octreotide: a case report 
Mohsin N. and et al. - 
Transplantation 
Proceedings 
2003 CR 
21. Complete reversal of an acute rejection 
treated for four months after resuming 
dialysis: a case report 
Mohsin N. and et al. - 
Transplantation 
Proceedings 
2003 CR 
22. WHO study (EMRO SPLT GRANT – 
TSA 03/23) –  Research proposal on 
“frequency of diagnosed  hypertension, 
proteinuria,  haematuria,  urinary tract 
infection impaired kidney function and 
their geographical distribution amongst 
different age group of individuals in 
Sultanate of Oman.” 
Principle, 
Al-Marhuby - 
Nephrology Services 
Oman, Ministry of 
Health, Muscat 
 
Booklet published by 
MOH on the national 
level 
2004 – 2005 
 
 
CS 
23. Low tacrolimus dose requirements in 
kidney transplant recipients in the Omani 
population: implications for 
pharmacogenetics? 
Mohsin N. and et al. - 
Transplantation 
Proceedings 
2005 OC 
24. High incidence of early post 
transplantation DM in Eastern population 
Mohsin N. and et al. - 
Transplantation 
Proceedings 
2005 OC 
25. Complete regression of visceral Karposie’s 
Sarcoma after conversion to sirolimus 
Moshin N. and et al. – 
Exp Clin Transplant 
2005 CR 
26. Incidence, prevalence and treatment of 
ESRD in the ME 
Abboud Omar - 
Ethnicity and Disease 
2006 RW 
27. Prevalence and predictors of  
microalbuminuria in patients with type 2 
DM: a cross-sectional observational study 
in Oman 
Al-Futaisi and et al. -  
Diabetes Research and 
Clinical practice  
2006 CS 
28. Donor Gender Balance in a living-related 
kidney transplantation program in Oman 
Mohsin and et al. 
Transplantation 
Proceedings 
2007 OC 
29. The Gulf Survey on anaemia management 
(GSAM 2005) 
Alsuwaida and  
Alwakeel - Saudi 
Journal of Kidney 
Disease transplant 
2007 CS 
30. Retinal injury as an early manifestation of 
post-transplant thrombotic 
mircoangiopathy: recovery with plasma 
exchanges and conversion to sirolimus: 
case report and review of literature 
Mohsin N. and et al. - 
Transplantation 
Proceedings  
2007  CR 
31. The history of Renal transplantation in the 
Arab World: a view from Saudi Arabia 
Al-Sayyari - American 
Journal of Kidney 
Diseases 
2008 RW 
32. Prophylaxis for opportunistic infections 
for kidney transplantation recipients at the 
Royal Hospital in Oman 
Al-Raisi and et al. - 
OMJ 
2009 OC 
33. Risk factors for CKD in Omani A-Nassry -  2009 HCBS 
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populations: a hospital based case-control 
study 
Medical Library -SQU 
34. Reasons of preclusion of living-related 
donor kidney transplants in Oman 
Mohsin and Metry - 
Journal of the Middle 
East Society for Organ 
Transplantation 
2010 OC 
35. Transplant kidney artery false aneurysm: 
case report and literature review 
Al-Wahaibi and  et al.- 
OMJ 
2010 CR 
36. Attitude of the Omani population toward 
organ transplantation 
Mohsin N and et al. - 
Transplant Proceedings 
2010 CS 
37. Diabetic nephropathy in the Arab World Farage and Al-Wakeel 
– Nephron Clinical 
Practice 
2011 RW 
38. Epidemiology and aetiology of dialysis-
treated ESRD in Libya 
Alashek and et al. - 
BMC Nephrology  
2012 CS 
39. Epidemiology of ESRD in the countries of 
the GCC: a systematic review 
Hassanien and et al. - J 
R Soc Med Sh Rep  
2012 SRW 
40. Prevalence and risk factors of DN in 
Omani Type 2 diabetics in Al-Dakhiliyah  
Alrawahi and et al. - 
OMJ  
2012 CS 
41. Nutritional assessment of Omani patients 
with diabetes and CKD: a case control 
study 
Waly and et al. - 
FASEB Journal 
2012 CS 
42. CKD in Arab World: a call for action Farag and et al. - 
Nephron - Clinical 
Practice.  
2013 RW 
43.  Paediatric versus adult kidney 
transplantation activity in Arab countries 
Saeed - Saudi Journal 
of Kidney Disease 
transplant 
2013 CS 
44. Fibro-polycystic disease of the liver and 
kidney in Oman 
Al-lawati - Arab 
Journal of 
Gastroenterology 
 
2013 OC 
R, report; RW, review; OC, observational cohort; CS, cross sectional; NA, either not available or 
not accessible; CR, case report; SRW, systematic review; HCBC, hospital case based case.  
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Appendix G - Field notes and general observations with 
discussion 
During data collection, some differences were noticed between the four locations of this 
study. RDC1 was the most organised and well-supplied dialysis centre. It was a very busy 
RDC but had nearly sufficient staff, an assigned dietician, an assigned pharmacist, and 
nearly sufficient nephrologists. However, this RDC was not prepared to deal with critical 
situations that members of the haemodialysis population may encounter at any moment. 
Most of the patients in this RDC were friendly and felt as if the RDC staff were part of 
their families. However, patients made some comments as follows: females requested 
separate halls apart from the males; patients asked to stop the night dialysis because they 
preferred to be at home at night, and also it is very difficult to find transportation at night; 
patients would prefer to have a spacious, separate dining room because at present they had 
to eat in the waiting areas, which was not comfortable. The staff asked for more staff to 
help in running the centre smoothly, and requested more training programmes to help the 
nephrology team deal with critical and emergency cases. 
RDC2 serve the population of subdivision 1 as well as RDC1, but RDC2 was the default 
RDC for subdivision 1, because it is built within the referral hospital of the governorate, 
and it is prepared to deal with any emergency that dialysis sub-population of subdivision 1 
may encounter. RDC2 was the smallest and the oldest dialysis centre of the four locations 
of this study. The patients and staff in this RDC asked to enlarge the RDC or even to shift 
it to another spacious place where they can have separate halls for males and females, and 
separate dining room and waiting area. RDC2 did not have a dietician or pharmacist for 
their patients. 
RDC3 was a very busy, old and small RDC. The corridors were full of boxes and resources 
because the RDC lacks sufficient space in which to store things. This RDC did not have 
sufficient staff; the patients were crowded in the main hall, and there was no separation of 
females from males. There was no dietician or pharmacist, and the nephrologists have long 
shifts. RDC3 had a completely paper-based documentation system where it was difficult to 
access all the details of the patients. 
RDC4 is located in a large referral hospital and should handle all critical cases, as RDC3 
cannot. However, this RDC was crowded and working on 24-hour shifts to accommodate 
the increasing number of patients assigned for dialysis. Genders were mixed in the halls. 
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The patients wished to have some flexibility in their timetable, but unfortunately the 
timetables were fixed, and very difficult to change. The patients reported that it was very 
difficult to access the dialysis centre directly in cases of emergency, and instead they have 
to go to the main emergency department of the hospital to go through all the routines there 
before being moved upstairs to the RDC for care. This prolongs their pains and suffering. 
Many patients reported that their kidney failure was because of their high blood pressure, 
which they either discovered very late or neglected to get treatment for. During dialysis 
sessions some patients would be sleeping, some keeping silent watch on others or looking 
at their mobile phones, and some were chatting with their fellow dialysis patients. There 
were no social workers to deal with these patients’ fears and negative thoughts, and the 
staff were busy with other duties of care. In Oman, the care of the psychological status of 
the patient is part of the staff nurses’ responsibilities unless there are social workers 
available to take over this duty. 
Some patients said that they were ignorant and did not know what haemodialysis meant: 
they simply thought it was the process of taking the kidney out of the body, washing it and 
returning it. These patients had not had anyone to explain to them at that stage what kidney 
failure is, what options were available for them, what the best options were for them, and 
what the best ways to receive the treatment were. 
A number of patients expressed their extreme sadness at witnessing some of their fellow 
dialysis patients passing away in front of their eyes, or sometimes hearing that a patient 
had had a road traffic accident and passed away on the way to or from dialysis sessions. 
As the kidney failure population - and especially the dialysis sub-population - are highly 
vulnerable, have a restrictive timetable, with less freedom to travel, and have a low quality 
of life in general, these patients need sustainable support to allow them to live happily. The 
patients’ requests during the data collection and field research are not impossible to 
achieve. First of all, all existing RDCs are not criticized here, and they were running and 
serving the needs of the kidney failure population reasonably well. However, satisfying the 
patients’ needs is always an aim to ensure. Therefore, RDCs should have a convenient 
infrastructure for these patients, such as separate renal dialysis centres, that are spacious, 
equipped with all facilities to handle these cases efficiently and safely, and with an 
independent emergency department for this population. These centres have to be spacious 
considering the Omani culture where patients of different genders feel more comfortable 
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when separated in different dialysis halls. These RDCs should be accessible for patients, 
and no patient should be allowed to travel a great distance for dialysis. Otherwise home 
dialysis training for the peritoneal dialysis should be initiated. Transportation might be 
provided for these patients, since they have pre-planned, frequent and known timetables for 
dialysis. Sufficient and trained staff should be provided, such as nephrologists, renal 
nurses, dieticians, pharmacists, machinery technicians, and social workers. The renal team 
should ensure that they run effective educational programmes for patients pre- and during 
dialysis or kidney transplantation. Timetables might be more flexible, and show care for 
patients’ circumstances where possible. 
 
 
o Haemodialysis dose, duration and timing 
 
In RDC1, the number of dialysis sessions per week was varied, but commonly limited to 
two or three sessions. Most of the participants (92.7%) were assigned three sessions per 
week and spent an average of 9-12 hours on a dialysis machine each week. More than half 
of the participants came for their dialysis session in the afternoon or evening; RDC1 is 
open 24 hours a day. Most of the participants (n = 104 = 84.6%) were happy with their 
dialysis session timings; the small number of participants who were not happy (n = 19 = 
15.4%) were those who were particularly attending night sessions (Figure  8-8). 
Most of the RDC2 participants (n = 37 = 84.1%) came for three sessions per week (at least 
nine hours of dialysis per week), and the remaining seven participants (15.9%) followed a 
pattern of two-session weeks (at least five hours of dialysis per week). Most of the RDC2 
participants had differing timings for dialysis, sometimes in the morning and other times in 
the afternoon. This RDC only opens for two shifts, from 7am-2pm and 2pm-9pm. The 
majority of the participants (n = 41 = 93.2%) were satisfied with their dialysis timetable 
(Figure  8-8). 
Most of the participants (n = 38 = 49.4%) in RDC3 attended three dialysis sessions per 
week and for a minimum of nine hours of dialysis weekly. This centre was open from 7am 
until 9pm, so participants attended a specific timetable whereby they should complete their 
dialysis before the closing time at 9pm. They might have had morning, afternoon or 
evening schedules, or even a combination. Most of the participants (n = 72 = 93.5%) were 
satisfied with their timetables and had no problems with them (Figure  8-8). 
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Most of the RDC4 participants (n = 70 = 72.2%) followed a dialysis timetable of two 
sessions per week, and a quarter of them (n = 24 = 24.7%) were on three sessions per 
week. Two participants (2.1%) said they had a mixed schedule of two or three sessions per 
week, and one participant (1%) said s/he was coming only once a week for dialysis. RDC4 
was open 24 hours, so only 23 participants (23.7%)  had morning dialysis sessions, and the 
remainder either had evening sessions (n = 40 = 41.2%) or a mixed timetable where they 
started the session in the morning but completed it during the afternoon. A few participants 
attended night sessions. Most of the participants (n = 79 = 81.4%) found their dialysis 
timetable fit with their lifestyle and were satisfied with it (Figure  8-8). 
 
